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Abstract  
 
Throughout the last century, medical imaging has come to revolutionise the way 
we diagnose disease, and is today an indispensable part of virtually any clinical 
practice. In cardiovascular care imaging is extensively utilised, and the development 
of novel techniques promises refined diagnostic abilities: ultrasound elastography 
allows for constitutive tissue assessment, 4D flow magnetic resonance imaging 
(MRI) enables full-field flow mapping, and micro-Computed Tomography (CT) 
permits high-resolution imaging at pre-clinical level. However, following the 
complex nature of cardiovascular disease, refined methods are still very much 
needed to accurately utilise these techniques and to effectively isolate disease 
developments. 
The aim of this thesis has been to develop such methods for refined cardiovascular 
image diagnostics. In total eight studies conducted over three separate focus areas 
have been included: four on vascular shear wave elastography (SWE), three on 
non-invasive cardiovascular relative pressure estimations, and one on tomographic 
reconstruction for pre-clinical imaging. 
In Study I-IV, the accuracy and feasibility of vascular SWE was evaluated, with 
particular focus on refined carotid plaque characterisation. With confined arterial 
or plaque tissue restricting acoustic wave propagation, analysis of group and phase 
velocity was performed with SWE output validated against reference mechanical 
testing and imaging. The results indicate that geometrical confinement has a 
significant impact on SWE accuracy, however that a combined group and phase 
velocity approach can be utilised to identify vulnerable carotid plaque lesions  
in-vivo.  
In Study V-VII, a non-invasive method for the interrogation of relative pressure 
from imaged cardiovascular flow was developed. Using the concept of virtual 
work-energy, the method was applied to accurately assess relative pressures 
throughout complex, turbulence-inducing, branching vasculatures. The method 
was also applied on a dilated cardiomyopathy cohort, indicating arterial 
hemodynamic changes in cardiac disease. 
Lastly, in Study VIII a method for multigrid image reconstruction of tomographic 
data was developed, utilising domain splitting and operator masking to accurately 
reconstruct high-resolution regions-of-interests at a fraction of the computational 
cost of conventional full-resolution methods. 
iii 
Together, the eight studies have incorporated a range of different imaging 
modalities, developed methods for both constitutive and hemodynamic 
cardiovascular assessment, and utilised refined pre-clinical imaging, all with the 
same purpose: to refine current state cardiovascular imaging and to improve our 
ability to non-invasively assess cardiovascular disease. With promising results 
reached, the studies lay the foundation for continued clinical investigations, 
advancing the presented methods and maturing their usage for an improved future 
cardiovascular care. 
 
Keywords: Medical imaging, Cardiovascular disease, Atherosclerosis, Hemodynamics, 
Ultrasound, Shear Wave Elastography (SWE), Magnetic Resonance Imaging (MRI), 4D flow 
MRI, Relative Pressure, Virtual Work-Energy, micro-Computed Tomography (micro-CT), 
Tomographic reconstruction, Pre-clinical imaging 
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Populärvetenskaplig sammanfattning 
 
Medicinsk avbildning utgör idag en central del av modern klinisk diagnostik, och 
bildgivande diagnostikverktyg har kommit att i grunden förändra sättet på vilket 
dagligt kliniskt arbete utförs. Medicinsk bildteknik används också i stor 
utsträckning inom hjärt-kärldiagnostik, och i takt med att nya tekniker utvecklas 
kan förfinad information inhämtas: ultraljudsbaserad elastografi möjliggör 
avbildning av vävnaders mekaniska egenskaper, fyrdimensionella 
blodflödesmönster kan kartläggas genom 4D flödes-magnetresonanstomografi 
(MRI), och mikro-Datortomografi (mikro-CT) möjliggör preklinisk avbildning i 
mikrometerupplösning. För att kunna dra nytta av dessa teknikers potential i ett 
kliniskt sammanhang behövs dock förfinade och validerade analysverktyg, särskilt 
med tanke på hjärt-kärlsjukdomars komplexa och multifaktoriella natur.  
Syftet med följande avhandling har varit att utveckla sådana metoder för förbättrad 
hjärt-kärlavbildning. Avhandlingen innehåller totalt åtta delarbeten fördelat över tre 
fokusområden: fyra inom vaskulär skjuvvågselastografi (SWE), tre inom icke-
invasiv tryckfallsmätning, och en inom pre-klinisk tomografisk bildrekonstruktion. 
I studie I-IV utvärderades vaskulär SWE, med särskilt fokus på teknikens potential 
för förfinad karaktärisering av karotisplack. I alla studier undersöktes SWE grupp- 
och fashastighet, med estimerade hastigheter och styvheter validerade mot 
mekanisk referensmätning eller kompletterande avbildning. Resultaten visar hur 
spatialt avgränsade kärl eller plack har en tydlig inverkan på SWE:s noggrannhet, 
men indikerar även hur rupturbenägna plack kan identifieras genom en 
kombination av grupp- och fashastighetsanalys. 
I studie V-VII utvecklades en ny metod för icke-invasiv tryckfallsmätning baserad 
uteslutande på uppmätt 4D-flödesdata. Genom en komplett flödesmekanisk 
beskrivning i kombination med ett virtuellt flödesfält kan exakta och robusta 
tryckfallsmätningar genomföras genom komplexa, turbulensinducerande, och 
kliniskt relevant kardiovaskulära strukturer. Metoden användes också för att 
analysera en klinisk kohort med dilaterad kardiomyopati, där tydliga förändringar i 
arteriellt blodtrycksbeteende detekterades. 
I studie VIII utvecklades en metod för multidimensionell bildrekonstruktion av 
tomografisk mikro-CT-data. Genom domän- och operatorseparering visar 
resultaten hur högupplöst rekonstruktion av en subdomän kan uppnås till en 
bråkdel av den totala tids- eller minnesåtgången som annars fordras för en 
fullupplöst bildrekonstruktion. 
v 
Tillsammans har de åtta delstudierna använt ett antal olika avbildningsmodaliteter, 
applicerat både vävnadsbaserat och hemodynamisk utvärdering av hjärt-
kärlsystemet, och slutligen inkluderat preklinisk avbildning, allt för att uppnå 
samma mål: att förbättra klinisk hjärt-kärlavbildning och ge en fördjupad förståelse 
av olika hjärt-kärlsjukdomars kliniska manifestation genom icke-invasiv avbildning. 
Avhandlingen utgör också grunden för fortsatta vetenskapliga studier, där de 
utvärderade metoderna kan komma att förfinas ytterligare som del av en mer 
omfattande klinisk implementering. 
 
Nyckelord: Medicinsk avbildning, Hjärt-kärlsjukdomar, Ateroskleros, Hemodynamik, 
Ultraljud, Skjuvvågselastografi (SWE), Magnetresonanstomografi (MRI), 4D flödes-MRI, 
Tryckfall, Virtuellt flöde, mikro-Datortomografi (mikro-CT), Tomografisk rekonstruktion, 
Preklinisk avbildning  
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Chapter 1 
 
Introduction 
 
Dear Sir or Madam, will you read my book? 
It took me years to write, will you take a look? 
Paperback writer (John Lennon & Paul McCartney), 1966 
 
There are many ways in which a thesis in biomedical engineering might begin, but 
with medical imaging being the primary focus of this work, appreciating images as 
a visual form of communication seems like a fitting start. 
Throughout the history of mankind, images have been used as an effective and 
direct way of conveying or transferring information. Prehistoric cave or rock 
paintings are today recognised as early forms of visual communication, and even 
though written communication has come to dominate following the invention of 
alphabetic languages, visual image-based data representation can be found 
throughout history. Hieroglyphic pictograms were used in ancient Egypt and 
Greece to communicate over cultural borders, breakthroughs in optical lens 
developments enabled planetary studies during the early Renaissance, and modern-
day understanding of imaging physics has allowed for the non-invasive assessment 
of complex biological phenomena. 
Studying scientific processes through image-based assessment, or using physical 
phenomena to generate image outputs have also been commonly employed 
throughout history. The Greek mathematician Euclid outlined fundamental optical 
physics in his work Optics around 300 BC [1], and in the early 1700s Isaac Newton 
expanded this knowledge with astounding scientific rigour in his work Opticks [2], 
in which he outlined the fundamentals of diffraction and polychromatic optical 
behaviour. Through the development of quantum mechanics in the early 1900s, 
and by understanding fundamental atomistic behaviour highly refined image-based 
tools are now available with electron microscopy providing sub-nm imaging [3], 
and with research-based image tools enabling real-time study of functional 
physiological processes [4]. 
The development of advanced imaging has also had a direct impact in the medical 
field, where imaging has come to revolutionise the way we diagnose, monitor, and 
1 
CHAPTER 1. INTRODUCTION 
treat patients. For cardiovascular disease – being the number one cause of death in 
the world today [5] – imaging is an indispensable part of clinical practice. 
Ultrasound imaging is routinely used to assess cardiovascular anatomy as well as to 
map intravascular flows or tissue motion [6]. X-ray fluoroscopy or Computed 
Tomography (CT) is commonly used to guide interventional cardiovascular 
procedures [7], and Magnetic Resonance Imaging (MRI) provides excellent soft 
tissue contrast, utilised to identify ischemic tissue changes or visualise complex 
congenital conditions [8]. Recent developments even promises novel imaging 
abilities: ultrasound elastography enables constitutive tissue evaluation [9], 4D flow 
MRI permits comprehensive assessment of vascular flows [10], and pre-clinical 
imaging renders acquisitions at µm resolution [11]. 
Evidently, there is no lack of data that can be generated. However this abundance 
of data requires careful consideration of the clinical impact of derived measures. In 
fact, refined tools and metrics are still very much needed to accurately and 
effectively make use of these novel developed imaging techniques, and it is only 
through careful, scientific studies that defined correlations between fundamental 
image behaviour and disease manifestation can be clarified. In this way, accurate, 
effective, and specific tools can be introduced into clinical practice, refining 
current-state clinical diagnostics and improving future health care through 
advanced imaging. 
This thesis entitled Non-invasive imaging for improved cardiovascular diagnostics – shear wave 
elastography, relative pressure estimation, and tomographic reconstruction aims at developing 
such technical tools for refined image-based clinical diagnostics. Studies on 
constitutive tissue behaviour, hemodynamic flow analysis, and pre-clinical imaging 
are combined to provide a comprehensive take on certain aspects of cardiovascular 
image diagnostics, advancing diagnostic measures in clinical areas where effective 
imaging tools are of particular importance: atherosclerotic plaque characterisation, 
hemodynamic flow assessment, and high-resolution pre-clinical tomographic 
reconstruction. 
The thesis consists of two parts. First, the research context is outlined within 
which all scientific studies have been performed. The research context is also 
presented together with a review of major methodological aspects, key results, 
main discussion points, and conclusions from all performed studies. Second, the 
main scientific contributions are given as a collection of appended papers and 
manuscripts, together with an outline of specific author contributions. 
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Chapter 2 
 
Aims 
 
The general aim of this thesis has been to refine current state cardiovascular image 
diagnostics, and to improve our ability to non-invasively assess cardiovascular 
disease. In addressing this aim, eight scientific studies have been performed and 
compiled to form this thesis. The specific aim of each respective study was: 
 
Study I To assess the accuracy of shear wave elastography (SWE) for 
vascular applications by evaluating the effect of confined geometry 
on shear modulus estimation in simplified geometries and arterial 
phantoms, comparing data to reference mechanical testing. 
Study II To assess the ability of SWE to differentiate atherosclerotic 
phantom plaques of different mechanical stiffness, quantifying 
output as a function of varying plaque geometry, acoustic radiation 
force push location, and imaging plane. 
Study III To evaluate the feasibility of using SWE on atherosclerotic plaque 
tissue by constructing an experimental ex-vivo setup with combined 
reference micro-CT. 
Study IV To evaluate the in-vivo performance of SWE for atherosclerotic 
carotid plaque characterisation by comparing output to reference 
MRI data in a defined patient cohort. 
Study V To develop, implement, and validate a non-invasive method for the 
estimation of relative pressure from acquired full-field velocity data, 
making specific use of the concept of virtual work-energy to enable 
arbitrary probing of relative pressures throughout any imaged 
vascular structure. 
Study VI To extend and evaluate the virtual work-energy method in Study V 
for incoherent, turbulence-driven flow fields. 
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Study VII To evaluate aortic hemodynamics in a cardiomyopathy cohort, 
specifically using non-invasive phase-contrast imaging to quantify 
changes in aortic relative pressure in patients with dilated 
cardiomyopathy. 
Study VIII To develop a method for multigrid tomographic reconstruction for 
pre-clinical micro-CT imaging, enabling reconstructions with 
multiple discretisation or regularisation domains at a fraction of the 
required full-resolution computational time or cost. 
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Chapter 3 
 
Background 
 
The following section outlines the basic concepts and scientific context in which 
this thesis has been performed. Following an initial review of fundamental 
cardiovascular physiology and disease development, details on cardiovascular 
image diagnostics are provided. Specifically, areas of particular relevance to the 
thesis (atherosclerotic plaque characterisation, refined image-based hemodynamic 
analysis, and pre-clinical imaging) are presented in detail. 
3.1. Cardiovascular physiology 
The cardiovascular system represents an integral part of the human body, being 
accountable for the circulation of blood. Through this circulation, the 
cardiovascular system is responsible for transporting oxygen, nutrients and 
hormones to, and waste products away from all cells of the body. The 
cardiovascular system also mediates the systemic transport of cells such as 
leukocytes or immune cells, recruited as a direct response to disease or injury. By 
so, the cardiovascular system plays a fundamental role in maintaining body 
homeostasis, controlling e.g. nutrient supply [12], temperature [13] and pH [14], 
and actively adapting and optimising response to different physiological and 
pathological states. 
Anatomically, the cardiovascular system consists of the heart and a fully connected 
vascular network of arteries and veins, permeating through all tissues of the body. 
Even though seen as two entities, the heart and the vasculature is working very 
much in parallel, forming a complex interplay of adaption and re-modelling in 
response to faced physiological or pathological condition. With the heart and 
vasculature transporting blood through the body, their interplay is also intuitively 
understandable as disruptions in e.g. the ejection of blood from the heart will 
directly affect and trigger a response from the downstream vasculature. Similarly, 
any blockage of vascular flow will instantly result in disrupted flow returning to the 
heart, and hence initiate cardiovascular system response. 
Despite this, to facilitate in the basic understanding of their fundamental 
physiology, the heart and the vasculature will here be presented in separate 
sections. However, connecting the two, subsequent sections on arterial-cardiac 
interaction and cardiovascular hemodynamics are also provided. Here basic 
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concepts on cardiovascular interaction, as well as the fundamental behaviour of 
blood, blood flow, and blood pressure are provided, depicting specifically how 
they cooperate in the cardiovascular system. 
3.1.1. Cardiac physiology 
 
a) Cardiac anatomy 
The heart, depicted in Figure 3.1(a), is the main muscular organ of the 
cardiovascular system, situated inside the thoracic cavity of all humans. Specifically 
positioned posteriorly and slightly to the left of the sternum, the heart resides 
inside the so called pericardium or pericardial sac. In short, the pericardium is a 
fibrous double-layer structure, connecting the heart to the neighbouring 
mediastinum as well as protecting and limiting the heart from excessive free 
motion. In fact, contrary to popular belief the pericardium or outermost shape and 
volume of the heart does not change significantly during cardiac pumping, but 
blood is rather ejected through piston-like displacement of the internal 
atrioventricular plane (AV-plane) [15]. To assist in this motion, the pericardium 
therefore acts as a lubricating layer, where intrapericardial fluid allows for a smooth 
and energy-optimised gliding of these internal structures against the pericardial sac. 
Inside the pericardium resides the myocardium or heart muscle, made up of four 
different compartments (two ventricles and two atria) typically sub-classified into 
two different sides (the right and the left heart). The right heart, consisting of the 
right atrium and right ventricle, is responsible for collecting deoxygenated blood 
entering from the inferior and superior vena cava, and subsequently ejecting this 
blood into the pulmonary circulation. Flowing through the pulmonary circulation, 
gas exchange of carbon dioxide (CO2) and inhaled oxygen (O2) is performed, re-
oxygenising blood that is later being directed through the pulmonary veins into the 
left atrium. In the left heart, re-oxygenised blood in the left atrium is then fed 
forward into the left ventricle, which acts as the main pump for the systemic 
circulation, or the circulation of blood through the rest of the body. 
With the right and left heart responsible for these two different circulation 
systems, the two sides also work against two different vascular resistances. In fact, 
under normal physiological conditions, the pulmonary circulation contains only 
around 1/10th of the total blood volume, and shows a vascular resistance of 
around 1/5th of that of the systemic circulation [16]. With flow 𝑄𝑄 and resistance R 
connected to the pressure gradient ΔP through 𝑄𝑄 = ∆𝑃𝑃𝑅𝑅 , (3.1) 
the left ventricle thus have to work against a pressure five times higher than that of 
the right ventricle in order to maintain equal flow over the two sides (a prerequisite 
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Figure 3.1: Illustration of the anatomy of the heart. (A) Depiction of all four heart chambers, as well 
as the major connecting arteries and veins. (B) Depiction of the intracardiac valves, visualised as an 
AV-plane cut through the heart. Modified with permission from Smart Servier Medical Art. 
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for maintained homeostasis). Consequently and following this increased 
mechanical load on the left side, the left ventricle is significantly thicker than the 
right one, and also requires more blood from the coronary arteries with two of the 
three main coronary arteries perfusing the left ventricle [12]. 
Keeping each heart chamber separated are the four intracardiac valves: the 
tricuspid valve, the pulmonary valve, the mitral valve, and the aortic valve, all 
depicted in Figure 3.1(b) cutting through the AV-plane of the heart. As seen, the 
tricuspid and mitral valve separates right and left atrium and ventricle, respectively, 
whereas the pulmonary and aortic valve is traversed after ejection from each 
respective ventricle. In principal, the opening and closing of each valve is a purely 
passive process, governed exclusively by the pressure differences between each 
cardiac chamber. Albeit passive, the valves do direct the flow in a unidirectional 
manner, optimising the efficiency of blood flow through the heart. 
In addition to the passive valve cusps, the two atrioventricular valves are also 
attached to intraventricular papillary muscles, connecting the valves to the 
intraventricular endocardium, and making sure that the tricuspid and mitral valves 
stay shut during ventricular ejection. With such, the closed valves prevent blood to 
flow in a reverse back-flow direction. 
Coupling to the basic anatomy of heart, it is important to underline that the heart 
is developed specifically to optimise the flow of blood, with the heart efficiently 
working against the physiological pressures of the pulmonary and thoracic aorta. In 
fact, the wrapping of the right heart around the larger left ventricle, or the half-
ellipsoidal shape of the ventricles have been proposed to optimise blood flow, 
through so called cardiac looping [17] or asymmetric redirection of blood flow 
[18]. With the valve cusps protruding into the ventricles, shear-layer formation 
creating vortex-like structures in the ventricles have similarly been suggested to 
play a fundamental role in the energy-efficient direction of blood through the heart 
[19]. On the same lines, the varying orientation of muscle fibres in the myocardium 
(undergoing a 180-degree directional shift from endocardium to epicardium [20]), 
as well as the principle direction of intraventricular pressure gradients [21-23] have 
also been proposed to streamline the ejection of blood from the heart. All this 
highlights the fact that the anatomy of the heart is in direct connection to the 
hemodynamic flow of blood through it. 
b) The cardiac cycle 
The cardiac cycle describes the interchanging phases of filling and ejection of the 
different heart chambers over time. The cardiac cycle can in principle be divided 
into two main phases: systole and diastole. During systole, the ventricles contract 
and eject blood through the pulmonary and aortic valves out into the pulmonary 
and systemic circulation. Conversely, during diastole the ventricles relax and are 
instead filled with blood coming from the two atria. 
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Figure 3.2: Wigger’s diagram depicting pressures and left ventricular volume over approximately two 
cardiac cycles. Additionally, a corresponding ECG-recording with identified P, Q, R, S, and T-
segments are marked. Modified with permission from Wikimedia commons.  
To aid in the understanding of the cardiac cycle, a so called Wigger’s diagram is 
depicted in Figure 3.2. Importantly, the diagram shows how the interchanging 
phases of contraction and relaxation (or ejection and filling) can be directly related 
to the intraatrial, intraventricular, and intraaortic pressures. 
Even though strictly initiated by a period of atrial contraction, we choose to 
describe the cardiac cycle from the onset of systole. The systolic phase is initiated 
at the peak of the R-wave, which triggers ventricular contraction, pulling the 
atrioventricular plane towards the apex, and consequently generating a rapid 
increase in intraventricular pressure. As soon as the pressure in the ventricle 
exceeds that of the atrium, the atrioventricular valve closes. Before the 
intraventricular pressure reaches that of the ascending aorta, there is therefore a 
short phase in which all heart valves are closed. This phase is typically described as 
the isovolumetric contraction (IVC); a phase of increasing intraventricular pressure 
without any detectable change in intraventricular volume (the phase is however not 
strictly isometric as studies have shown interchangeable myocardial fibre 
shortening and lengthening during the IVC-phase [24, 25]). 
With increasing contraction, the intraventricular pressure increases and at a certain 
point exceeds that of the aorta. As soon as this happens, the intraventricular blood 
will push open the aortic (or, in the right heart, pulmonary) valve, and initiate a 
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phase of so called rapid ejection. For a short period of time, the intraventricular 
pressure exceeds that of the aorta, whereas in the later reduced ejection phase, the 
opposite is true. At the late stages of systolic ejection, the aortic and pulmonary 
valves however still remain open following the forward-flowing momentum of the 
ejected blood [26]. 
With the ventricles now going from contraction to relaxation, the inertia of the 
ejected blood decreasing, and the intraventricular pressures similarly going down, 
the aortic and pulmonary valves close shut. Again, a phase of isovolumetric change 
is initiated, however this time in the form of isovolumetric relaxation (IVR). This 
represents the end of ventricular systole, and the start of diastole. 
As soon as the intraventricular pressure goes below that in the atria, the mitral and 
tricuspid valves open, allowing blood to flow from the atria into the ventricles. 
With the intraventricular pressure below the atrial pressure during this early rapid 
filling phase, the induced pressure gradient causes a distinct suction of blood from 
atria into the ventricles [27, 28], sometimes depicted as the E-wave of the diastolic 
phase. 
With the pressure gradient causing blood to flow from atria to ventricles, the 
pressure differences quickly evens out between the respective compartments, and a 
subsequent slow filling phase called diastasis starts [29]. 
Once the entire myocardium is relaxed, the onset of a new cardiac cycle is initiated 
through atrial contraction, during which a small increase in atrial pressure and 
subsequent ventricular volume can be detected. This late filling during diastole 
(caused by atrial systole) is sometimes depicted the A-wave of the diastolic phase. 
The continuous contraction and relaxation of the myocardium is controlled by an 
electrical conduction system. Continuous polarisation and depolarisation of 
myocytes (governed by the continuous change of cell membrane permeability 
towards ionic substances) creates so called excitation-contraction coupling, where 
electrical excitation generates muscular contraction. Starting by a depolarising of 
the sinus node (situated at the top end of the right atrium), a cardiac cycle is 
initiated by this electrical pulse spreading to the atrioventricular node (inside the 
top part of the intraventricular septum), with a subsequent splitting of this pulse 
into both left and right bundle branches (depolarising both right and left 
ventricles). This sequence of depolarisation and returning repolarisation is typically 
depicted in an electrocardiogram, shown at the lower end of the Wigger’s diagram 
in Figure 3.2. In short, the cardiac cycle in an electrocardiogram is initiated by the 
P-wave, representing the depolarisation of the atria starting at the sinus node, 
initiating atrial contraction. Following this, the QRS-complex completes the spread 
of ventricular depolarisation, the ST-segment represents the time during which the 
ventricles are depolarised, and the T-wave represents the final repolarisation of the 
ventricles; all happening during the systolic phase. With an electrocardiogram 
(ECG) easily measured non-invasively using the technique of electrocardiography, 
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analysis of electrocardiogram abnormalities is a very common first-line diagnostic 
procedure for incoming cardiac patients. 
3.1.2. Vascular physiology 
 
a) Vascular anatomy 
The vasculature is the overall name of the complex network of arteries and veins, 
originating from the heart and distributing blood to capillary beds throughout the 
body. In general, the vasculature can be classified into an arterial and a venous side, 
with arteries transporting oxygenated blood away from the left ventricle and veins 
transporting deoxygenated blood back to the right atrium. Note that a slight 
exception to this classification is present in the pulmonary circulation where the 
pulmonary arteries transport deoxygenated blood away from the right ventricle (to 
be re-oxygenised in the pulmonary capillaries), and the pulmonary veins transport 
this re-oxygenised blood back to the left atrium. 
On both the arterial and venous side the vasculature consists of a branched vessel 
systems, depicted in Figure 3.3. On the arterial side, all blood ejected from the left 
ventricle enters the ascending aorta, which then branches off into smaller arteries 
transporting blood throughout the body: the carotid arteries directing blood to the 
cerebral vasculature, the subclavian arteries carrying blood to both arms, the 
abdominal aorta directing blood caudally, itself branching off into renal arteries, 
femoral iliac arteries, etc. Importantly, at the very beginning of the ascending aorta 
and right behind the aortic valve cusps, two small coronary arteries (the left and 
right coronary artery) also branch off to perfuse the myocardium itself. 
Once transported through the main arteries, the vasculature bifurcates further into 
smaller arterioles and finally capillaries, where the main exchange of nutrients and 
waste products are performed between the transported blood and the apparent cell 
tissue. 
After exiting the capillaries, the blood now enters the venous side of the 
vasculature, which to some extent can be seen as the mirrored, collecting system, 
to the branching and distributing arterial side. On the venous side, the capillaries 
fuse into venules, which then collect further and form larger veins. As a final stage 
on the venous side, the large inferior and superior vena cava collects all returning 
deoxygenised blood, directing it back into the right atrium where yet another 
cardiac cycle can be initiated. 
The fundamental layer structures of vascular tissue will be described in-detail in the 
upcoming section, but it is worth mentioning that the structural properties of the 
vasculature are optimised for an efficient transportation of blood. The role of the 
arteries is to transport and transfer the transiently pumped blood from the heart, 
into a continuously flowing stream of blood in the more peripheral capillaries. 
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Figure 3.3: Illustration of the anatomy of the vasculature, including both the arterial (red) and 
venous (blue) side. Modified with permission from Wikimedia commons. 
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Specifically, this is achieved by the mainly elastic and distensible properties of the 
arteries, where part of the initial systolic pulse is stored as potential energy in the 
distended arteries. During diastole, the elastic recoil of the arteries revert this 
potential energy into kinetic energy, maintaining a forward-flowing blood stream, 
making sure that there is a continuous supply of blood flow in the peripheral 
capillaries. 
Note that in addition to the elastic component described above, arteries do show a 
defined viscous constitutive component as well [30], albeit not as pronounced as 
its elastic counterpart [31, 32]. 
b) Vascular tissue structure 
In principle, all vascular tissue in the body has the same structural layout. In short, 
three distinctive layers can be identified: the intima (tunica intima), the media 
(tunica media), and the adventitia (tunica adventitia or tunica externa), depicted in 
Figure 3.4. 
The intima represents the lumen-facing innermost layer of the vessel, with its 
primary function related to cellular signalling and transport between blood stream 
and internal tissue [33]. The intima consists of a thin layer of endothelial cells, 
shown to have a significant influence on the initiation and development of vascular 
disease following its regulation of vascular tone and inflammatory response 
mechanisms [34]. However, the intima does not markedly influence the structural 
integrity of the vessel wall due to its limited thickness and lack of structural 
components [35]. 
The media is the middle layer of the vessel wall. In contrast to the intima, the 
media has a defined structural component, with the layer made up of a complex 
network of smooth muscle cells (SMCs), elastin and collagen fibres. In fact, sub-
medial layers (so called medial lamellar units (MLU) [36]) have been identified, 
with the orientation of collagen fibres in each MLU directly affecting the 
distribution of mechanical stress in the vascular wall [37, 38]. By such, the medial 
layer is identified as the mechanically most significant layer of the vessel wall [35], 
at least during the strain levels typically faced under normal physiological 
conditions. 
The outermost layer of the vessel wall is the adventitia, mainly made up of bundles 
of collagen fibres in larger so called fibrils (themselves intertwined in a helical 
arrangement [39]). With its high collagen content, the adventitia acts as an outer 
protective mechanical layer, attaching the vessel to surrounding tissue and giving 
mechanical support at high intraluminal load, preventing vascular overstretch [35]. 
As mentioned, these three layers are in principle present throughout the 
vasculature, however differing in distribution and size throughout the body. 
Specifically, the cellular content and structural components within each layer of the 
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Figure 3.4: The structure of the vascular wall, showing its three main layers: tunica intima, tunica 
media, and tunica adventitia. Also, a diagram of tissue composition throughout the vasculature is 
given, illustrating differences in tissue structure. Modified and reproduced with permission [39, 40]. 
vessel wall vary distinctly based on the functional property of the given 
vasculature. As shown in Figure 3.4, the larger arteries and veins all have a 
relatively high degree of elastic tissue, together with reinforcing fibrous tissue and 
SMC content [40] in order to maintain the important distensible properties of the 
tissue, whilst still giving support for the forward-flowing blood. Notice also how 
the arterial side has a distinctly thicker vascular wall compared to the venous side, 
following the higher absolute blood pressures on the arterial side. 
Conversely, in the more peripheral arterioles, capillaries, and venules, the elastic 
content of the vascular wall is significantly smaller, with the capillaries consisting 
almost exclusively of the thin intima endothelial layer [41]. This is all possible 
following the slow and continuous flow of blood in these peripheral parts of the 
vasculature. 
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3.1.3. Arterial-cardiac interaction 
As described, the heart and the vasculature interact in a closed loop system, 
working in parallel to provide adequate blood flow throughout the pulmonary and 
systemic circulation. By so, cardiac alterations will result in vascular reactions, and 
vice versa – a concept often referred to as arterial-cardiac interaction or 
ventricular-vascular coupling [42, 43]. 
Two important concepts worth mentioning with regards to arterial-cardiac 
interaction are the pressure-volume diagram, and remodelling following vascular 
stiffening. 
The pressure-volume diagram is a commonly deployed metric used to describe the 
relation between ventricular volume and pressure throughout the cardiac cycle, as 
depicted schematically in Figure 3.5. In principle, the pressure-volume loop 
connects the constitutive relation between pressure and volume at ventricular 
relaxation (the end-diastolic pressure-volume relation (EDPVR)) and the 
constitutive relation between pressure and volume at full ventricular contraction 
(the end-systolic pressure-volume relation (ESPVR)). 
During diastole, the ventricles are filled and increase in volume from the end 
systolic volume (ESV) to the end diastolic volume (EDV), with the pressure-
volume relation converging towards the EDPVR. At the point of EDV, the mitral 
valve closes, and the IVC is represented by the build-up in pressure without 
change in ventricular volume, as seen by the vertical rise in the pressure-volume 
diagram at EDV. Once the aortic valve opens, the curve loops back all the way to 
the ESPVR, reached just as the aortic valve closes. The cardiac cycle is then 
finalised and the pressure-volume diagram is closed once the IVR is completed. 
Importantly, this type of diagram depicts the relation between cardiac pressure and 
volume, and how increasing ventricular volumes will be resisted by an increasing 
work-load or counter-acting pressure. The diagrams can also help in the intuitive 
understanding of how myocardial constitutive behaviour affects cardiac efficiency, 
where myocardial stiffening (increasing slopes of EDPVR and ESPVR) will result 
in increased filling resistance. Similarly, the pressure-volume diagrams entail 
information on arterial influence, where the so called effective arterial elastance 
(Ea, connecting ESPVR and EDVR in Figure 3.5) will shift the pressure-volume 
relation as a function of peripheral resistance, preload, afterload, and heartrate, to 
name only a few [44-46]. 
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Figure 3.5: Example of a normal pressure-volume loop (left), showing the relation between left 
ventricular pressure and volume which connects the end-systolic pressure volume relation (ESPVR) 
with the end-diastolic volume relation (EDPVR). Note the rapid changes in volume at the end 
systolic volume (ESV) and end diastolic volume (EDV), respectively, as well as the effective arterial 
elastance (Ea). The slope of Ea will also be related to several factors (right) such as total peripheral 
resistance (TPR), heart rate (HR), or preload. Modified and reproduced with permission [47]. 
3.1.4. Cardiovascular hemodynamics 
As described in the previous few sections, the central role of the cardiovascular 
system is to transport blood throughout the entire body, maintaining systemic 
homeostasis. For this reason, disruptions in the natural flow of blood are often 
directly related to the onset of cardiovascular disease [48-51]. Similarly, it is by the 
unifying flow of blood that the heart and vasculature can interact and adapt to 
different physiological states [52, 53]. For this reason, a short review of the basics 
of cardiovascular hemodynamics is essential when reviewing cardiovascular 
function, and is here provided as a final and unifying component of cardiovascular 
physiology. 
 
Figure 3.6: Schematic single pipe flow, used to describe Bernoulli’s principle. Modified with permission 
from Wikimedia commons. 
16 
3.1. CARDIOVASCULAR PHYSIOLOGY 
a) Governing physical principles 
From a fluid mechanical perspective, blood can be described in identical fashion to 
that of any given viscous fluid. By so, blood also follows the fundamental laws of 
fluid mechanics, described briefly in this section. Importantly, these theoretical 
descriptions provide a direct coupling between blood flow and blood pressure, and 
describe how these two interact at any given spatial or temporal point. 
Even though strictly governed by the complete Navier-Stokes equations (explained 
in subsequent paragraphs), it is worth starting from a simpler description of flow. 
The Bernoulli equation is such a simplified formulation, stating that for an inviscid 
non-conductive fluid the sum of kinetic and gravitational potential energy is 
constant [54, 55]. If assessing a system such as the one depicted in Figure 3.6, this 
states that 12 𝑣𝑣12 + 𝑝𝑝1𝜌𝜌 + 𝑔𝑔ℎ1 = 12 𝑣𝑣22 + 𝑝𝑝2𝜌𝜌 + 𝑔𝑔ℎ2, (3.2) 
with 𝑣𝑣 the velocity, 𝑝𝑝 the pressure, 𝜌𝜌 the density, 𝑔𝑔 the gravitational acceleration, 
and ℎ the height above a given reference plane. Index 1 and 2 refers to arbitrary 
positions along the vessel as shown in Figure 3.6. Assuming negligible gravitational 
effects (as commonly done in clinical practice [56, 57]), and re-ordering Equation 
3.2, we reach a direct relation between velocity and pressure where 𝑝𝑝2 − 𝑝𝑝1 = 12 𝜌𝜌(𝑣𝑣12 − 𝑣𝑣22). (3.3) 
In other words, a decrease in velocity will be reflected by an increase in pressure. 
Or: at any vascular narrowing where the cross-sectional decrease will lead to an 
increase in velocity (due to the conservation of mass), we will experience a 
decrease in pressure. Such changes in relative pressure is therefore a typical metric 
for assessing vascular coarctation narrowing [58, 59], valve stenosis [60, 61], etc. 
The Bernoulli equation is however only strictly valid for an inviscid non-
conductive fluid. Additionally, the Bernoulli equation originates from a steady-state 
system, meaning that any transient inertial effects will not be taken into account. In 
the greater vessels of the vasculature, where we have a continuous pulsatile flow of 
blood, this is clearly not the case. 
Expanding into an inviscid, non-conductive case however allowing for transient 
changes, Euler’s momentum equation states that 𝜕𝜕𝒗𝒗𝜕𝜕𝜕𝜕 + 𝒗𝒗 ∙ ∇𝒗𝒗 = − 1𝜌𝜌 ∇𝑝𝑝 + 𝒈𝒈, (3.4) 
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with 𝒗𝒗 denoting the 3D velocity vector. Reformulating Equation 3.4 into a 1D 
problem and re-organising terms, we get an expression for the infinitesimal 
pressure difference as 𝜕𝜕𝑝𝑝𝜕𝜕𝜕𝜕 = −𝜌𝜌 �𝜕𝜕𝑣𝑣𝜕𝜕𝜕𝜕 + 𝑣𝑣 𝜕𝜕𝑣𝑣𝜕𝜕𝜕𝜕 + 𝑔𝑔 𝜕𝜕ℎ𝜕𝜕𝜕𝜕�. (3.5) 
Again ℎ depicts the height above the reference plane in Figure 3.6, whereas 𝜕𝜕 and 𝑑𝑑𝜕𝜕 is a streamline and infinitesimal streamline step from 1 to 2, respectively. 
Integrating along 𝜕𝜕 and neglecting again all gravitational effects, we end up with the 
so called Unsteady Bernoulli equation [62], for which 𝑝𝑝2 − 𝑝𝑝1 = 𝜌𝜌 �12 (𝑣𝑣12 − 𝑣𝑣22) − � 𝜕𝜕𝑣𝑣𝜕𝜕𝜕𝜕𝑠𝑠 𝑑𝑑𝜕𝜕�. (3.6) 
As seen, Equation 3.6 is very similar to Equation 3.3, however now including the 
transient kinetic component of the velocity along 𝜕𝜕. 
For a complete description of 3D blood flow we however resort to the Navier-
Stokes equations, describing the conservation of mass and momentum for any 
incompressible fluid. Specifically, the Navier-Stokes equations state that for an 
isothermal, incompressible, Newtonian, viscous fluid the following holds 𝜌𝜌 𝜕𝜕𝒗𝒗𝜕𝜕𝜕𝜕 + 𝜌𝜌𝒗𝒗 ⋅ ∇𝒗𝒗 − 𝜇𝜇𝛻𝛻2𝒗𝒗 +  𝛻𝛻𝑝𝑝 = 0 (3.7) ∇ ⋅ 𝒗𝒗 = 0, (3.8) 
with 𝜇𝜇 depicting the dynamic viscosity of the fluid. Importantly, the different 
terms in Equation 3.7 represents different fluid mechanical components of the 
flow. Specifically, the first and second term represent the kinetic and advective (or 
convective) inertia terms, describing the temporal and spatial flow resistance. The 
third term involves the viscous resistance, originating from the viscosity of the 
fluid, and lastly, the fourth term involves the spatial gradient of the pressure field. 
In addition to this, Equation 3.8 states the conservation of mass or divergence-free 
requirement, valid for any incompressible fluid. 
Again, the fluid mechanical description gives us a direct connection between 
pressure and velocity, this time at any given 3D spatiotemporal point. However, 
non-linear terms and second order derivatives complicates accurate computation, 
and these full-form description are therefore rarely used in clinical practice [60, 61]. 
However, their incorporation may improve the accuracy of prediction [63-65], 
which will be a main topic of discussion in this thesis. 
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b) Turbulence 
In the healthy human cardiovascular system, blood flows in a relatively stable way 
and transition into so called turbulent flow regimes are seldom encountered [66]. 
However following pathological disturbances, increasing vascular constriction and 
flow complexity may result in the development of these turbulent flow regimes 
[67-69]. 
Just as for laminar flows, the kinetic and advective inertia, viscous resistance, and 
pressure distribution can be described by the Navier-Stokes equations. However, 
for turbulent flows, stochastic and chaotic flow fluctuations will disturb the 
analytical assessment of the given flow field, introducing turbulence-driven 
variations in the evaluated terms. 
A fully analytical description of turbulence is still not reached, in part because of 
the stochastic nature of turbulence [70, 71]. In laminar blood flow, the movement 
of blood is roughly assumed to repeat itself over consecutive cardiac cycles. On the 
contrary, even though turbulent regimes can be identified in given vascular 
structures, the specific flow behaviour at a given spatial positon will not be 
analytically repetitive. Instead, we will experience chaotic, stochastic fluctuations 
within these turbulent regimes. For that reason, we may treat turbulence in a 
statistical rather than analytical way. 
Instead of assessing blood flow at a specific time point, we instead choose to 
observe the velocity field 𝒗𝒗 over 𝑛𝑛 number of cardiac cycles with period 𝑇𝑇 . By so 
we can define a linear expected value operator 𝐸𝐸 (commonly used in probability 
theory [72]) collecting data over all cycles such that 𝐸𝐸[𝑣𝑣(𝜕𝜕)] = 1𝑛𝑛�𝑣𝑣(𝜕𝜕 + 𝑘𝑘𝑇𝑇 ).𝑛𝑛𝑘𝑘=1  (3.9) 
Applying 𝐸𝐸 to our Navier-Stokes equations in 3.7-3.8, we get 𝜌𝜌 𝜕𝜕𝐸𝐸[𝒗𝒗]𝜕𝜕𝜕𝜕 + 𝜌𝜌∇ ∙ 𝐸𝐸[𝒗𝒗𝒗𝒗] − 𝜇𝜇𝛻𝛻2𝐸𝐸[𝒗𝒗] +  𝛻𝛻𝐸𝐸[𝑝𝑝] = 0 (3.10) ∇ ∙ 𝐸𝐸[𝒗𝒗] = 0. (3.11) 
Further, by setting 𝑽𝑽 = 𝐸𝐸[𝒗𝒗] and 𝑃𝑃 = 𝐸𝐸[𝑝𝑝] to be the mean of our observed 
velocity and pressure field, we can expand Equations 3.10 and 3.11 into 𝜌𝜌 𝜕𝜕𝑽𝑽𝜕𝜕𝜕𝜕 + 𝜌𝜌∇ ∙ 𝐸𝐸[𝒗𝒗𝒗𝒗] − 𝜇𝜇𝛻𝛻2𝑽𝑽 +  𝛻𝛻𝑃𝑃 = 0 (3.12) ∇ ∙ 𝑽𝑽 = 0. (3.13) 
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Lastly, it can be shown that 𝐸𝐸[𝒗𝒗𝒗𝒗] = 𝐸𝐸[𝒗𝒗]𝐸𝐸[𝒗𝒗] + Cov[𝒗𝒗, 𝒗𝒗] = 𝑽𝑽𝑽𝑽 + Cov[𝒗𝒗, 𝒗𝒗]. 
Here, Cov[𝒗𝒗, 𝒗𝒗] is the so called covariance matrix, describing the product of 
deviations in velocity from their expected mean value 𝑽𝑽 . Using this in 
Equations 3.12-3.13 renders a final modification to the Navier-Stokes equations 𝜌𝜌 𝜕𝜕𝑽𝑽𝜕𝜕𝜕𝜕 + 𝜌𝜌∇ ∙ (𝑽𝑽𝑽𝑽 ) + 𝜌𝜌∇ ∙ Cov[𝒗𝒗, 𝒗𝒗] − 𝜇𝜇𝛻𝛻2𝑽𝑽 +  𝛻𝛻𝑃𝑃 = 0 (3.14) ∇ ∙ 𝑽𝑽 = 0, (3.15) 
where specifically the term 𝜌𝜌∇ ∙ Cov[𝒗𝒗, 𝒗𝒗] numerically handles flow deviations, 
typically arising from turbulent flows. 
In summary, turbulence-driven stochastic flow fluctuations can thus be 
incorporated numerically into the analytical Navier-Stokes equations. From a 
practical point of view, this would be achieved by not only assessing the mean 
velocity and pressure field, but by including measures of covariance or deviation 
within an assessed flow field. As an example of how such incoherent velocity 
fluctuations might appear, Figure 3.7 depicts the flow in a stenotic flow 
phantom, where typical stochastic variations can be seen in velocity, together 
with an increase in flow deviations post-stenosis [73]. 
 
Figure 3.7: Illustration of incoherent flow fluctuations after a stenosis, presented for data from a  
stenotic flow phantoms: (top) phantom geometry and velocity field, with flow going from left to 
right, (middle) velocity standard deviations along the pipe length, and (bottom) velocity fluctuations 
over time post-stenosis. Modified and reproduced with permission [73]. 
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c) Blood flow 
Blood flow is a term typically used to refer to the motion of blood, or rather the 
velocity of blood in the cardiovascular system (a measure of distance travelled per 
unit time). With blood being continuously ejected from the heart, and with the 
anatomy of the vasculature changing throughout the body, blood flow will vary 
distinctly throughout the cardiovascular system. Inside the heart, peak velocities 
are typically encountered when blood is passed from atrium to ventricle during the 
early diastolic filling, with healthy peak intracardiac velocities of around 1.5 m/s 
[74]. The intracardiac movement of blood is itself a very complex process, where 
rotational spinning [18], vortex formation [75], and optimised redirection of blood 
towards ejection [76], seem to be common ventricular features. 
Once ejected from the heart, slightly higher velocities can be seen across the 
pulmonary and aortic valves, however these quickly decrease as the blood travels 
towards more peripheral vessels. In fact, in the microcirculation significantly lower 
velocities of only a few mm/s are observed [77], before velocities are increased in 
the venous return. 
The assessment of blood flow has become an instrumental part of routine clinical 
care. Blood flow over the intracardiac valves are part of echocardiography standard 
practice [6, 8] to evaluate valvular stenosis [61] or regurgitation [78], where 
guidelines are directly referring to velocity values in classifying disease stage [6, 61, 
78]. Additionally, the development of full-field techniques such as 4D flow MRI, 
has opened up for expanded flow-based cardiovascular analysis, evaluating the 4D 
distribution of flow [10, 76, 79], vortices [19, 75], kinetic energy [80] and 
turbulence [81, 82], to mention only a few. 
To quantify blood flow and describe cardiac function, a few standard metrics are 
commonly deployed. A few of these are: 
i. End Diastolic Volume (EDV): Total amount of ventricular blood at the 
end of diastole. Typically around 140 mL in the healthy left ventricle [83].  
ii. End Systolic Volume (ESV): Total amount of ventricular blood at the end 
of systole. Typically around 50 mL in the healthy left ventricle [83]. 
iii. Ejection Fraction (EF): The ratio of ESV/EDV, representing the fraction 
of blood being ejected from the ventricle. Typically around 55-70% [83]. 
iv. Stroke Volume (SV): The volume of blood being ejected in one heartbeat 
(EDV – ESV). Typically around 95 mL [83]. 
v. Cardiac Output (CO): The volume of blood being ejected per unit time, 
generally given by SV times the patient heartrate. Typically around  
4 L/min at rest [84].  
All terms above by default refer to the left ventricle, but right ventricular values 
(given by an ‘RV’ prefix) can also be identically reported. 
21 
CHAPTER 3. BACKGROUND 
d) Blood pressure 
Pressure is defined as force per unit area. For the cardiovascular system, this can 
be translated into that blood pressure is the pressure exerted by the blood onto the 
vascular wall. 
A typical blood pressure curve recorded at two different points in the thoracic 
aorta is provided in Figure 3.8, showing the peak in systolic pressure, followed by a 
dropped diastolic pressure. The dicrotic notch typically appears following the 
closure of the aortic valve, hence representing the end of systole. 
However, as described briefly in previous sections, blood pressure changes 
throughout the cardiovascular system partially follow the functional roles of the 
different parts of the vasculature. At the aortic outlet when the blood is ejected 
from the left ventricle, typical blood pressures values of 120/80 mmHg 
(systolic/diastolic) are reported [85]. However, following pathological changes, 
hypertensive or hypotensive states can significantly alter the range of both systolic 
and diastolic blood pressures seen in patients [86, 87]. 
With the ejected blood, a blood pressure pulse starts travelling through the 
cardiovascular system, changing its appearance and absolute values as showcased 
in Figure 3.8. The pressure wave gets distorted as it travels through the vasculature, 
and specifically, the systolic pressure peak increases and narrows in extension as we 
travel away from the heart. There are multiple reason to this change, but it 
originates in part from the narrowing of the arterioles, the changing velocity of the 
travelling pulse wave, the bifurcations and tortuous geometry of the vasculature, as 
well as from biomechanical properties of the vessel wall [40, 66, 88]. 
The increase in pressure pulse diminishes as the blood travels into the arterioles, 
where a distinct increase in vascular cross-section dampens both velocity and 
pressure. Again this is to enable nutrient exchange in the microcirculation [77]. 
As the pressure pulse changes throughout the vasculature, the assessment of 
relative pressure or pressure difference is common in clinical practice, reflecting 
this change in the travelling pressure pulse. Quite simply, the relative pressure 
denotes the difference in pressure between two given points. Figure 3.8 shows the 
absolute pressure recorded at the ascending and descending aorta, together with a 
subtraction of the two rendering the relative pressure between ascending and 
descending aorta. 
With the pressure pulse varying with arterial properties, and similarly with pressure 
magnitude changing with changing cross-section (as described theoretically at the 
beginning of Section 3.1.4.), assessment of relative pressure can act as a valuable 
tool in assessing cardiovascular function. The metric is used as a recommended 
guideline metric for valvular stenosis and aortic coarctation [59, 61, 78], and have 
similarly shown value in assessing intracardiac pressure drops in patients with 
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hypertrophic cardiomyopathy [89, 90]. Similarly, the assessment of novel metrics 
such as so called hemodynamic forces [22, 91] have been related to evaluated 
pressure gradients, underlining the use of relative pressure. 
A last note is that, confusingly, relative pressure nomenclature differs in literature, 
and different terms have interchangeably been used clinically. Typically we use the 
term pressure drop to denote the difference in pressure between two given 
positions. This is identical to the relative pressure. The pressure gradient is 
however the pressure drop over length between the same two positions. 
 
Figure 3.8: Example of catheterised pressure measurements in the ascending (A) and descending (B) 
aorta, showing absolute pressure traces, as well as a derived relative pressure (A-B). 
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e) Hemodynamic cardiovascular interaction 
Summing up the basics of cardiovascular hemodynamics, it is important to 
remember that blood flow and blood pressure do not reside as separate entities. 
Instead, the two are tightly connected to one another, with velocity changes 
causing direct pressure response, and vice versa. However, as the relation between 
the two is non-linear, the derivation of one from the other is not a simple task, and 
external factors such as vessel geometry and time scale will influence both flow and 
pressure. 
That flow and pressure interact in the cardiovascular system is however clear. The 
velocity increase over stenotic regions is directly connected to the pressure drop 
over the same stenosis [61]. Valvular regurgitation (backflow) will conversely affect 
the pressure build-up in the preceding heart chamber [78]. Along the same lines, 
hypertensive aortic pressures will increase cardiac afterload, requiring higher 
intraventricular systolic pressures and consequently a more forceful intraventricular 
flow [92]. If not, a decrease in EF will be present, initiating a complex chain of 
cardiac remodelling mechanisms, further altering hemodynamic behaviour [52]. To 
this, the hemodynamic interaction between flow and pressure will have a joint 
impact on the constitutive remodelling of vascular tissue, where e.g. vascular 
stiffening will have a direct influence on the travelling pressure wave. Further 
details on specific cardiovascular disease and its hemodynamic alteration are 
provided in Section 3.2. 
3.2. Cardiovascular disease 
Cardiovascular disease (CVD) is the leading cause of death in the world today, 
responsible for approximately 31% of all deaths worldwide [5], being a major 
health concern in all regions of the world [93]. Within the umbrella term of CVD, 
a majority of all deaths are accounted for by either ischemic heart disease (mainly 
myocardial infarction due to blockage of coronary arteries, ~38-46% of all CVD) 
or cerebrovascular disease (mainly cerebrovascular stroke, ~34-37% of all CVD) 
[5]. 
Following its immense societal impact, extensive research and development efforts 
have been invested in understanding the development, manifestation, diagnosis, 
and prevention of CVD. This includes the development of novel and refined 
pharmaceuticals, genetic identification of CVD-related risk alleles [94], refinement 
of non-invasive image-based diagnostic tools, as well as the identification of 
primary and secondary prevention techniques, where life-style related factors such 
as smoking, obesity, and diet all have shown to have a direct influence on CVD-
development [95-97]. 
In the following, a condensed summary of the most common CVD types is 
presented. In particular, emphasis will be given on the development of 
atherosclerotic plaque (a key component in both myocardial and cerebrovascular 
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disease) as well as the relation between disrupted hemodynamics and CVD 
development in a few selected disease types. The following review is divided into a 
cardiac and a vascular subsection. 
3.2.1. Cardiac disease 
Cardiac disease or heart disease are disease types affecting the myocardium or 
other intracardiac structures. By so, heart disease is directly related to a disrupted 
ability to pump blood out into the vasculature, manifested either through systolic 
or diastolic dysfunction. Below follows a short review of some of the most 
common cardiac diseases, including definitions, primary diagnostics, as well as 
details on disease-specific hemodynamic alterations. 
a) Ischemic heart disease 
Ischemic heart disease is characterised by a restricted or impaired blood supply of 
the myocardium, caused by a complete or partial blockage of one or several 
sections of the coronary arteries (also referred to as coronary artery disease). This 
is itself typically caused by the build-up of intraluminal atherosclerotic plaque, 
where a complete coronary blockage from plaque rupture, plaque erosion, or 
complete plaque build-up lead to acute myocardial ischemia (for a detailed review 
on the process of atherosclerotic plaque development, see Section 3.2.2.). 
Depending on the degree of coronary blockage, the ischemic event can be either 
transient or persistent, where in the latter case risk for permanent myocardial 
damage is imminent. If such myocardial necrosis occurs, the disease is referred to 
as a myocardial infarction [98] (or heart attack), where a regional section of the 
myocardium is permanently impaired. 
Regarding diagnosis, ischemic heart disease is initially assessed through the 
manifestation of stable or unstable angina. With such, ECG monitoring is the 
recommended method of establishing the presence of myocardial infarction [99], 
where regional complete myocardial damage (i.e. including both subendocardial 
and subepicardial damage) is characterised by a typical ST-elevation. When more 
subtle myocardial damage is observed, there might be cases where no ST-elevation 
is observed, and instead further referring to coronary angiography or angiogram 
might be performed [100]. In both cases however, assessed coronary blockage 
might be treated by re-opening of the damaged vessel through so called coronary 
stenting, performed through a percutaneous coronary intervention (PCI). 
With ischemic heart disease directly affecting the myocardium, it also has a direct 
impact on the pumping mechanisms and hemodynamic abilities of the heart. 
Specifically, a blockage in coronary flow will increase coronary resistance, and 
consequently require increased cardiac work-load following a potentially slightly 
increased afterload (which itself may lead to further remodelling through cardiac 
hypertrophy, hypertension, etc.) [101]. Additionally, an infarcted myocardial area 
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will similarly affect intracardiac hemodynamics. Image-based studies have shown 
that patients with myocardial infarction have altered intraventricular diastolic 
vortex formation [102] as well as valvular net flow [103], and that some of these 
flow metric might even differentiate patient groups from one another [104]. 
Similarly, alterations in the main direction of the intraventricular pressure gradient 
(referred to as the hemodynamic force) has shown to correlate to left ventricular 
dyssynchrony [22], potentially resulting from regional myocardial damage. Along 
the same lines, it has been shown how patients with an ST-elevated myocardial 
infarction manifest elevated right- and left-sided filling pressures [105], working as 
a compensatory mechanism to maintain cardiac output in patients with this 
impaired pumping mechanism.   
Apart from the intracardiac hemodynamic changes described above, coronary 
stenosis or coronary blockage will also directly impair the hemodynamics inside the 
coronary arteries. As previously described, the narrowing of a stenotic coronary 
vessel will be characterised by a drop in intracoronary pressure where such can be 
clinically assessed by either indirect stenosis degree assessment [106, 107], or direct 
invasive pressure evaluation during PCI [108]. Note however that with the 
restricted dimensions of the coronaries, the observed pressure drops and related 
coronary blood velocities are typically fairly low, and related down-stream 
turbulence is consequently low or even negligible in such low-flow regimes. 
b) Cardiomyopathies 
Cardiomyopathies refer to diseases directly affecting the myocardium. 
Cardiomyopathies cover a heterogeneous group of diseases, with mixed definitions 
occurring in literature [109, 110]. Traditionally, a sub-classification into dilated, 
hypertrophic, and restrictive cardiomyopathies is however performed, and will for 
simplicity be used below.  
i) Dilated cardiomyopathy 
Dilated cardiomyopathy (DCM) is a cardiac disease characterised by dilation and 
impaired contraction of one or two of the ventricles, typically occurring in the 
absence of abnormal loading conditions (from e.g. valvular disease or 
hypertension) [109]. The degree of dilation varies, but in severe cases a doubling of 
the ventricular dimension has been clinically reported [111] (importantly however 
is that the degree of dilation is not a univocal predictor for patient outcome [112]). 
The underlying cause for the dilation is not clearly defined, but is rather a 
multifactorial combination of genetic, infectious, inflammatory, and metabolic 
factors [113]. 
In DCM, the dilation develops gradually, and with the increasing ventricular size 
DCM patients typically observe increasing systolic dysfunction (following from 
increasing ventricular volumes and decreasing EF), which at an advanced stage 
may induce heart failure [114]. 
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Regarding diagnosis, DCM is manifested through fatigue and shortness of breath, 
and can non-invasively be assessed through standard echocardiography, where 
specifically longitudinal monitoring can uncover the degree of increasing dilation. 
For more refined measurements of ventricular geometry, cardiovascular MRI can 
be performed [115], as can endocardial biopsy reveal specific etiological factors 
[116]. With the dilation generally seen as an irreversible process, treatment is 
typically introduced to suppress underlying disease factors (through e.g. anti-
inflammatory agents) or to reduce the loading of the heart by implantable assist 
devices [117]. 
The myocardial changes associated with DCM will directly affect cardiac function 
and cardiovascular hemodynamics. The increase in ventricular size alone will 
increase both EDV and ESV, and consequently intraventricular pressures will 
decrease unless the heart increases the exercised load. This decrease in 
intraventricular pressure typically decreases the heart’s ability to eject blood into 
the vasculature [118]. To further compensate for this, an even more pronounced 
dilation may develop, progressing the patient into a more severe DCM state. 
Apart from the intraventricular pressures, DCM ventricular dilation will also 
reduce intraventricular blood flow velocities, as well as increase the residence time 
and amount of blood residing inside the ventricles over several cardiac cycles [119]. 
With such, the dilation constitutes to an increasing risk for intraventricular thrombi 
formation and subsequent systemic embolisation [120]. 
ii) Hypertrophic cardiomyopathy 
Hypertrophic cardiomyopathy (HCM) is a disease where a section of the heart 
(generally including the intraventricular septum) becomes abnormally enlarged. 
The thickening of the myocardium will cause a protrusion into the intraventricular 
cavity, and often decrease ventricular stroke volume unless a simultaneous dilation 
is induced (a combination of HCM and DCM is in fact not uncommon [109]). 
HCM is typically regarded as an inherited cardiomyopathy [109], even though 
myocardial thickening may also be induced by chronically increased pre- or 
afterload [121]. 
For diagnosis, HCM is as other cardiomyopathies typically assessed by non-
invasive imaging; first-line through echocardiography but more advanced stages 
can be evaluated using cardiovascular MRI [90]. With its defined heredity, genetic 
testing is also part of recommended guidelines [122] even though such techniques 
are not routinely available in daily clinical practice. For treatment, common cardiac 
pharmacological agents (beta blockers, calcium channel blockers, etc.) are typically 
used, whereas any other invasive procedure such as surgical removal of part of the 
protruding myocardium is only done in more advanced or non-compliant cases 
[90, 122]. 
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Hemodynamically, HCM is dominantly manifested through diastolic dysfunction 
[123]. In particular, HCM is associated with increased diastolic filling pressure 
following the reduced intraventricular cavity, as well as a reduced diastolic 
relaxation due to the decrease in ventricular compliance and the remaining systolic 
contraction load from the obstructed ventricular outflow tract [124]. Generally, 
HCM typically increases intraventricular pressures and the obstructing myocardial 
mass has even shown to induce the development of distinct systolic 
intraventricular pressure gradients [90]. In severe cases of HCM, the 
intraventricular septal thickening will even cause an obstruction of the left 
ventricular outflow tract, representing a major problem for the ejection of blood 
into the vasculature [125]. In such cases, changes in intraventricular and valvular 
pressure drops are observed, and the outflow tract obstruction is in guidelines even 
defined by the magnitude of this induced pressure drop [122]. Along the same 
lines, the stenotic narrowing of the outflow tract has been associated with 
increased post-stenotic turbulence production [126], however the exact clinical 
implications and impact of such is still to be determined. 
iii) Restrictive cardiomyopathy 
Restrictive cardiomyopathy is a more rare form of heart disease, where 
pathological myocardial stiffening is observed without any noticeable hypertrophy. 
This stiffening will cause an increase in EDPVR and hence complicate diastolic 
filling (decreasing EDV). Apart from that, ventricular size is generally preserved, 
however the stiffened myocardium typically renders an atrial dilation as a response 
to the noncompliant ventricles [127]. 
As with the other cardiomyopathies, ECG monitoring and echocardiographic 
imaging are first-line evaluation techniques, even though restrictive 
cardiomyopathy might be difficult to diagnose following the apparent normal 
ventricular shape. Tissue Doppler or cardiac MRI offers more refined tools for 
quantifying restrictive cardiomyopathy [90]. 
Hemodynamically, the increased myocardial stiffening typically manifests itself 
through diastolic dysfunction, even though varying degrees of systolic dysfunction 
has also been reported especially in more advanced staged of restrictive 
cardiomyopathy [128, 129]. The reduced diastolic filling of restrictive 
cardiomyopathy subjects typically leads to a pattern of increased early diastolic 
filling velocities, but a sharp decrease in late diastolic flow [128]. With progression, 
the disease may lead to compensatory dilation or hypertrophy, which at more 
advanced stages may result in acute heart failure [130]. 
c) Valvular disease 
A very common form of heart disease is so called valvular disease, where abnormal 
changes of one or several of the intracardiac valves affect blood flow and cardiac 
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efficiency. In the following, a short description of the two most common types, 
valvular stenosis and valvular regurgitation, will be presented. 
Valvular stenosis refers to an abnormal narrowing of a valve opening, typically 
caused by atherosclerotic formation on the valve leaflets [131], congenitally valve 
malformation [132], or as a result of rheumatic heart disease [133]. In all cases the 
narrowing of the valve causes an increase in inflow velocity, and consequently an 
increased pressure drop. For this reason, echocardiographic flow assessment or 
invasive pressure measurements are typically recommended in characterising the 
severity of a diagnosed stenosis [134]. In fact, in advanced stages of valvular 
stenosis such as severe aortic stenosis, aortic outflow velocities of above 3-4 m/s 
may lead to post-stenotic turbulence and irreversible pressure drops [81, 135], 
where the degree of such could correlate to disease staging. 
In valvular regurgitation (or valvular insufficiency) the valve does not close shut 
after its open phase, resulting in abnormal back-flow or leakage through the valve. 
There are several causes initiating valvular regurgitation, where so called valvular 
prolapse (collapse of a valvular leaflet) [136] or myxomatous valve degeneration 
(deterioration of valve tissue) [137] are the most common identified ones. With the 
back-flowing valve leakage, regurgitation shifts the pressure differences between 
cardiac chambers and disrupts the isolvolumetric phases. For the left ventricle, this 
means that mitral regurgitation (leakage from left ventricle to left atrium) increases 
preload, whilst at the same time decreases afterload. Together this will result in a 
slight decrease in forward-flowing aortic ejection, as part of the SV is now used to 
push blood backwards through the mitral valve. Conversely, in aortic regurgitation 
(leakage from aortic outlet to left ventricle), an increased SV is ejected into the left 
ventricular outflow tract to compensate for the back-flow. By so, the ascending 
aorta will be abnormally extended, increasing systolic blood pressure, and 
subsequently decreasing diastolic blood pressure (likened to the effect introduced 
by arterial stiffening) [138]. 
As with valvular stenosis, valvular regurgitation is typically examined using 
echocardiography, but other imaging techniques such as computed tomography 
(CT) or cardiac MRI are mentioned in current guidelines [78]. 
In both valvular stenosis and valvular regurgitation, the impairment in flow 
through the heart impacts exerted pressure and resulting volumes. As a 
consequence pathological remodelling mechanisms of hypertrophy, dilation, or 
even hypertension may occur, transferring the patient into a long-term worse 
cardiac state with the risk for future acute heart failure [78, 130]. 
3.2.2. Vascular disease 
Vascular disease are disease types affecting the vascular part of the cardiovascular 
system and, as with all CVD, directly affects and disrupts the systemic transport of 
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blood. Below follows a short review of some of the most common vascular 
diseases, with specific focus on the development of atherosclerotic plaque. 
a) Atherosclerosis 
Atherosclerosis is a systemic, inflammatory disease, characterised by the build-up 
of intraluminal plaques, protruding into the luminal cavity. As the plaque 
development progresses, increased regional stenosis and risk for subsequent plaque 
rupture poses a major health risk, where thrombus formation or complete vascular 
blockage as a result from a ruptured or eroded plaque often lead to life-threatening 
complications. 
The development of atherosclerotic plaques is a complex and heterogeneous 
process, and several different plaque types have been identified [139, 140] with a 
range of different risk-factors deemed influential in the establishment of the 
disease [141, 142]. However, some general stages have been identified in the 
development of the disease, as outlined below. A summarising illustration is also 
provided in Figure 3.9. 
i) Atherosclerosis typically initiates from systemic endothelial 
dysfunction [139]. Specifically, the intima endothelium loses its ability 
to properly regulate vascular tone and permeability [143], and instead 
triggers localised inflammation (a wide range of both modifiable and 
non-modifiable risk factors have been identified in triggering 
endothelial dysfunction, such as e.g. high blood cholesterol levels 
[144], hypertension [145], diabetes [146], diet [95], and smoking habits 
[96]). 
ii) The endothelial dysfunction renders an upregulation of vascular 
permeability of lipoproteins, leading to the initiation of an atheroma 
beneath the endothelial layer. This is typically formed by neutrophils 
and monocytes, who in a subsequent step recruit circulating blood 
cholesterol (low-density lipoproteins, LDL) into the wall. Once inside 
the wall, oxidised LDL (oxLDL) crystals form so called fatty streaks 
in-between the intima and media layer – a typical hallmark of early-
stage atherosclerosis. 
iii) With oxLDL crystals trapped inside the vessel wall, macrophages start 
to encompass them forming larger so called foam cells, representing 
the core of the developed plaque [147]. 
iv) The process in iii) continues with the plaque increasingly protruding 
into the intraluminal space. At this stage, smooth muscle cells from 
the media migrate to the intima, producing extracellular matrix 
molecules and encapsulating the plaque core with a so called collagen- 
rich fibrous cap [148]. Inefficient clearance of dead cells inside the 
atheroma might form a lipid-rich necrotic core of the plaque [139], 
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Figure 3.9: (A) Development stages of atherosclerosis from initiation to rupture, depicting important 
progression steps, as well as acting plaque constituents (residual lipoproteins (RLP), low-density 
lipoprotein (LDL), oxidised-LDL (ox-LDL) and C-reactive protein (CRP)). (B) A few identified 
vulnerable plaque types. Reproduced with permission [141, 149]. 
and atheroma macrophage activation might also promote calcium 
deposition within this necrotic core, forming so called 
microcalcifications [150]. 
v) At this stage, the atherosclerotic plaque might develop in many 
different ways, and the distribution and formation of fibrous cap, 
necrotic core, and calcifications in iv) varies greatly between different 
plaques. The further progression of the plaque is thus highly 
heterogeneous, but using very crude classification one might 
differentiate between a stable plaque, where an inactive core is covered 
by a relatively thick layer of fibrous tissue, and an unstable or vulnerable 
plaque, where a highly active and proliferating core is covered by a 
thin fibrous cap (so called thin-cap fibroatheroma, TCFA) [151, 152]. 
vi) Both stable and unstable plaques protrude into the intraluminal cavity, 
but whilst stable plaques do not develop much beyond v), the thin 
fibrous cap of the unstable vulnerable plaques are prone to rupture as 
a consequence of increasing internal load [152] or upon collagen 
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degeneration [153]. At plaque rupture, thrombogenic factors from the 
plaque interior attracts platelets in the blood stream, forming a 
thrombus coagulant that severely disrupts or even fully blocks the 
downstream blood flow. 
Following the established development process, classifications have been proposed 
in staging atherosclerotic plaque development. A commonly deployed classification 
score comes from the America Heart Association (AHA), with a conventional (for 
histopathological analysis) and a modified classification (for image-based MRI 
analysis), both depicted in Table 3.1 [140]. 
Table 3.1: Conventional and modified AHA classification of atherosclerotic plaque 
Regarding clinical symptoms of atherosclerosis, the increasing protrusion of the 
plaque will obstruct the flow of blood, giving rise to e.g. angina pectoris, fatigue, or 
vascular claudication. If ruptured or eroded, more severe thrombotic events might 
lead to local ischemia or acute emboli formation such as myocardial infarction or 
stroke, each with its associated clinical indicators. However, a defined complication 
of atherosclerosis is that patients might be asymptomatic up until relatively 
Conventional AHA Classification Modified AHA Classification 
Type I: Initial lesion with foam 
cells 
Type I-II: Near-normal wall 
thickness, no 
calcification 
Type II: Fatty streak with multiple 
foam cell layers 
  
Type III: Preatheroma with 
extracellular lipid pools 
Type III: Diffuse intimal 
thickening or small 
eccentric plaque with no 
calcification 
Type IV: Atheroma with a 
confluent extracellular 
lipid core 
Type IV-V: Plaque with a lipid or 
necrotic core surrounded 
by fibrous tissue with 
possible calcification 
Type V: Fibroatheroma   
Type VI: Complex plaque with 
possible surface defect, 
haemorrhage, or 
thrombus 
Type VI: Complex plaque with 
possible surface defect, 
haemorrhage, or 
thrombus 
Type VII: Calcified plaque Type VII: Calcified plaque 
Type VIII: Fibrotic plaque without 
lipid core 
Type VIII: Fibrotic plaque without 
lipid core and with 
possible small 
calcifications 
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advanced development stages [141]. High-risk patients will be assigned preventive 
lipid-lowering, antiplatelet therapy [144], and non-invasive imaging has been 
proposed as a monitoring tool for the progression of atherosclerosis [8, 100]. Once 
symptomatic, guidelines still however very much rely on evaluating the degree of 
stenosis, where a stenotic protrusion of above 60-75% generally leads to invasive 
endarterectomy (surgical removal of the atherosclerotic plaque) [106]. Other 
invasive procedures also include vascular stenting or bypass surgery [154], to 
relieve the effect of the developed plaque. 
As evident above, the key clinical question in atherosclerosis lies in so called plaque 
risk stratification – separating vulnerable rupture prone plaques from the more 
stable plaque formation. This will be discussed in-detail in Section 3.4.1., but in-
short the multifactorial background of atherosclerosis makes such differentiation 
complicated. Whilst we can classify different plaque types morphologically, it is 
paradoxically not always the plaque with the highest stenosis that is the most 
rupture-prone [155, 156]. Also, even if morphology seems evidently important, a 
range of different types of vulnerable plaque types have been identified in literature 
(including a thin fibrous cap, large necrotic core, increased plaque inflammation, 
increased neovascularisation, intraplaque haemorrhage, and active plaque 
inflammation, as shown in Figure 3.9) [141], complicating the diagnosis. The in-vivo 
assessment of plaque morphology is also not univocal, and echogenicity [157], 
inflammation [158] and constitutive behaviour [151, 152] have all been proposed as 
substitute in deriving plaque vulnerability. 
Lastly on specific hemodynamic considerations of atherosclerosis, it is clear how 
atherosclerotic development and local stenotic protrusions disrupt blood flow and 
increase local blood velocities and pressure drops. Hence, assessment of absolute 
velocity magnitudes or absolute pressure drops through invasive catheterisation 
has been used to analyse plaque development or evaluate the need for coronary 
stenting [159, 160]. Another interesting hemodynamic factor is evident in how local 
atheroma and lipid-retention is triggered from a generally systemic endothelial 
dysfunction. For such, increased wall shear stresses and non-laminar flow around 
vascular bifurcations have been identified as possible hemodynamic factors 
initiating plaque development [51]. Hypertension has also been identified as a risk 
factor for atherosclerosis [145], even though the isolated influence of elevated 
pressure on plaque formation are still under investigation. 
b) Hypertension 
Hypertension is a pathological state in which the arterial blood pressure is elevated 
above normal values, and where the cardiovascular system consequently has to 
work against a persistently higher work-load. Even though varying between 
individuals, guidelines cut-off values for diagnosed hypertension are set at systolic 
blood pressures ≥ 140 mmHg and diastolic blood pressures ≥ 90 mmHg (albeit 
isolated systolic hypertension is also identified) [161]. 
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Elevated blood pressure is generally asymptomatic, but the connection between 
increased blood pressure and cardiovascular risk has been extensively investigated 
[162], with hypertension deemed an independent risk factor for stroke, myocardial 
infarction, heart failure, and sudden cardiac death [161], to name only a few. 
Hypertension is also a highly prevalent disease, with an estimated 25-45% of the 
entire adult population identified as hypertensive [161, 163], with numbers 
increasing with increasing age. 
Hypertension is a multifactorial disease, and the underlying causes are difficult to 
isolate. For some specific pathology such as renal or endocrine disease, 
hypertension is identified as secondary following the onset of the primary 
pathology [164]. However, so called primary hypertension is more diffusely 
developing without any cofounding pathophysiological initiation, and only specific 
risk factors such as genetic variations, smoking, obesity, or age have been identified 
to increase the risk for the disease [161]. 
From a hemodynamic perspective hypertension greatly influence the behaviour of 
the cardiovascular system. The increased arterial blood pressure is equivalent to an 
increased afterload, which the heart needs to work against to maintain sufficient 
ejection of blood. By that, a hemodynamic reaction of increasing intraventricular 
velocities and increasing intraventricular blood acceleration [165] is observed, 
which may further trigger pathological remodelling through hypertrophy or 
dilation [166]. The hypertensive hemodynamics also leads to increased turbulent 
and erratic flow, through which hypertension is a risk factor for valvular stenosis 
[61]. Conversely, pulmonary hypertension (increased blood pressure in the 
pulmonary circulation) typically affects the diastolic abilities of the left heart, being 
a hypothesised component in diastolic heart failure [167], as well as being a risk 
factor for right ventricular failure [168]. 
The relation between hypertension and arterial stiffening is also worth mentioning. 
The increase in arterial stiffness with age is evident [169], so is the increasing 
prevalence of hypertension [163]. That the two coincide is not surprising: with 
increasing blood pressure the arteries have to withstand increased exerted load, 
triggering arterial remodelling and upregulation of collagen production. 
Conversely, stiffened aortas will decrease distensibility, and hence increased 
pressures are required to maintain systemic circulation. The order in which the two 
manifest themselves are still under evaluation, but it has been hypothesised that 
slight vascular stiffening might precede the onset of clinically evident hypertension 
[170, 171]. 
c) Other vascular disease 
Even though atherosclerosis and hypertension are by far the most common 
vascular diseases, a few other vascular complications are worth mentioning within 
the scope of this thesis. Specifically, aortic coarctation and aortic dissection are 
mentioned in brief. 
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i) Aortic coarctation 
Aortic coarctation is a generally congenital condition, represented by a local 
narrowing of the aorta typically in or around the initial aortic bend. The disease 
accounts for around 4-6% of all congenital heart defects, with an overall 
prevalence of around 4 per 10 000 births [172]. Hemodynamically, the narrowing 
can be treated as a local stenotic region, where the cardiovascular system needs to 
overcome an additionally imposed pressure gradient to successfully pump blood 
through the systemic circulation. Thus, assessing local pressure drops are part of 
guidelines for aortic coarctation monitoring [59], and systemic arterial hypertension 
is common among this specific patient cohort [173]. This increased afterload will 
render compensatory effects on the cardiac side, leading to potential cardiovascular 
remodelling. 
ii) Aortic dissection 
Aortic dissection is a pathological condition where an intraluminal injury allows 
blood to tear open and flow in-between the layers of the arterial wall. By so the 
condition represents a serious cardiovascular event, associated with high mortality 
and the need for acute surgical repair [174]. The disease is not congenitally present, 
but high incidence-rates are reported in patients with a congenital bicuspid aortic 
valve potentially following the disrupted outflow [175], as well as in patients with 
other more rare congenital heart conditions [176]. However, severe hypertension 
and aortic stiffening have also shown to correlate to aortic dissection, where the 
risk of initiating vascular damage seems elevated [176]. Hemodynamically the 
opening of a parallel false lumen severely complicates blood flow, induces regions 
of high turbulence and irregular flow [177]. 
3.3. Cardiovascular imaging 
Medical imaging has become an indispensable part of modern-day clinical 
diagnostics, and even though used in virtually every diagnostic field, imaging has 
come to play a particularly central role in cardiovascular health care. 
Echocardiography has become a cornerstone of first-line cardiovascular 
diagnostics, providing direct assessment of cardiac structure as well as refined 
information on intracardiac flow and tissue constitutive behaviour. For alternative 
diagnostics, cardiac MRI and CT provide excellent spatial resolution and image 
contrast, with specific developments of 4D flow MRI enabling the 3D(+time) 
study of blood flow through the entire cardiovascular system. With other emission-
based modalities such as Positron Emission Tomography (PET) and Single-
Photon Emission Computed Tomography (SPECT) providing refined information 
on tissue metabolism and function, a comprehensive mapping of cardiovascular 
physiology is thus enabled through medical imaging. 
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Figure 3.10: Examples of structural and functional cardiovascular imaging, provided by ultrasound 
((A) B-mode and (D) Colour Doppler), MRI ((B) T1-weighted and (E) 4D flow) and CT ((C) spiral 
CT and (F) Coronary angiography). Reproduced with permission from Wikimedia commons and [79]. 
In the following section, a basic review of cardiovascular imaging is provided 
focussing primarily on ultrasound imaging, MRI, and CT, respectively. For the sake 
of the thesis, specific emphasis is given on the assessment of cardiovascular flow 
and ultrasound elastography. An example of some of the structural and functional 
imaging provided by ultrasound, MRI, and CT is given in Figure 3.10. 
3.3.1. Ultrasound imaging  
The use of ultrasound as a tool for clinical diagnostics dates back to 1942, when 
Dussik in a pioneering work showed how acoustic waves could be used to detect 
neuromas in brain tissue [178]. From this, Edler and Hertz showed its first 
application to cardiac assessment, correlating received pulse-echoes to the 
movement and position of the myocardial walls [179]. With clinical scanners 
introduced in the late 1960s, the diagnostic usage of ultrasound imaging has since 
increased exponentially, and today ultrasound imaging of the heart and the 
vasculature constitutes routine practice in modern-day clinical diagnostics. 
Ultrasound is defined as acoustic pressure waves, propagating with frequencies 
above the audible limit of human hearing (20 kHz). As the propagation of these 
acoustic waves depends on the density and compressibility of the traversed tissue, 
any change in such imposed by material boundaries or inhomogeneities will give 
rise to changes in propagating wave form and reflection. Internal structures can 
thus be reconstructed by recording the amplitude and travel-time of echoes 
originating from an emitted ultrasound wave. 
a) Fundamental imaging physics 
From a theoretical point of view, the propagation of an acoustic wave can be 
related to the internal stresses imposed on the traversed material. This can be 
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described by the homogeneous equation of motion for a seismic wave (Euler’s 
equation of motion), which with neglected body forces states that 𝜌𝜌 𝜕𝜕2𝒖𝒖𝜕𝜕𝜕𝜕2 − ∇ ∙ 𝜎𝜎 = 0, (3.16) 
where 𝜌𝜌 is the medium density, 𝒖𝒖 the wave displacement tensor, and 𝜎𝜎 the stress 
tensor. 
Through constitutive relations, 𝜎𝜎 is related to the imposed strains 𝜀𝜀 by 𝜎𝜎 = 𝐶𝐶𝜀𝜀, (3.17) 
where 𝐶𝐶 is the elasticity tensor of a given material, describing its specific 
constitutive behaviour. For an isotropic, homogeneous, and linear elastic material, 𝐶𝐶 can be represented exclusively by the two Lamé constants 
 𝜆𝜆 = 2𝜈𝜈𝜈𝜈1 − 2𝑣𝑣 
 
(3.18) 
𝜇𝜇 = 𝜈𝜈, (3.19) 
where 𝜈𝜈 is the elastic shear modulus (describing the material resistance to shear 
deformation), and 𝑣𝑣 is the Poisson’s ratio (describing the relation between 
transverse and axial strain upon imposed deformation). 
Inserting Equations 3.17-3.19 into 3.16, this renders Navier’s equation of motion 
for isotropic elastic medium 𝜌𝜌 𝜕𝜕2𝒖𝒖𝜕𝜕𝜕𝜕2 − 𝜇𝜇∇2𝒖𝒖 − (𝜆𝜆 + 𝜇𝜇)∇(∇ ∙ 𝒖𝒖) = 0. 
 
(3.20) 
A common way of solving Equation 3.20 is by a so called Helmholtz 
decomposition, where the wave propagation 𝒖𝒖 is split into a rotational component 𝛻𝛻 × 𝑯𝑯 and a non-rotational component ∇𝜙𝜙. Combined with Equation 3.20 this 
renders an equation system on the form ∇2𝜙𝜙 − 1𝑐𝑐𝐿𝐿 𝜕𝜕2𝜙𝜙𝜕𝜕𝜕𝜕2 = 0 (3.21) ∇2𝑯𝑯 − 1𝑐𝑐𝑠𝑠 𝜕𝜕2𝑯𝑯𝜕𝜕𝜕𝜕2 = 0. 
 
(3.22) 
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Importantly, this shows how an acoustic wave propagates in two separate modes: one 
compressional pressure wave, and one shear wave, with compressional and shear wave 
speeds 𝑐𝑐𝐿𝐿 and 𝑐𝑐𝑠𝑠 given by 𝑐𝑐𝐿𝐿 = �𝜆𝜆 + 2𝜇𝜇𝜌𝜌  
 
(3.23) 
𝑐𝑐𝑠𝑠 = �𝜇𝜇𝜌𝜌. 
 
(3.24) 
However, the two wave modes not only differ in apparent wave speed, but also in 
their respective mode of propagation. The compressional wave travels through 
alternating compression and rarefaction of the traversed medium (with 
displacements parallel to the direction of propagation), whereas the shear wave 
travels by local shearing of the material (with displacements perpendicular to the 
direction of propagation), see Figure 3.11. 
It can be shown that inside an infinite homogeneous medium, the two wave modes 
travel without any virtual interaction [180]. However, in the presence of 
geometrical boundaries, interactions between compressional and shear wave 
modes complicate the theoretical description, and more refined analytical solutions 
are needed. For the sake of cardiovascular imaging, this becomes a pressing issue 
when imaging thin vascular tissue or geometrically confined plaques. 
When referring to clinical ultrasound imaging, we are typically referring to 
compressional pressure waves travelling through the imaged tissue. The wave 
propagation is then described using the non-rotational part in Equation 3.20, with 
 
Figure 3.11: The two different modes of acoustic wave propagation: Compressional wave 
propagation (alternating compressions and rarefactions in the direction of the wave propagation), and 
Shear wave propagation (localised isovolumetric shearing transverse to the direction of the wave 
propagation). Modified and reproduced with permission [181]. 
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the wave propagation governed by the compressional wave speed 𝑐𝑐𝐿𝐿. Importantly, 
the compressional speed of acoustic waves varies very little between different 
biological tissue [182], and is usually assumed to be 1540 m/s. In fact, this 
assumption of constant wave speed is essential in clinical ultrasound imaging, 
where elapsed pulse-echo time can be directly converted to travelled distance. 
Conversely, shear wave propagation is less utilised in routine clinical ultrasound 
imaging. However, within ultrasound elastography imaging, externally imposed 
shear waves are utilised to provide information on the distribution of shear 
properties within an imaged object. As the shear wave speed of acoustic waves 
varies markedly between biological tissue (~103 Pa for glandular soft tissue, ~108 
Pa for epidermis cartilage) [182], a differentiation of different tissue structures 
could be achieved by analysing their constitutive properties. 
b) Pulse-echo imaging 
The main principle of clinical ultrasound is the pulse-echo technique, in which a 
brief ultrasound wave is transmitted into an imaged object before being 
subsequently registered through its returning echoes. As the wave propagation 
changes as a function of traversed material, and as the amplitude and intensity of 
the reflected echo is related to the material interfaces encountered, a 
reconstruction of the imaged interface boundaries can be achieved, as depicted in 
Figure 3.12. Importantly, reflections will not only occur at defined tissue 
boundaries, but also from small scatters within a tissue section. Such scatters give 
rise to typical speckle-patterns, detectable by conventional ultrasound imaging. 
 
Figure 3.12: Schematic overview of the principle of ultrasound pulse-echo imaging with a 
transmitted wave reflected back to the transducer at tissue boundaries. The magnitude of the 
reflected amplitude corresponds to the difference in acoustic impedance between materials A, B, and 
C, respectively. 
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The above depicted simple pulse-echo sequence is sufficient for single-element 
imaging, however, in clinical practice imaging is typically performed using a range 
of elements inside an imaging transducer. By exciting elements in different 
sequence, varying element-weighting over the transducer (apodisation), steering the 
ultrasound beam during the imaged session, or shifting focus-depth (again by 
shifting element excitation), acquisitions can be optimised for specific application 
tasks. 
To this, post-processing of the retrieved echo signal (the so called radio frequency 
(RF) data) can be altered to enhance certain regions of the imaged object, dampen 
the effect of certain high- or low-frequency artefacts (through band-pass filtering), 
or compensate for increased attenuation at increasing depth (time gain 
compensation (TGC)). 
c) Structural imaging 
Using the general principles of pulse-echo imaging, the basic structure of biological 
tissue can be directly reconstructed. If staying with a one-element setup (the basic 
pulse-echo technique) so called amplitude (A)-mode imaging can be generated. 
Here, the amplitude of the retrieved echo-signal is directly displayed. Albeit directly 
showing the interactions of the retrieved echo signal (identical to the data displayed 
by Edler and Hertz in the 1950s [179]) its clinical usage is today very limited 
Brightness (B)-mode imaging is the most commonly used display mode, created by 
showing amplitude data from sequentially aligned transducer elements. With that, a 
grey-scale depiction of the amplitude represents a 2D slice of the imaged object. B-
mode imaging is typically used in imaging the myocardium in echocardiography, or 
to evaluate arterial dimensions and the presence of plaques by vascular ultrasound 
[6]. 
Motion (M)-mode imaging is an alternative amplitude display mode, where a single 
line transducer output is displayed as a function of time. This is typically used in 
assessing intracardiac valve behaviour [61], or when assessing potential myocardial 
dyssynchrony [6]. 
d) Functional imaging 
Medical ultrasound can also be used to assess functional properties. In particular, 
imaging of intracorporeal blood flow through Doppler imaging has become a 
standardised tool in routine medical ultrasound. Additionally, assessment of 
constitutive behaviour through ultrasound elastography has gained increasing 
attention over the last few decades. 
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i) Doppler imaging 
When imaging static tissue, the principles described in previous sections hold 
where the reflected echo-signal can be interpreted as defined interfaces inside the 
imaged object. However, when imaging a moving object (such as the flow of 
blood), the reflected wave will experience a shift in frequency. This phenomenon 
has been well known for a long time, and is called the Doppler effect after its 
discoverer. Consequently, in Doppler imaging, the frequency shift between emitted 
and received echo-signal is related to the velocity of the imaged object. 
It can be shown that the relation between the frequency shift 𝑓𝑓𝑑𝑑 and emitted 
frequency 𝑓𝑓0 is related by 𝑓𝑓𝑑𝑑 = 2𝑓𝑓0 𝑣𝑣 cos 𝜃𝜃𝑐𝑐 , (3.25) 
where 𝑣𝑣 is the velocity of the moving object and 𝑐𝑐 the propagation speed of the 
ultrasound. Importantly, 𝜃𝜃 is the insonation angle between the ultrasound beam 
and the velocity of the moving object, indicating clearly the angle dependency of 
Doppler ultrasound [183]. In other words: in ultrasound Doppler we are assessing 
the velocity component in the direction of the ultrasound beam. Following directly from 
the trigonometric cosine-function, an insonation angle of 10° corresponds to an 
error of 1.5% in maximum velocity, whereas an insonation angle of 30° 
corresponds to an error of 23.5%. Clinical guidelines typically recommend an 
insonation angle of no more than 60° [61], but even assessment errors of up to 
50% might occur. Specifically, even though angle compensation algorithms are 
typically incorporated into current clinical imaging systems, the accuracy of 
Doppler ultrasound will decrease if assessing tortuous vasculature or turbulent 
flow (refined ultrasound-based Doppler flow assessment is however under current 
development [184-186]). 
Clinically, two sets of Doppler modes are typically utilised: Continuous-wave 
(CW)-Doppler and Pulsed-wave (PW)-Doppler. In CW-Doppler, continuous 
transmission of a single-frequency wave is performed together with a continuous 
receiving of the reflected, Doppler-shifted signal. This provides direct assessment 
of the Doppler shift, but does not enable any spatial positioning of the retrieved 
signal. Instead, PW-Doppler assesses the frequency shift at a specific depth-of-
interest. 
Both CW- and PW-Doppler are commonly used in echocardiography, primarily to 
assess intraventricular flow velocities and stage degrees of both stenosis and 
regurgitation [61, 78]. Doppler assessment of the moving myocardium (tissue 
Doppler) is also used to assess both systolic and diastolic dysfunction [183], and 
qualitative classification of intraventricular flow can be achieved using so called 
colour Doppler (2D visualisation of Doppler shift frequencies). 
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ii) Elastography 
Elastography refers to a set of medical imaging techniques used to map the 
constitutive properties of investigated tissue. In part the technique originated from 
the fact that tissue constitutive behaviour will affect acoustic wave propagation, 
but also from the observation that pathological changes often relate to a change in 
tissue elasticity [187-190]. Age-induced arterial stiffening has been well-known for 
a long time [169], and similar stiffening of the myocardium seem evident in 
restrictive cardiomyopathies [127] and in patients with heart failure with preserved 
ejection fraction [191]. Additionally, plaque constitutive behaviour has been related 
to plaque stability [192], and consequently elastographic techniques have been 
gaining increasing attention in the field of cardiovascular diagnostics. 
In short, elastography is based on inducing a local tissue displacement, and then 
subsequently imaging the tissue reaction to this displacement. The local tissue 
displacement can be either induced by external (static or transient) excitation [187], 
by direct excitation through a focussed ultrasound-generated acoustic radiation 
force [182, 193], or induced naturally by physiological processes [194]. Following 
this, the imaging of tissue reaction can either be performed by directly assessing 
the induced displacement or strain field, or by tracking the acoustic waves 
propagating from the initial point of excitation. Once assessed, the displacement, 
strain, or induced wave propagation can further be related to apparent elastic 
properties, providing an imaged-based mapping of tissue elasticity. 
With such, the field of ultrasound elastography contains a range of different sub-
techniques, all with its defined image specifications and setup. Excellent reviews of 
different techniques can be found in in [193, 195], but to mention a few of the 
most prominent ones intravascular strain imaging uses an intravascular probe to 
directly assess the imposed strain-field from intravascular pressure [194], acoustic 
radiation force impulse (ARFI) imaging assesses direct strain fields using an 
imposed acoustic radiation force induced displacement [196], and shear wave 
elastography (SWE, sometimes also supersonic shear imaging, SSI) tracks the 
induced shear wave following an initiated acoustic-radiation force displacement, 
and maps tissue elasticity as a function of the assessed shear wave speed [182]. 
Among the sub-techniques of ultrasound elastography, SWE is one of the more 
prominent techniques having been explored and applied for both cardiac [197] and 
vascular [198] stiffness estimation. In short, SWE consists of three main steps: 
1. Local, transient tissue excitation, giving rise to the propagation of shear 
waves through the investigated tissue  
2. Image-based tracking of the shear waves by ultrafast plane wave imaging 
3. Reconstruction of constitutive properties from the estimated shear wave 
motion 
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Figure 3.13: Schematic overview of the principle of shear wave elastography. A local tissue 
deformation is induced by a focussed acoustic radiation force (pushing) which initiates shear wave 
propagation. By fast switching to ultrafast plane wave imaging (imaging) the motion of the travelling 
wave can be captured in a series of sequential ultrasound images. By cross-correlation (processing) 
the deformation and wave front can be visualised as a function of time. With shear wave speed 
correlated to tissue elasticity, the wave front will distort in the presence of, in this case, a stiffer 
nodule. By correlating wave speed to constitutive behaviour a quantitative image of shear elasticity 
can be generated (mapping of shear elasticity). Note how elasticity variations can be present even in 
the case of homogeneous echogenicity. 
Step 1. is achieved by focussing an ultrasonic beam in one (SWE) or several (SSI) 
locations, where this focussed acoustic radiation force push gives rise to a sudden 
and local tissue displacement. As a constitutive response to this local displacement, 
acoustic waves will start to propagate from the epicentre of the push, out through 
the imaged tissue. Importantly, both compressional and shear waves will be 
induced in the tissue, however, following the difference in bulk and shear modulus 
in biological soft tissue the two will propagate with significantly different wave 
speeds (as given in Equations 3.23 and 3.24). 
In fact, shear waves will propagate at a wave speed of a few m/s in soft biological 
tissue. The motion of such a wave cannot be captured using conventional B-mode 
frame rates, however using the concept of ultrafast plane wave imaging (where an 
unfocussed ultrasound beam is transmitted by simultaneous excitation of all 
transducer elements) [199] frame rates of >1 kHz can be achieved. By so, the 
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propagation of the travelling shear wave can be captured by quickly switching from 
the focussed acoustic radiation push (step 1. in the list above), to ultrafast plane 
wave imaging (step 2. in the list above). 
The wave propagation can then be recovered by image cross-correlation [200], 
where subsequent images of the displacement and non-displaced state are 
combined to amplify displaced tissue regions. With such, the wave propagation can 
be visualised and apparent wave speeds quantified (step 3. in the list above). As 
outlined in Equation 3.24, shear modulus can be directly derived from shear wave 
speed, under the assumption of infinite media wave propagation. This is commonly 
deployed in conventional elastography assessments, but is violated in thin vascular 
or constricted plaque tissue. In such cases, wave guide theory would have to be 
utilised to relate shear wave speed to apparent thickness [201-203]. 
An illustrative overview of the basic principles of SWE is provided in Figure 3.13. 
As depicted, the shear wave front is altered when entering a stiffer nodule. 
Importantly, such variations in shear elasticity may even be present in regions with 
homogeneous B-mode echogenicity. 
3.3.2. Magnetic resonance imaging 
MRI is a medical imaging modality utilising the distribution of net magnetic 
polarisation in an object in the presence of an externally applied magnetic field. 
Originally discovered in the form of nuclear magnetic resonance (NMR) [204], 
refinement by Lauterbur, Bloch, and Purcell [205-207] made the technique viable 
for clinical purposes. Today, MRI is used as a powerful tool for non-invasive 
structural and functional analysis, and is used for a number of purposes in 
cardiovascular diagnostics: accurately assessing intracardiac dimensions [208], 
differentiating myocardial scar tissue from myocardial injury [209], estimating 3D 
flow features throughout the cardiovascular system [10], and even assessing 
intracardiac fibre orientation using diffusion tensor MRI [210]. 
a) Fundamental imaging physics 
The fundamental concept of MRI lies in the magnetic momentum or spin of sub-
atomic particles. The magnetic momentum can be likened by a magnet, where the 
particle has a positive and a counter-acting negative magnetic pole. For clinical 
imaging purposes the proton has such a defining spin, meaning that it also 
possesses certain magnetic properties. 
Under normal circumstances, the spins of the protons in the human body is 
randomly oriented. However, if subjected to an externally applied magnetic field 𝐵𝐵0, the net spins will align and start to precess around the axis of 𝐵𝐵0. Specifically, 
the precession or Larmor frequency 𝜔𝜔 will be related to the field strength of 𝐵𝐵0 by 𝜔𝜔 = 𝛾𝛾𝐵𝐵0, (3.26) 
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where 𝛾𝛾 is the gyromagnetic ratio. 
However, all spins will not orientate themselves identically, but rather there will 
exist a slight favouring of parallel orientation over anti-parallel orientation. 
Consequently, in the presence of 𝐵𝐵0, there will be a net magnetisation 𝑀𝑀  in the 
investigated tissue (being parallel to the applied 𝐵𝐵0). 
Now by invoking a pulsed external field 𝐵𝐵1 (often called an RF-pulse) orthogonal 
to 𝐵𝐵0, 𝑀𝑀  will be tipped away from 𝐵𝐵0 (see Figure 3.14). Specifically 𝑀𝑀  will flip 
down towards the transverse plane orthogonal to 𝐵𝐵0, with the flip angle (deviation 
of 𝑀𝑀  from 𝐵𝐵0) governed by the strength and duration of the RF-pulse. 
Once the RF-pulse is removed, an opposite motion will occur and the spins will 
start to relax back into their original 𝐵𝐵0-governed equilibrium state. The relaxation 
is what forms the actual MRI-image, and is in principle governed by two processes: 
i) T1-relaxation or spin-lattice relaxation, describing the time required for 
the recovery of magnetisation in the direction of 𝐵𝐵0 
ii) T2-relaxation or spin-spin relaxation, describing the time required for 
the decay of magnetisation in the direction of 𝐵𝐵1 
As the spin orientation and net magnetisation returns into the orientation of 𝐵𝐵0, 
these relaxation times or net movement of magnetic momentum will be 
proportional to the Larmor frequency of the tissue, enabling mapping of tissue 
morphology using dedicated receiver coils. 
 
Figure 3.14: Fundamental principles of MRI signal generation. With the imposed magnetic field 𝐵𝐵0 a 
net magnetisation 𝑀𝑀  will be present. With an induced orthogonal RF-pulse, the net magnetisation 
will flip an angle 𝜔𝜔1 (maximum 90°). Once terminated, the net magnetisation will relax back from the 
flipped to the non-flipped configuration, with the change in magnetisation measured either as a 
function of magnetisation recovery in z-direction (T1) or as magnetisation decrease in the transverse 
xy-plane (T2). 
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b) Image formation 
As described above, following an exciting RF-pulse different tissue structures can 
be identified based on their proton density and relaxation time. However, simple 
observation of the induced signal is not enough to spatially position the acquired 
data. For this, a specific pulse sequence needs to be applied to spatially encode the 
induced signal. 
The gradient echo sequence is a typical MRI sequence used for such 3D 
positioning. In principle, a gradient echo sequence consists of three different 
sequential steps: 
i) Slice selection, or selective RF excitation is represented by a spatial 
magnetisation gradient 𝜈𝜈𝑧𝑧 applied in the direction of the main field 𝐵𝐵0, and simultaneous with the RF-pulse. Since the spins will now be 
excited to a gradient in the z-direction, the RF pulse can be tuned to 
only excite spins within a specific frequency range; only spins in 
resonance with the RF-pulse will be excited. Thus, positioning of the 
retrieved signal in z-direction can be achieved.  
ii) Frequency encoding is represented by yet another spatial magnetisation 
gradient, but this time by 𝜈𝜈𝑥𝑥. Using 𝜈𝜈𝑥𝑥, the Larmor frequency of the 
excited spins will vary as a function of x-position, and can be analysed 
separately through Fourier decomposition of the retrieved output 
signal. Thus, positioning of the retrieved signal in x-direction can be 
achieved. 
iii) Phase encoding represents the final spatial encoding, achieved by yet 
another gradient 𝜈𝜈𝑦𝑦. Here the phase of the signal (rather than 
frequency) is analysed, where progressively increasing or decreasing 𝜈𝜈𝑦𝑦 is applied to accumulate different phase changes along the y-axis. 
By analysing the final phase shift as a function of location, positioning 
of the retrieved signal in y-direction can be achieved. 
In addition to the above, when imaging cardiovascular structures, data might also 
vary as a function of time (due to e.g. the AV-plane motion of the heart, or the 
respiratory displacements inside the intrathoracic cavity). For such, image gating is 
typically utilised, where data is sampled over a number of consecutive cycles and 
either prospectively or retrospectively assigned to a specific temporal gate. For 
cardiovascular imaging, simultaneous ECG recording provides excellent 
correlation to specific cardiac phases, where acquisitions are typically triggered at 
the detection of a new R-tag (systolic onset). This however also means that data is 
acquired as a mean average over a number of cycles, and highly transient events 
might be difficult to capture. 
 
46 
3.3. CARDIOVASCULAR IMAGING 
c) Structural imaging 
Using the principles in the previous section, the structure of biological tissue can 
be reconstructed based on their respective relaxation time. As described both T1 
and T2-relaxation occur, wherefore structural MRI images are either described as 
T1-weighted or T2-weighted. For cardiovascular purposes, T1-weighted images are 
the most commonly used, with these images enhancing soft tissue contrast [211], 
as well as providing excellent contrast between blood pool and vascular tissue. T2-
weighted images are less common for cardiac assessment, but has been employed 
to identify reperfusion injury [212], myocardial iron overload [213], and even global 
myocardial inflammation [214]. 
d) Functional imaging 
MRI does not only enable the study of morphology, but also offers the ability to 
study functional physiological processes. To exemplify, functional MRI (fMRI, 
evaluating changes in oxygen-saturated haemoglobin) has been utilised to study 
brain activity [215], and time-of-flight MR angiography (evaluating the temporal 
process of magnetic saturation) has successfully been employed to identify 
aneurysmal developments [216]. For cardiovascular purposes, the use of phase 
contrast MRI (PC-MRI) to assess cardiovascular blood flow has become a 
fundamental part of cardiac MRI assessment [217]. In the following section, 
fundamental basics of PC-MRI are provided. 
i) Phase-Contrast MRI 
The imaging basics of PC-MRI is in part identical to the spatial position imaging 
described above; by applying varying gradients and utilising spin relaxation times, 
an image can be formed. In PC-MRI however, the application of a bipolar gradient 
is utilised: first a de-phasing is introduced by a positive gradient, which is then 
reversed by an identical but negative gradient. Any static particle will thus return to 
its original un-phased state, however any particle that has moved inside the object 
during the application of the bipolar field will have a net phase shift 𝜙𝜙. The 
concept is depicted graphically in Figure 3.15, showing that particles moving at 
identical velocity will after the bipolar gradient have identical phase shift. 
Since velocities are assessed by an induced phase shift, a pre-defined velocity 
window or velocity encoding (VENC) will exist corresponding to 𝜙𝜙 = ±180°. Any 
larger velocities inducing larger phase shifts will induce aliasing (wrapping), 
typically encountered in high-velocity PC-MRI flows. In such cases, an increased 
VENC (by modifying the magnitude of the bipolar gradient prior to acquisition) or 
unwrapping algorithms (during post-processing) has to be applied. Importantly, 
the VENC will affect the resolution in acquired velocities, and is also directly 
related to image quality. In fact, it can be shown that VENC is related to signal-to-
noise-ratio (SNR) as 
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Figure 3.15: Fundamental principles of phase-contrast MRI. Using a bipolar gradient (+𝜈𝜈/−𝜈𝜈) 
spins with increasing phase shift 𝜔𝜔 will be induced by the initial positive gradient, before being 
reverted by the subsequent negative gradient. Static tissue (upper and lower row) will thus have a 
resulting net 𝜔𝜔 = 0. However, for moving tissue (middle row, moving to the right with velocity 𝒗𝒗), 
the movement through the spatial gradient will cause 𝜔𝜔 ≠ 0. Specifically, after the bipolar gradient, a 
given 𝜔𝜔 will be related to a given 𝒗𝒗 (with constant 𝒗𝒗 in the figure, the entire mid-row ends up with 
identical 𝜔𝜔). 𝑆𝑆𝑆𝑆𝑅𝑅 = √2𝜋𝜋 𝑉𝑉𝐸𝐸𝑆𝑆𝐶𝐶𝜎𝜎 , (3.27) 
where 𝜎𝜎 is the standard deviation in the acquired velocity field. 
Using slice selection, phase encoding, and frequency encoding, blood flow can also 
be mapped in 3D. Most commonly though is the selection of a single-plane PC-
MRI, where so called 2D time-resolved (CINE) PC-MRI images are acquired, 
providing information on one-directional velocity through a given image plane. 
ii) 4D flow MRI 
If applying bipolar gradients in all spatial dimensions, a comprehensive mapping of 
3D flow can be achieved. Adding image gating, so called 4D flow MRI (3D flow 
over time) can be assessed [10, 76, 79]. With such, complete mapping of 
cardiovascular flow is in principle enabled, and the technique has been extensively 
applied to study intracardiac flow, derive refined 3D flow parameters for 
cardiovascular assessment, as well as investigate flow in vascular disease [19, 22, 76, 
91, 218-221]. Importantly however is to recall that with bipolar gradients applied in 
all three dimensions, 4D flow MRI typically requires relatively long scan times (to 
date around 5-10 minutes). Improvements have been made using accelerated pulse 
sequences or readout techniques [222, 223], but the acquired flow field will still 
represent a mean average of the cardiovascular flow over the entire scan time. 
3.3.3. Computed Tomography 
Computed Tomography (CT) is an imaging modality using the attenuation of 
photons to reconstruct internal tissue structures. X-rays were discovered by 
Roentgen in 1895 [224], and the reconstruction of 3D structures through 
sequential X-ray acquisitions around an object was exploited for medical purposes 
by Hounsfield, Cormack, and Oldendorf in the 1960s [225-227]. Since then the 
clinical field of CT has expanded significantly, being utilised for a range of 
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different diagnostic purposes. For cardiovascular analysis, CT is commonly used to 
assess coronary artery blockage [228], intracranial bleeding [229], or to examine the 
degree of plaque intrusions within the vasculature [106]. Angiogram imaging (2D 
X-ray imaging) is also used to guide clinicians during coronary reperfusion [7], 
atrial fibrillation ablation [230], aneurysm coiling [229], or other invasive catheter 
procedures [7]. 
a) Fundamental imaging physics 
The fundamental physical process of CT imaging lies in the interactions of 
photons with matter. When travelling through any given media, photons interact in 
four principle ways 
i) Photoelectric absorption, where the entire energy of the photon is 
transferred into the interacted media by excitation or ejection of a 
photoelectron. 
ii) Compton scattering, where part of the photon energy is inelastically 
transferred to the excitation of a bound electron, resulting in a 
deviation in the photon’s travelling direction. 
iii) Rayleigh scattering, where photon energy is elastically transferred by 
excitation of the complete interacting atom, again resulting in a 
deviation in the photon’s travelling direction. 
iv) Pair production where a photon of sufficiently high energy (>1.022 
MeV) transfers all of its energy into creating an electron-positron pair 
near an interacting nucleus. 
The probability of the above four varies as a function of photon energy and 
interacting media, and photon-matter interaction is typically described by the 
attenuation coefficient 𝜇𝜇 given as the cross section per unit volume for a given 
interaction type. 
At photon energies used for medical imaging purposes (spectrum <120 keV) 
Compton scattering is the dominant interaction mode in soft biological tissue, and 
it is only at fairly low energies (<30 keV) that photoelectric absorption becomes 
the dominating interaction mode. The exact threshold value however directly 
depends on the matter element or compound, and scales with atomic number. 
If allowing 𝑆𝑆0 photons to travel into an investigated object, the number of 
photons, 𝑆𝑆 , transmitted without interaction through the entire object can be 
described by the Beer-Lambert law as 𝑆𝑆 = 𝑆𝑆0  exp�−� 𝜇𝜇(𝑥𝑥,𝐸𝐸)𝑑𝑑𝑑𝑑𝑙𝑙 � , (3.28) 
where 𝑑𝑑 is the total length that the photons need to traverse in unit direction 𝑥𝑥. 
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Figure 3.16: Fundamental principles of X-ray CT using a fan-beam geometry. Projection data is 
acquired by rotating the source-detector pair around the imaged object, with each projection collected 
as a function of 𝜕𝜕 and 𝜃𝜃. Assembling these over the entire image session generates the so called image 
sinogram (bottom left, white vertical lines highlighting the three acquisition positions in the upper 
row). The sinogram can then be used to reconstruct the imaged object (bottom right). 
Clearly, the number of transmitted photons will be strongly dependent on 𝜇𝜇. 
Solving for 𝜇𝜇, Equation 3.28 can be converted into 𝑝𝑝 = − ln �𝑆𝑆𝑆𝑆0� = −� 𝜇𝜇(𝑥𝑥,𝐸𝐸)𝑑𝑑𝑑𝑑𝑙𝑙 , (3.29) 
where 𝑝𝑝 is the projection value, typically measured in an energy-integrated form. 
The above forms the basis of CT, acquired by a source and detector system 
rotating around the imaged object, as shown in Figure 3.16. Using a mathematical 
description of the acquisition system, the interior structure of the imaged object 
can subsequently be reconstructed. 
To describe the sequential rotation and collection of 𝑝𝑝 in a CT, we utilise the 
Radon transform, 𝑅𝑅, defining that 𝑅𝑅[𝑓𝑓(𝑥𝑥, 𝑦𝑦)](𝜕𝜕, 𝜃𝜃) = � 𝑓𝑓(𝑥𝑥, 𝑦𝑦)𝑑𝑑𝑥𝑥𝑑𝑑𝑦𝑦𝑙𝑙(𝑡𝑡,𝜃𝜃)  (3.30) 
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where 𝜃𝜃 is the angular position of a given acquisition point, 𝜕𝜕 is the position 
orthogonal to the source-detector direction, and 𝑓𝑓  is the function of interest (in 
our case 𝜇𝜇). 
Sampling 𝑅𝑅[𝑓𝑓(𝑥𝑥, 𝑦𝑦)](𝜕𝜕, 𝜃𝜃) over a given number of projection angles renders an 
image sinogram (see Figure 3.16), where the energy-integrated projection value in 
each detector pixel is displayed as a function of angular position. Depending on 
the object attenuation traversed, different projection values will be collected at 
different detector positions and angles, respectively. 
b) Image formation 
In principle, CT is about sampling 𝑅𝑅[𝑓𝑓(𝑥𝑥, 𝑦𝑦)](𝜕𝜕, 𝜃𝜃) as described above. In its most 
simplistic form, this is achieved by a source and detector setup, where the two are 
positioned facing one another. By fixing the two onto a rotating gantry, their 
respective position around the object can be altered, and data can be collected over 
a range of angular positions. 
Even though simple in theoretical terms, some complicating circumstances exist. 
Firstly, the X-ray source is seldom monochromatic but rather emits a 
polychromatic spectrum of photons from an X-ray source filament. This means 
that photons of different initial energy will impinge into the field-of-view, 
interacting differently as they traverse the object (as 𝜇𝜇 = 𝜇𝜇(𝐸𝐸)). The effect of such 
is in standard image reconstruction typically neglected, but beam hardening artefacts 
commonly occur where the probability of interaction will depend on photon path 
and photon energy, respectively. Post-processing techniques exist to calibrate for 
such typically by acquiring an additional image of a water-equivalent phantom 
[231], but refined reconstructions have also been proposed incorporating the 
polychromatic behaviour of the photon spectrum into the mathematical 
formulation [232]. 
Secondly, the fan, or in 3D cone, -beam distribution of photons from the source to 
the detector differs slightly from the parallel beam distribution assumed if using 
direct Radon transform reconstruction. Instead the photon path has to be 
incorporated into the description of the system, giving rise to the need for 
reformulated reconstruction approaches [233, 234]. 
c) Image reconstruction 
Once data is sampled for all projection angles, what is left is to reconstruct the 
sought after 𝑓𝑓(𝑥𝑥, 𝑦𝑦) from this data. The reconstruction of an object from such 
indirect observations is mathematically described as an inverse problem. Following 
conventional variable representations, inverse problems deal with the 
reconstruction of a function 𝑓𝑓  given observed data 𝑔𝑔, knowing that 
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where 𝐴𝐴 is the so called forward operator, modelling how the data is generated from 
the given object 𝑓𝑓 . 𝐴𝐴 can incorporate information on scanner geometry, angular 
sampling, and even spectrum distribution, in its attempt to accurately model the 
measurements 𝑓𝑓 . To this 𝛿𝛿𝑔𝑔 represents additional noise appearing in all imaging 
systems. 
A problem in medical tomographic imaging is however that the inverse problems 
we are facing are ill-posed, meaning that we cannot easily identify 𝐴𝐴−1, that 
solutions are non-unique, and that small variations in 𝑔𝑔 will give rise to significant 
changes in reconstructed 𝑓𝑓 . 
In addition to directly inverting the Radon transform in Equation 3.30 (typically by 
so called filtered back projection (FBP) [235]), we resort to optimisation schemes in 
trying to minimise the error or data discrepancy between 𝐴𝐴(𝑓𝑓) and 𝑔𝑔 in a given setup. 
One example is the Moore-Penrose or generalised solution 𝑓𝑓†, given such that 𝑓𝑓†     minimises   ‖𝐴𝐴(𝑓𝑓) − 𝑔𝑔‖22, (3.32) 
with the data discrepancy minimised by assessing the 𝐿𝐿2-norm. The first-order 
optimality condition for this problem can be expressed as the normal equation 𝐴𝐴∗(𝐴𝐴(𝑓𝑓) − 𝑔𝑔) = 0, (3.33) 
where 𝐴𝐴∗ is the adjoint operator to 𝐴𝐴. Hence if identifying 𝐴𝐴 and 𝐴𝐴∗, and given 𝑔𝑔, 
numerical reconstruction schemes can be employed to either directly or iteratively 
minimise the above and generate a sufficient 𝑓𝑓† to approximate the true 𝑓𝑓 . 
Another option in solving 𝐴𝐴(𝑓𝑓)  =  𝑔𝑔 is using so called regularisation techniques. In 
contrast to Equation 3.31, a regularisation-based reconstruction introduces a 
regularisation function, 𝑆𝑆, acting on 𝑓𝑓 , such that our solution 𝑓𝑓† now satisfies 𝑓𝑓†     minimises   ‖𝐴𝐴(𝑓𝑓) − 𝑔𝑔‖22 + 𝜆𝜆𝑆𝑆(𝑓𝑓) . (3.34) 
Again the 𝐿𝐿2-norm is chosen for the data discrepancy, but in addition 𝑆𝑆 
regularises 𝑓𝑓† by penalising unwanted or unrealistic solutions, scaled specifically by 
the regularisation parameter 𝜆𝜆. Importantly, by selectively choosing 𝑆𝑆 and 𝜆𝜆, 
certain features in the imaged object can be emphasised, such as enhanced tissue 
boundary contrast or enforced image smoothness. 
With the above in mind, a rich spectrum of available numerical techniques exists to 
solve a tomographic inverse problem, extending far beyond the scope of this 
thesis. Excellent reviews with extensive mathematical detail are provided in [235], 
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but for clinical purposes the most commonly deployed reconstruction technique is 
the aforementioned FBP, utilising the inverse of 𝑅𝑅 with filtering in the frequency 
domain, with similar solution schemes existing for fan- or cone beam setups [233, 
234]. Common in research are the families of algebraic or iterative reconstruction 
techniques [236, 237], together with the aforementioned (variational) regularisation 
techniques [238]. For all these cases, task-specific reconstruction has proven 
successful in enhancing image contrast or diagnostic value, particularly for thoracic 
or cardiovascular purposes [239-241]. 
3.4. Cardiovascular image diagnostics 
In the following section, a review of a couple of selected areas of cardiovascular 
image diagnostics is provided. Specifically, image-based atherosclerotic plaque 
characterisation, hemodynamic pressure assessment, and pre-clinical imaging will 
be reviewed, being in direct connection to the research work carried out in this 
thesis. 
3.4.1. Carotid atherosclerotic plaque characterisation  
The prevalence and associated risks of atherosclerosis are wide-ranging, and 
extensive work has been put into understanding and staging the disease. In 
particular, the rupture or erosion of plaques is strongly correlated to embolic 
cardiovascular events, and thus so called atherosclerotic risk assessment or plaque risk 
stratification is central. How can it be clinically determined whether a plaque is a 
dangerous rupture-prone one, or whether it is a safe, stable one? Albeit simple to 
formulate, the question has occupied scientists for decades, and even though the 
mechanisms of plaque development seem evident, the multifactorial complexity 
and range of plaque types complicates risk stratification. Cardiovascular imaging 
and image diagnostics has however provided clinicians with a powerful tool to 
assess atherosclerotic development in-vivo, and several methods have shown 
promise in early-stage clinical implementations [242-247]. 
a) Clinical routine assessment 
Typically, clinical assessment of atherosclerosis is initiated on the basis of 
occurring cardiovascular symptoms (angina, exercise difficulties, fatigue, etc.). In 
fact, current guidelines advice against routine screening of asymptomatic patients, 
following the lack of evidence of any cardiovascular risk reduction [228, 248]. 
Once admitted, the first-line of evaluation is to assess the degree of luminal plaque 
protrusion or vascular stenosis. This is done by B-mode ultrasound imaging, as well as 
through Duplex imaging where B-mode and colour Doppler is overlaid. Using 
such, the degree of stenosis can be quantified both using geometrical dimensions 
as well as through hemodynamic flow assessment. Alternative complements to 
Duplex evaluations are CT angiography (CTA) or MRI, where again the degree of 
stenosis can be assessed through visual inspection. However, simple stenosis 
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assessment does not reveal any information on plaque morphology, and counter-
intuitively, plaque vulnerability is not always correlated to a higher degree of 
stenosis [155, 156, 249]. This is partly due to positive arterial remodelling [250, 
251], where a compensatory arterial enlargement is initiated during plaque 
progression, but stenosis-based assessment is also problematic since severe 
intraluminal protrusion only occurs at fairly late stages of plaque development 
[141, 252]. 
Instead, methods assessing plaque composition and morphology have been 
developed. Below follows a short review of such techniques, organised by imaging 
modality. Specific focus is given on ultrasound and ultrasound elastography, 
partially following the methods’ clinical availability and cost-effectiveness, but 
primarily following the promising results such techniques have shown in 
quantifying plaques of different morphology and composition [242, 243, 246, 253-
255]. An illustrative overview of some of the described techniques is given in 
Figure 3.17. 
b) Ultrasound imaging for the assessment of carotid atherosclerosis 
A wide range of ultrasound-based techniques exist to assess plaque morphology or 
vulnerability. In short, we might classify these as evaluating plaque morphology 
either by structural assessment, elastographic assessment, or by indirect assessment. 
Structural assessment: In this thesis, structural assessment refers to methods directly 
evaluating the morphological appearance of a plaque in ultrasound B-mode 
imaging. This direct measurement of plaque echogenicity has in early studies showed 
to differentiate lipid-rich plaques from more fibrotic and calcified ones [256], and a 
number of studies have since indicated a correlation between echogenicity and 
plaque vulnerability [157, 257]. With echogenicity initially graded on a qualitative 
scale (the Gray-Weale scale [256]), a refined metric of plaque echogenicity has been 
proposed in the so called grayscale median (GSM), where the median average of all 
plaque pixel intensities is derived to determine plaque vulnerability. An inherent 
drawback of using plaque echogenicity however lies in the methods wide-ranging 
sensitivity [258], potentially following from the overlap in echogenicity between 
several different plaque features. As indicated in [258], both a lipid core and a 
fibrous plaque appear as echolucent homogenic, and both a calcified plaque and a 
plaque with intraplaque haemorrhage appear as echogenic heterogenic. 
An alternative way of evaluating structural plaque features is by using contrast-
enhanced ultrasound (CEUS), where studies have shown that intraplaque 
haemorrhage and intraplaque vasa vasorum can be visualised, showing correlation 
to an active, vulnerable, plaque centre [259, 260]. Similarly, CEUS might aid in 
differentiating soft echolucent plaque features from the intraluminal blood flow, 
even though the overlap in echogenicity within the plaque remains. The technique 
is however limited by the use of an external contrast agent, and has so far only 
been applied in a few clinical cases. 
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Figure 3.17: Overview of a few image techniques for plaque characterisation or plaque risk 
assessment. (A) Duplex ultrasound. (B) Echogenicity assessment through B-mode imaging. (C) 
Contrast-Enhanced Ultrasound, here used to identify intraplaque neovascularisation. (D) 
Intravascular ultrasound virtual histology. (E) Acoustic Radiation Force Impulse (ARFI) Imaging. (F) 
Shear Wave Elastography (SWE). (G) B-mode imaging for intima-media thickness (IMT) estimation. 
(H) CT Angiography of the coronary arteries. (I) Coronary artery calcification (CAC) scoring by CT. 
(J) Intraplaque soft tissue differentiation by MRI. (K) Optical coherence tomography. (L) PET/CT to 
evaluate plaque inflammation. Assembled and reproduced with permission [255, 261-266]. 
A method that refines traditional B-mode plaque assessment is the so called virtual 
histology [244]. Here, Fourier-based analysis of the RF-data is performed where 
different plaque features are identified based on statistical classification of each 
composites frequency distribution. Implemented for intravascular ultrasound 
(IVUS), the method has been applied in a number of clinical trials [267-269], 
however is limited by its invasiveness. 
Elastographic assessment: Elastographic assessment refers to methods evaluating 
plaque vulnerability based on its constitutive properties. With plaque composition 
related to its stability, mapping of plaque elasticity could be similarly related to 
vulnerability. As shown in [192], calcified, fibrous, non-fibrous, and lipid-rich 
plaque constituents differ significantly in radial elastic modulus, indicating the 
potential of elastography plaque differentiation. 
In its most direct form, strain imaging by speckle-tracking utilises formed speckle 
patterns to derive strain maps of investigated tissue [270, 271]. The strains are here 
induced by the intraluminal pressure pulses, and several studies have employed the 
technique to assess plaque composition, significantly distinguishing lipid-rich 
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plaques in a study by Naim et al. [192]. Similarly, non-invasive strain imaging has 
been applied to detect lipid compartments and calcified nodules in carotid plaques 
[242], to differentiate asymptomatic from symptomatic plaques [254], as well as to 
detect fibro-atheromatous plaques by refined beam compounding [253]. 
Strain imaging can also be utilised in IVUS, forming the field of IVUS 
elastography. As with non-invasive strain imaging, strains induced by intraluminal 
pressures are used to retrieve tissue strain distribution maps [194]. The technique 
has most prominently been employed in coronary arteries [272], successfully 
identifying lipid-rich and macrophage-prevalent areas in-vivo as well as 
demonstrating both high sensitivity and specificity [273]. As with the case of virtual 
histology however, IVUS elastography is clinically limited by the need for invasive 
catheterisation. 
In contrast, acoustic radiation force-based methods uses externally induced 
displacements, having shown similar promise for refined plaque characterisation. 
ARFI imaging has been applied in several studies [243, 274, 275], specifically 
correlating areas of low displacement to collagen-rich components in-vivo [276]. 
However, soft-plaque components (lipid core, intraplaque haemorrhage) seem to 
show similar peak displacement values in ARFI [277], impairing its clinical 
application. 
SWE similarly uses an externally imposed regional displacement, however tracks 
induced shear waves through the investigated tissue. The technique has been 
employed for plaque characterisation in-vivo [255, 278], but a complication exists in 
the geometrical constriction of arterial and plaque tissue. In such cases, the 
propagation of the induced shear waves will exhibit guided dispersion behaviour, 
where the assumptions of Equation 3.24 no longer holds. 
To recapitulate, in the case of isotropic, homogeneous, infinite wave propagation, 
Equation 3.24 holds, giving a direct relation between estimated shear wave velocity 
and shear modulus. However, for non-infinite wave propagation, geometrical 
boundaries will interfere with the propagating wave. Analytical solutions have been 
derived for wave propagation through plates (using so called Lamb wave theory 
[201]), as well as for hollow cylinders [202], however in the case of more 
complicated geometries, numerical approximations have to be utilised to describe 
the propagating wave. For the specific case of arterial SWE, Bernal et al. [203] 
derived a practical analytical expression for the so called zero-order antisymmetric 
mode in a solid plate submerged in an inviscid incompressible fluid, which has 
since been successfully used to describe shear wave propagation in arterial and 
atherosclerotic phantoms in-vitro [198, 279]. Specifically, the expression states that 
under such circumstances, the relation between compressional and shear wave 
velocity, 𝑐𝑐𝐿𝐿 and 𝑐𝑐𝑠𝑠, is given by 
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(3.35) 
where 𝛽𝛽 is defined as 𝛽𝛽 = �� 𝜔𝜔𝑐𝑐𝐿𝐿�2 − �𝜔𝜔𝑐𝑐𝑠𝑠�2 , 
 
(3.36) 
with 𝜔𝜔 the angular frequency, and ℎ the estimated vessel wall thickness. With 𝛽𝛽 
and the embedded 𝑐𝑐𝑠𝑠 proportional to shear elasticity, experimental arterial SWE 
results can be fitted to Equation 3.35 by varying resulting media elasticity. Note 
that this involves analysing the acquired shear wave’s frequency-dependent velocity 
behaviour, or phase velocity, in contrast to the wave package group velocity, typically 
assessed using Equation 3.24. 
Wave model-based elasticity measures have been performed both in-vitro [279] and 
in-vivo [280] for cardiovascular purposes. The techniques’ accuracy and applicability 
is however still under investigation. 
Finally on elastographic assessment techniques, a less explored technique is the so 
called thermal strain imaging (TSI) technique, where the fact that lipid-rich tissue 
exhibits a temperature dependent acoustic wave speed (compared to water-rich 
tissue) is utilised to classify tissue components [281]. Even though applied 
successfully in animals, the technique’s applicability in humans remains to be 
investigated. 
Indirect assessment: In this thesis, indirect assessment refers to methods indirectly 
evaluating plaque vulnerability by imaging of adjacent or related tissue structures. A 
common metric is the intima-media thickness (IMT), a quantity distinguishable by 
the difference in echogenicity between blood pool, intima-media, and adventitia, 
respectively. IMT measurements have even been applied for earlier-stage plaque 
assessment [282] showing relation to increased cardiovascular risk [283]. However, 
the method does naturally not differentiate between plaque types, and even though 
the method is part of clinical guidelines for assessing high-risk patients [8], a 
systematic review study found no support for the use of IMT in low to 
intermediate risk cohorts [284]. 
Lastly, another indirect assessment of the manifestation of atherosclerosis is by 
assessing arterial stiffness. Even though the causal direction is unclear [285] several 
studies have correlated increased arterial stiffness with atherosclerosis [286, 287]. 
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Clinical guidelines recommend the estimation of pulse wave velocity (PWV) to 
estimate arterial stiffness [288], where the velocity of the arterial pressure pulse is 
related to arterial stiffness through the Moens-Korteweg equation [289]. The 
estimate is however often based on crude assessment of the arterial pulse, and 
inherent assumptions in the Moens-Korteweg equation limits accuracy. Instead, 
refined arterial stiffness estimations can be achieved either by elastography imaging 
or by pulse wave imaging (PWI), where regional stiffness is assessed by ultrafast 
tracking of intraarterial displacements, induced by the passing pressure wave [290]. 
The technique has mostly been employed for aneurysm developments [291] but a 
few examples exist of its application towards atherosclerotic evaluations [292]. 
c) CT for the assessment of carotid atherosclerosis 
Transmission-based imaging can also be used to assess atherosclerotic lesions, and 
is as mentioned part of guidelines for stenosis grading. Both 2D digital subtraction 
angiography (DSA) [293] and 3D CTA can be used, however without revealing 
information about plaque composition. 
Attenuation-based plaque characterisation can however be attempted with 
standard CT. With the attenuation of calcium far exceeding the attenuation of 
surrounding lipid-rich soft tissue, dense calcification can be detected at very high 
specificity and sensitivity levels using CT. This had led to the development of the 
coronary artery calcification (CAC) score [294] being one of few image-based 
plaque characterisation scores used in clinics. Being semi-quantitative, the scores 
weigh the attenuation of a given plaque with identified risk factors such as 
hypertension, obesity, and age, to determine the risk for future cardiovascular 
events. Studies have been performed indicating correlation between CAC score 
and event rate [295, 296], however plaque calcification is still not regarded as one 
of the hallmarks of a vulnerable plaque. Instead, calcification is typically seen as an 
advanced-stage stabilising force [297], and it remains to be seen whether CAC is 
comparable to more recently proposed soft-component plaque differentiation 
(using e.g. aforementioned ultrasound based techniques) in larger clinical studies. 
Developments in the field of dual-energy or spectral CT (using energy-
differentiating detectors) have also shown promise for plaque characterisation, 
where differentiation of lipid, calcium, and atheroma-included iron has been 
achieved both ex-vivo [298] and in pre-clinical in-vivo trials [299]. The techniques are 
though still in early-stage development, and their clinical usage remains to be 
evaluated. 
Summarising the above, CT is a viable modality for plaque assessment, and is 
particularly advantageous for coronary artery assessment following its high spatial 
resolution. Its radiation-based nature however limits applicability, particularly as a 
screening-based imaging modality. 
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d) MRI for the assessment of carotid atherosclerosis 
With the excellent soft tissue contrast of MRI, the modality has potential for 
accurate plaque characterisation. In fact, differentiation of soft tissue plaque 
components such as lipid-rich necrotic core, intraplaque haemorrhage, or fibrous 
tissue have been successfully achieved using MRI in a number of studies [140, 245, 
300, 301], with high sensitivity and specificity reported specifically when 
combining T1- and T2-weighted images [302]. 
Alternative measures of plaque initiation have also been proposed by flow-based 
MRI. Regional wall-shear stresses and turbulence production, metrics proposed to 
correlate to plaque initiation [300, 301, 303, 304], can both be measured using 4D 
flow MRI [81, 305]. Additionally, as in the case of ultrasound imaging, MR 
elastography (MRE) has the theoretical potential for refined plaque analysis. 
However, to date no larger application of MRE for atherosclerotic analysis exists, 
primarily due to the restricted spatial resolution. 
MRI is hence another interesting option for refined plaque characterisation, not 
least in acting as a non-invasive validation technique. However, clinical MRI is still 
limited by relatively poor spatial resolution, long acquisition times, and expensive 
equipment. 
e) Other imaging techniques for the assessment of carotid atherosclerosis 
In addition to the more conventionally used stenosis grading or plaque 
characterisation modalities above, a few other techniques for plaque analysis are 
worth mentioning. 
A first class are the optical techniques, where an intravascular probe emitting near-
infrared light is used to analyse plaque constituents. Specifically, Optical Coherence 
Tomography (OCT) has been successfully used in a number of coronary plaque 
studies [306-308], where differentiation of several soft tissue plaque components 
has been achieved at very high spatial resolution. The method has also been 
proposed as a viable technique for the assessment of plaque erosion [309]. This is a 
potentially important implication, since plaque erosion has been found to cause up 
to 30% of all sudden cardiac death events (compared to ~60% counted for by 
plaque rupture) [310], and is in general much less understood than plaque rupture. 
Secondly, emission-based imaging such as PET or SPECT could be useful in their 
ability to identify regions of local inflammation. [18F]-Fluorodeoxyglucose (FDG) 
PET has been used to image plaque inflammation [266] and has shown the 
potential of differentiating unstable plaques from smaller asymptomatic lesions 
[310]. However, apart from inflammatory identification, no differentiation between 
soft-tissue components can be achieved, and the technique is still hampered by its 
use of radiation and high cost. 
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3.4.2. Hemodynamic pressure assessment 
The following section will focus on the hemodynamic assessment of blood 
pressure, or changes in blood pressure as the pressure wave travels through the 
cardiovascular system. As already mentioned, this is a clinically important metric 
describing the driving force of blood in the cardiovascular system, and is part of 
several clinical guidelines [59, 61, 90]. 
Despite its clinical value, pressure measurements are still largely restricted to 
invasive procedures, or to crude simplifications of the assessed hemodynamic 
environment. In part, this originates from the fact that pressure cannot be directly 
assessed using currently available imaging techniques, but is rather a metric that has 
to be derived from direct measurements of flow. With such, the accuracy of the 
assessment will depend both on the accuracy of the flow measurement, as well as 
on the accuracy of the fluid mechanical flow description. However, with refined 
imaging techniques now enabling full-field assessment of cardiovascular flow, 
refined pressure assessment methods have been proposed. In the following, a few 
of the most promising ones are reviewed and presented. 
a) Clinical routine assessment 
In clinical practice, the use of catheterised pressure sensors is regarded as gold-
standard for the assessment of regional blood pressure [78]. Using such catheters, 
1D real-time pressure data can be obtained, with a clinician guiding the position of 
the catheter tip by simultaneous angiographic imaging. The method enables the 
direct measurement of absolute pressure, but is also commonly used to assess 
relative pressure by either using a so called pullback procedure (where the catheter 
tip is pulled from one position to another), or by using a double-sensor probe. In 
cardiovascular diagnostics pressure assessment by catheterisation is a common 
procedure, however, the technique is still limited by its inherent invasiveness and 
the risks associated with such [311]. In fact, a recent study did show a significant 
increase in cerebral embolism in patients undergoing AV catheterisation [312], 
underlining the technique’s limitation as a general-purpose method. 
An alternative but even more common way of assessing absolute blood pressure is 
by sphygmomanometer cuffing, where an inflatable cuff and mechanical 
manometer are used to assess peripheral systolic and diastolic blood pressure. 
Even though accurate in assessing these two metrics, sphygmomanometer cuffing 
does not provide any information about central blood pressure, and is limited to 
peripheral limbs. 
Medical imaging is also used in clinical routine to assess cardiovascular pressure. 
Specifically, relative pressure or pressure drops are typically measured by Doppler 
echocardiography, where acquired velocities are correlated to pressure changes by 
the Bernoulli principle. In its most basic form, and as used in clinical guidelines 
[313], the Bernoulli equation given in Equation 3.2 is simplified into 
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where ∆𝑝𝑝 is the pressure drop between pressure 𝑝𝑝2 and 𝑝𝑝1, and 𝑣𝑣𝑚𝑚𝑚𝑚𝑥𝑥 is the 
maximum velocity at the most narrow part of an assessed stenosis or valve. The 
coefficient 4 comes from assumptions on blood density values (𝜌𝜌 = 1060 kg/m3), 
as well as on the conversion required from Pa to mmHg (1 mmHg = 133 Pa). 
Even though effective under certain conditions, it is important to remember that 
Equation 3.37 originates from a simplified description of cardiovascular flow, 
where any influence from kinetic or viscous behaviour is neglected. Similarly, the 
above assumes complete pressure recovery, meaning that any laminar or turbulent 
pressure loss is similarly neglected. 
Consequently, apparent differences have been observed when comparing Doppler-
based pressure assessment to invasive gold-standard catheterisation [314-316]. 
Specifically, it has been shown that a Doppler-based simplified Bernoulli approach 
typically overestimates true pressure drops, and that this overestimation increases 
with increasing stenosis degree [64]. This overestimation not only originates from 
the neglected viscous and kinetic flow components, but also from the fact that 
Doppler-measurements only evaluate flow in the direction of the interrogating 
ultrasound beam (as described in Section 3.3.1.). That is, in Doppler-based 
pressure assessment, the blood flow is considered as a single streamline; an 
assumption typically violated in stenotic flow. Additionally, energy dissipation due 
to turbulence production is also neglected in the simplified Bernoulli approach, 
having shown to similarly skew relative pressure assessment [317]. 
b) Alternative image-based techniques 
Several methods have been proposed to extend on the simplified Bernoulli 
approach. Staying with the Doppler-based assessment, a modification by 
incorporating energy loss as a function of effective valve orifice area (EOA) was 
proposed by Garcia et al. [318], stating that ∆𝑝𝑝 = 𝑝𝑝2 − 𝑝𝑝1 = −4𝑣𝑣𝑚𝑚𝑚𝑚𝑥𝑥2 �1 − 𝐸𝐸𝐸𝐸𝐴𝐴𝐴𝐴𝐴𝐴 �2, 
 
(3.38) 
where 𝐴𝐴𝐴𝐴 is the vessel cross-sectional area. With this extended Bernoulli 
effectively measuring pressure recovery (following the evaluated energy loss), the 
method has been shown to correlate to invasive catheterisation in simple 
geometries [318], and has similarly been proposed as a refined metric for grading 
valvular stenosis [316]. However, the extended Bernoulli approach still assumes 
negligible viscous effects (potentially deteriorating accuracy in low-flow regimes), 
and it has been hypothesised to perform less well in regions of mild-diffuse or 
multiple orifice stenosis [317]. Similarly, using Doppler assessment still assumes the 
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aforementioned single streamline setup, where an increased systematic bias may be 
observed with increasing stenosis degree. 
Extending on the above, the development of full-field imaging techniques (4D 
flow MRI, ultrasound vector velocity imaging) has permitted a more accurate and 
complete description of cardiovascular flow. If assessing the transient velocity field 
along a given flow path or streamline, the unsteady Bernoulli formulation in 
Equation 3.6 can be utilised to derive relative pressures [62]. With such, the effect 
of inertial accelerations is added to the approach of the simplified Bernoulli 
equation. However, by only evaluating the velocity over a centre streamline of the 
velocity field, a large portion of the entire flow is still neglected, and applications 
into low-flow or complex vasculatures becomes restricted. 
Instead, incorporating data from the full 3D(+time) velocity field, the complete 
Navier-Stokes equations (Equations 3.7-3.8) can be utilised to derive relative 
pressure, as was early suggested on acquired MRI data [319]. In a relatively recent 
approach, the re-formulation of the problem into a so called Poisson Pressure 
Equation (PPE) has been exploited to derive relative pressure from acquired 
clinical data [220, 320]. Specifically, the spatial pressure gradient ∇𝑝𝑝 is redefined as 
a volume source term 𝑏𝑏, stating that 𝑏𝑏 = ∇𝑝𝑝, (3.39) 
or, utilising Equation 3.7, reading 
𝑏𝑏 = ∇𝑝𝑝 =  𝜇𝜇𝛻𝛻2𝒗𝒗 − 𝜌𝜌 𝜕𝜕𝒗𝒗𝜕𝜕𝜕𝜕 − 𝜌𝜌𝒗𝒗 ⋅ ∇𝒗𝒗. (3.40) 
By applying the divergence operator on both sides, we reach what is typically 
denoted as a Poisson’s equation, namely ∇ ∙ 𝑏𝑏 = ∇ ∙ ∇𝑝𝑝. (3.41) 
Using numerical solution schemes (typically the Finite Element Method (FEM)) 
the above can be solved at relatively high accuracy, with results provided as a 3D 
pressure field over the entire evaluated domain. 
The PPE is advantageous in that it incorporates all components of the Navier-
Stokes equations. However, by the application of an additional divergence operator 
in Equation 3.41 the pressure field will be assessed using higher order derivatives. 
By such, the method has shown to be very sensitive to the definition of the flow 
domain [64, 321], and in fact, even under simplified conditions, the PPE-approach 
has shown to have a strong underestimation bias [322]. Additionally, the complete 
FEM-solution of a 3D pressure field can be fairly computationally demanding, 
wherefore a PPE-approach might be limited in its clinical use. 
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As a variation on the PPE approach, Švihlová et al. [323] presented the Stokes 
estimator (STE), where an auxiliary flow field 𝒘𝒘 is solved for as a Stokes problem 
with right-hand side defined by the pressure gradient ∇𝑝𝑝. Specifically this means 
solving ∇2𝒘𝒘 + ∇𝑝𝑝𝑆𝑆𝑆𝑆𝑆𝑆 = 𝑓𝑓(𝒗𝒗), (3.42) ∇ ∙ 𝒘𝒘 = 0, (3.43) 
with 𝑓𝑓(𝒗𝒗) =  𝜇𝜇𝛻𝛻2𝒗𝒗 − 𝜌𝜌 𝜕𝜕𝒗𝒗𝜕𝜕𝜕𝜕 − 𝜌𝜌𝒗𝒗 ⋅ ∇𝒗𝒗. (3.44) 
In Švihlová et al. Equations 3.42-3.43 are computed using an FEM-solver, 
rendering a relative pressure field ∇𝑝𝑝𝑆𝑆𝑆𝑆𝑆𝑆 associated to the auxiliary flow field 𝒘𝒘. 
However, as this is constrained by Equation 3.44, given by the acquired real 
flow field 𝒗𝒗, it will be directly correlated to the real relative pressure field ∇𝑝𝑝. 
The STE approach has shown increased accuracy compared to the PPE-
approach [322], however has so far only been implemented in simplified in-silico 
geometries [323]. As with PPE, STE also potentially requires a computationally 
demanding solver, and the method’s sensitivity to the defined flow domain 
remains to be investigated (even though the higher order derivatives of 
Equation 3.41 are avoided in the Stokes approach of Equations 42-43). 
In an attempt to overcome the need for higher order derivatives, and to avoid the 
complete solution of a pressure field through an FEM-solver, a direct energy-based 
approach can instead be used. In particular, the so called Work-Energy Relative 
Pressure (WERP) method was proposed by Donati et al. [324], where the work-
energy relation of the acquired flow field is evaluated. Specifically, to obtain the 
work-energy equation of the acquired flow, the Navier-Stokes equations in 
Equation 3.7-3.8 is multiplied by the velocity field 𝒗𝒗, and integrated over the 
domain Ω, yielding 𝜌𝜌2 𝜕𝜕𝜕𝜕𝜕𝜕� (𝒗𝒗 ∙ 𝒗𝒗)𝑑𝑑Ω +Ω 𝜌𝜌 � (∇ ∙ 𝒗𝒗𝒗𝒗) ∙ 𝒗𝒗𝑑𝑑ΩΩ − 𝜇𝜇 � ∇2𝒗𝒗 ∙ 𝒗𝒗𝑑𝑑ΩΩ + � ∇𝑝𝑝 ∙ 𝒗𝒗𝑑𝑑Ω = 0Ω . (3.45) 
Again, Equation 3.45 now describes the work-energy within the acquired flow field 𝒗𝒗, in the direction of the same field 𝒗𝒗. Through integration by parts (converting 
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volume integrals over Ω to surface integrals over the domain boundary Γ with 
normal 𝒏𝒏) the above can be expressed as a function of separate energy entities as 𝜕𝜕𝜕𝜕𝜕𝜕𝜕𝜕 + 𝐴𝐴 − 𝑆𝑆 + 𝑉𝑉 + 𝐻𝐻(𝑝𝑝) = 0 (3.46) 
where 𝜕𝜕𝜕𝜕𝜕𝜕𝜕𝜕 = 𝜌𝜌2 � (𝒗𝒗 ∙ 𝒗𝒗)Ω 𝑑𝑑Ω, (3.47) 𝐴𝐴 = 𝜌𝜌 � (𝒗𝒗 ∙ ∇𝒗𝒗) ∙ 𝒗𝒗 𝑑𝑑ΩΩ , (3.48) 𝑆𝑆 = � (𝜇𝜇∇𝒗𝒗 ∙ 𝒏𝒏) ∙ 𝒗𝒗𝑑𝑑Γ,Γ  (3.49) 𝑉𝑉 = � 𝜇𝜇∇𝒗𝒗 ∶ ∇𝒗𝒗Ω 𝑑𝑑Ω, (3.50) 𝐻𝐻(𝑝𝑝) = � 𝑝𝑝 𝒗𝒗 ∙ 𝒏𝒏𝑑𝑑ΓΓ . (3.51) 
Specifically, 𝜕𝜕 denotes the kinetic energy of 𝒗𝒗 within Ω, 𝐴𝐴 the advective energy 
transfer of 𝒗𝒗 in and out of 𝛺𝛺, and 𝑉𝑉  the viscous energy dissipation. 𝐻𝐻 and 𝑆𝑆 
denotes the energy input to the system, represented by the hydraulic power and 
shear energy rate, respectively. 
By splitting the domain boundary 𝛤𝛤  into an inlet, outlet, and vessel wall domain 
respectively (Γ = Γ𝑖𝑖  ∪ Γ𝑜𝑜 ∪ Γ𝑤𝑤), and assuming nearly constant pressure over 
inlet and outlet planes, we can expand the hydraulic power as 𝐻𝐻(𝑝𝑝) = 𝑝𝑝𝑖𝑖 �  𝒗𝒗 ∙ 𝒏𝒏𝑑𝑑ΓΓ𝑖𝑖 + 𝑝𝑝𝑜𝑜 �  𝒗𝒗 ∙ 𝒏𝒏𝑑𝑑ΓΓ𝑜𝑜 + 𝑝𝑝𝑤𝑤 �  𝒗𝒗 ∙ 𝒏𝒏𝑑𝑑ΓΓ𝑤𝑤 , 
 
(3.52) 
which, when negligible vessel compliance is assumed (i.e. |𝒗𝒗 ∙ 𝒏𝒏| ≪ 1) simplifies 
into 𝐻𝐻(𝑝𝑝) = 𝑝𝑝𝑖𝑖 �  𝒗𝒗 ∙ 𝒏𝒏𝑑𝑑ΓΓ𝑖𝑖 + 𝑝𝑝𝑜𝑜 �  𝒗𝒗 ∙ 𝒏𝒏𝑑𝑑ΓΓ𝑜𝑜 = ∆𝑝𝑝 ∙ 𝑄𝑄. 
 
(3.53) 
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In the above, the relative pressure ∆𝑝𝑝 = 𝑝𝑝𝑜𝑜 − 𝑝𝑝𝑖𝑖 is thus related to 𝐻𝐻 by the 
surface flux 𝑄𝑄, defined as 𝑄𝑄 = �  𝒗𝒗 ∙ 𝒏𝒏𝑑𝑑ΓΓ𝑜𝑜 = − �  𝒗𝒗 ∙ 𝒏𝒏𝑑𝑑ΓΓ𝑖𝑖 . (3.54) 
where 𝑄𝑄 is the flux (or blood flow rate) through Γ𝑖𝑖 or Γ𝑜𝑜, respectively. Note 
that Equation 3.54 is valid when the flow in and out of the domain Ω is equal, 
i.e. under strict mass conservation. This holds when assessing a single-vessel 
geometry (such as a stenosis or valve) but becomes violated if assessing 
bifurcating vasculatures. 
With the shear energy rate 𝑆𝑆 virtually zero when no major gradient exist in the 
direction of the boundary normal 𝒏𝒏, we can thus rewrite Equation 3.46 as 
Thus, by assessment of kinetic, advective, and viscous energy components 
(directly computable from the velocity field as per Equations 3.47, 3.48 and 
3.50) an estimation of relative pressure between a given inlet and outlet surface 
can be obtained (for detail of the mathematical derivation, see [324]). 
Since presented, WERP has shown promise in assessing transvalvular relative 
pressure, specifically in situations where simplified Bernoulli estimates fail [64]. 
Also, WERP has shown to perform favourably to PPE-estimates in simplified 
geometries [322]. However, as mentioned Equation 3.55 only holds in the 
absence of bifurcating flow, and similarly the division with 𝑄𝑄 in Equation 3.55 
also limits the method to systolic high-flow pressure events. 
c) Alternative image-based techniques incorporating turbulence 
In addition to the above mentioned methods, a separate sub-class of techniques 
exists, where the effect of turbulent flow features is incorporated in the fluid 
mechanical description (for the importance of turbulent flow structures, see 
Section 3.1.4.). 
Some earlier work correlating the production of turbulent kinetic energy (TKE) to 
irreversible pressure drop exist in literature [81, 325], but for a direct derivation of 
relative pressure, two explicit methods are worth mentioning. 
First, Gülan et al. [326] proposed computing turbulence production by a shear-
scaling method, where the turbulence-driven relative pressure can then be 
computed by 
Δ𝑝𝑝 = − 1𝑄𝑄�𝜕𝜕𝜕𝜕𝜕𝜕𝜕𝜕 + 𝐴𝐴 + 𝑉𝑉 �. (3.55) 
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CHAPTER 3. BACKGROUND Δ𝑝𝑝 = − 1𝑄𝑄� 2𝜇𝜇𝑺𝑺𝑺𝑺 + 𝑐𝑐𝑆𝑆𝜌𝜌‖𝑺𝑺‖diag(Cov[𝒗𝒗, 𝒗𝒗]) 𝑑𝑑ΩΩ , (3.56) 
where 𝑺𝑺 is the strain rate tensor of the mean velocity field (more specifically the 
symmetric component of the spatial gradient, i.e. 𝑺𝑺 = 12[∇𝒗𝒗+∇𝒗𝒗𝑇𝑇 ]). The method 
has proven accurate in-silico, but in-vitro evaluations have shown a significant 
dependence on the empirical scaling coefficient 𝑐𝑐𝑆𝑆 [317]. 
Second, Ha et al. [82] presented a method similarly using turbulence production, 
however expressing the pressure drop in terms of analysing work-energy in the 
acquired field (similar to the aforementioned WERP approach). With such the 
method is similar to the WERP formulation of Equation 3.55, and in case of a 
purely turbulence-driven relative pressure takes the form Δ𝑝𝑝 = − 𝜌𝜌𝑄𝑄� Cov[𝒗𝒗, 𝒗𝒗] 𝑺𝑺𝑑𝑑ΩΩ , 
 
(3.57) 
again utilising the strain rate tensor of the mean velocity field together with the 
covariance to derive relative pressure. As with the shear-scaling method, the 
turbulence production-based method in Equation 3.57 has rendered promising 
results in-vitro [317], however with in-vivo results still to be presented. Importantly, it 
should also be noted that the above has only been evaluated in steady-state static 
flow scenarios, and the expansion into transient kinetic flows is not directly 
permitted by the expression given in Equation 3.57. 
3.4.3. Pre-clinical cardiovascular imaging 
Pre-clinical imaging typically refers to imaging of living animals or ex-vivo tissue, 
carried out in a controlled laboratory environment. As such, pre-clinical imaging is 
an important research tool for in-depth studies of biological processes, where 
fundamental concepts or protocols can be developed prior to any implementation 
in humans (a pre-clinical phase, often including imaging session, are a fundamental 
first part of any clinical trial [327]). Importantly, following its non-invasive nature 
pre-clinical imaging also allows for longitudinal observations, where the complete 
natural progression of a disease or interventional effects can be studied. 
Pre-clinical imaging and animal models are extensively used in cardiovascular 
research. In particular, with the development of gene knockout and transgenic 
murine breeds, animal models have become extremely effective in isolating causal 
factors for specific cardiovascular disease. The apolipoprotein-E knockout mice 
(ApoE-/-) is specifically designed for developing complex atherosclerotic lesions 
[328], and similar Leiomodin 2 knockout (Lmod2-/-) has shown to initiate 
pathologic cardiac dilation in mice [329]. Interventional procedures can also 
effectively induce certain pathological conditions, where coronary artery balloon 
occlusion is a typical procedure for initiating myocardial infarction [330] and 
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similarly pacemaker-induced chronic tachycardia can be used to initiate heart 
failure [331]. 
With specific disease initiated or pathways identified, imaging of these animal 
models is also common. As clinically, pre-clinical MRI can be performed to assess 
cardiac dimensions or plaque constituents [332], and emission-based tomographic 
imaging (SPECT or PET) can effectively reveal the degree of myocardial infarction 
[333] or image general metabolic function [334] in mice. Pre-clinical systems also 
allow for high-resolution imaging beyond what is possible using conventional 
clinical imaging. Micro-CT has been used to image rat myocardial infarction at sub-
mm resolution [335], contrast-enhanced ultrafast ultrasound has recently been 
shown to effectively image the mouse cerebrovasculature at super-resolution 
(~µm) [336], and pinhole apertures have enabled pre-clinical sub-mm SPECT 
imaging [337]. Even though yet to be applied in the field of cardiovascular 
research, rapid detector and acquisition developments promise pre-clinical imaging 
at even higher spatial (nm [338]) or temporal (ps [339]) scale. 
Similarly, ex-vivo imaging of tissue samples is an effective tool for non-invasive, 
detailed investigation in cardiovascular research. Again, micro-CT has been used in 
a number of studies to image endarterectomy or autopsy plaque specimens, 
revealing details of the vasa vasorum [340], comparing equivalent to 
histomorphometric analysis [341], and even used to correlate pre-clinical to clinical 
CT findings [247]. Similarly, pre-clinical MRI of myocardial tissue has been used to 
evaluate cardiac fibre orientation [247] or laminar structure [342]. Lastly, pre-
clinical ex-vivo tissue imaging can also serve as an important bench-mark or 
validation for continued in-vivo analysis, such as shown in a number of arterial 
elastography studies [280, 343]. 
The technical details of pre-clinical imaging systems however differ from human-
size clinical ones. In particular, translating clinical technologies to miniaturised pre-
clinical scale requires improvement in system resolution and performance 
(comparative specifications for clinical versus pre-clinical imaging systems are 
provided in Table 3.2). 
To achieve high-resolution CT-imaging (as in pre-clinical micro-CT) both X-ray 
source and detector have to be modified. For the X-ray source, so called micro-
focus tubes are typically utilised where a µm focal spot size can be achieved, 
however at the cost of limited output power. Further, detector elements in the µm-
range have to be employed. Technically, decreasing pixel size is not a 
manufacturing problem, however affects the detected photon flux and 
corresponding relative SNR in each pixel. To exemplify: changing from a 1 mm2 
pixel in a clinical system to a 10 µm2 pixel in a pre-clinical one means that the 
photon flux of one clinical pixel is now divided onto 10000 pre-clinical pixels. 
Consequently, significantly increased X-ray flux or acquisition time is required to 
gain similar contrast in the pre-clinical system (as seen in the differences in typical 
scan time in Table 3.2). For static ex-vivo imaging this is not a major obstacle, but 
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for dynamic or longitudinal animal studies, this reduced spatial resolution or 
required increase in dose might influence output results.  
For pre-clinical MRI, again the modification of required spatial resolution poses 
high demands on improved hardware. In practice, this means using stronger 
magnetic fields and applied gradients, dedicated receiver coils, and refined 
acquisition sequences. Specifically, field strengths of up to 21T have been used for 
pre-clinical MRI [344], differing significantly from clinical standard fields (~1.5T). 
To this, small and dedicated RF-coils [345] typically using phased-array setups with 
coil frequencies ~500Hz have to be utilised to induce and capture tissue 
electromagnetic relaxation. Additionally, as in micro-CT imaging, pre-clinical MRI 
SNR scales with acquisition time [346] wherefore pre-clinical MRI requires 
significantly longer scan times compared to clinical MRI acquisitions (see Table 
3.2). 
In its technical setup, pre-clinical ultrasound imaging does not necessarily differ 
from clinical imaging. Instead, an increase in transducer frequency allows for 
increased axial resolution, although at the expense of limited penetration depth. 
For pre-clinical imaging this is however not a major problem, as the imaged animal 
or tissue are typically fairly small. 
For micro-ultrasound imaging, dedicated high-frequency transducers of up to 70 
MHz can be used [347] to push acquired resolutions into the µm range. To this, 
developments of plane wave acquisitions schemes have in a pre-clinical setup been 
shown to enable single-digit µm resolution [336]. Importantly, both these setups 
do not compromise scan-time, wherefore pre-clinical ultrasound imaging can be 
virtually performed real-time, being of significant advantage to other pre-clinical 
modalities when studying dynamic phenomena. 
Pre-clinical emission-based imaging (PET and SPECT) is also actively employed in 
small-animal and ex-vivo studies. Naturally, pre-clinical PET and SPECT systems 
require smaller image pixels, but the primary difference in SPECT-imaging is the 
collimation. By using pinhole instead of clinical standard parallel-hole collimation 
[337], a magnification of the imaged object is achieved, pushing image resolution 
into the sub-mm range. For PET, the reduction in ring diameter brings with it an 
improved spatial resolution, however the apparent fundamental physical resolution 
limit in PET (acollinearity of the annihilation photons, tissue positron range, etc. 
[348]) confines the possible resolution range of pre-clinical PET. 
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Table 3.2: Comparative specifications for typical clinical and pre-clinical imaging. Modified with 
permission from [349]. 
Modality Spatial resolution Study time 
Pre-clinical 
design 
requirements 
 Clinical Pre-clinical Clinical 
Pre-
clinical  
Ultrasound ~1 mm ~10 µm -  1 mm Real-time Real-time Increased transducer frequency 
CT ~0.1-1 mm ~10-100 µm ~5 s ≥15 min Increased X-ray flux, reduced focal spot size, increased 
magnification 
MRI ~1-10 mm ~200 µm ≥10 min ≥60 min Increased field-strength, dedicated 
receiver coils 
PET ~5 mm 1-2 mm 5-60 min 5-60 min Reduced detector-element size, faster read-
out electronics 
SPECT ~1 cm 0.5-2 mm 30-90 min 30-90 min Pinhole collimation 
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Chapter 4 
 
Methodology 
 
The following section presents a review of the material and methods used in the 
eight studies of this thesis. The section is divided into three main parts, reflecting 
the three focus areas of the thesis: Vascular shear wave elastography, Non-
invasive cardiovascular relative pressure estimation, and Tomographic 
reconstruction for pre-clinical imaging. 
4.1. Vascular shear wave elastography 
Four studies have been completed within Vascular shear wave elastography, 
utilising ultrasound SWE to evaluate vascular function with a particular focus on 
atherosclerotic plaque assessment. 
4.1.1.  Study overview 
With the four SWE-studies completed in serial sequence over a period of five 
years, they all build upon each other, utilising particular findings of one study to 
develop and optimise the setup of another. In particular, refined shear wave 
analysis has been implemented and tested from in-vitro validation to a final clinical 
in-vivo feasibility test with the general aim of progressing conventional SWE into 
cardiovascular diagnostics. As an illustrative overview, Table 4.1 summarises the 
basic methodological features of the four studies. 
4.1.2.  Experimental setup 
With the four different SWE-studies ranging from in-vitro to in-vivo, a few different 
sets of experimental SWE setups were used. 
a) In-vitro design 
For Study I and II, phantom material samples were used as a substitute for real 
biological tissue. Poly(vinyl alcohol) (PVA) cryogel was used as phantom material. 
PVA was initially deployed as a phantom material for arterial vessels [350], and has 
been extensively used in imaging research. Primarily, PVA is a useful phantom 
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Table 4.1: Methodological overview of the four SWE-based studies. 
material following the excellent correspondence in acoustic and elastic tissue 
properties between PVA and soft biological tissue [351, 352]. Secondly, PVA is 
also a versatile phantom material due to the fact that its mechanical elasticity can 
be altered during manufacturing. By changing the number of freeze-thaw (FT)-
cycles (the number of times the material is frozen and thawed during production) 
the material stiffness can be adjusted, with increasing stiffness following with an 
increasing number of FT-cycles. 
In short, three groups of PVA phantoms were created: 
i) For Study I, a set of fundamental geometrical shapes were 
manufactured to study the effect of geometrical constriction on wave 
propagation and SWE accuracy. Specifically, a thin plate (160x130x12 
mm), a solid cylinder (diameter: 12 mm, height: 100 mm), and a 
hollow cylinder (same dimensions as the solid cylinder, but with an 
inner hollow opening of diameter: 6 mm) were created. For all three, 3 
FT-cycles of 12 hours at approximately 22/-22°C was utilised. 
ii) For Study I, a second set of arterial phantoms were manufactured to 
study SWE accuracy as a function of phantom stiffness. The hollow 
cylinder geometry from the geometrical analysis in i) was used, 
however with nine phantoms created: 3 at 3 FT-cycles, 3 at 4 FT-
cycles, and 3 and 5 FT-cycles, respectively. 
 
Study 
I II III IV 
Application 
area 
Vascular +    
Atherosclerotic  + + + + 
Study 
design 
In-vitro + +   
Ex-vivo  + +  
In-vivo    + 
Data 
analysis 
SWE Group 
velocity + + + + 
SWE Phase 
velocity + + + + 
Reference 
or 
validation 
method 
 
Mechanical 
tensile 
testing 
Geometrically 
unconfined 
SWE 
Micro-
CT MRI 
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iii) For Study II, a set of phantom plaques were manufactured to study 
SWE accuracy on plaque stiffness differentiability. The phantom 
plaques were all 20 mm long, had an outer diameter of 14 mm, and 
varying tapered intraluminal openings. Specifically, intraluminal 
openings of 3.5, 5, and 7 mm were used, with a centred and off-
centred (1:3 shift off-axis) lumen setup utilised. With each setup 
created at 2, 3, 4, and 5 FT-cycles, respectively, this created a total of 
24 phantom plaques (4 stiffness levels, 3 intraluminal diameter 
openings, and 2 lumen positions, respectively). 
To produce the above, custom made phantom moulds were created. For Study I, 
an acrylic block mould was created, with internal opening equal to the dimensions 
of the arterial phantoms. Grip fixations were added at each end grip to allow for 
easier fixation during imaging and reference mechanical testing. For Study II, 3D 
printed plaque moulds were created, where complementary plastic mould parts 
were enclosed by a surrounding poly(methyl methacrylate) cylinder, again to create 
an internal hollow compartment equalling the desired phantom plaque shape. For a 
summary, both moulds and generated phantoms are showcased in Figure 4.1. 
In all in-vitro cases, the PVA phantoms were created from a solution in mass 
percentage of 87% deionised water, 10% fully hydrolysed PVA (molecular weight: 
56.14 g/mol, density: 1.27 g/cm3, Sigma-Aldrich, St. Louis, MO) and 3% graphite 
powder (molecular weight: 12.01 g/mol, density: 5 g/cm3, particle size < 50 µm, 
Merck KGaA, Darmstadt, Germany). The solution was heated to approximately 
65°C during continuous stirring before being poured into the phantom moulds. 
Once created, the above arterial phantoms were mounted into specific 
experimental setups. 
For Study I, again two sets of experiments were performed: one for the 
fundamental geometries, and one for the arterial phantoms. 
For the plate geometry, the phantom was submerged in water and held up on each 
end by supporting acrylic blocks, allowing for a direct image assessment of the 
mid-part of the submerged plate. 
For the solid and hollow cylinder, as well as for the nine arterial phantoms, a 
customised cylindrical fixation enclosure was created. Using the end fixtures of the 
arterial phantoms, the phantoms could be positioned in the middle of the 
enclosure, whilst being pressurised by connected inlet and outlet openings. 
Specifically, for the arterial phantoms, the cylindrical fixation box was connected to 
a vertical water column, pressurising the mounted phantoms at static pressures of 
60, 80, 100, and 120 mmHg, respectively. Note that using a toric joint fixture, the 
outlet end of the fixation enclosure could be adjusted in axial direction, allowing 
for a slight pre-stretching of the phantoms to avoid any out-of-plane bulging 
following the intraluminal pressurisation. 
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Figure 4.1: Phantoms and moulds used for Study I and II, showing (A) arterial phantoms, and (B) 
plaque phantoms. All dimensions are given in mm.  
Once mounted, an upper opening in the fixation enclosure allowed for a mounted 
ultrasound transducer to image the arterial phantom. An overview of the 
experimental setup including fixation enclosure, pressure column, and mounted 
image transducer, is given in Figure 4.2. 
For Study II, the plaque phantoms were used in a combined ex-vivo setup, with 
details provided in the subsequent section. 
b) Ex-vivo design 
For Study II, the manufactured phantom plaques were mounted into a customised 
ex-vivo setup. For this setup, a porcine aorta (female Swedish Yorkshire pig, weight: 
32 kg, collected during medical training) was used to simulate the human carotid 
artery (length: 100 mm, diameter: 14 mm), with surrounding fascia removed and 
intercostal arterioles glued shut. 
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Figure 4.2: Experimental SWE setup used in Study I, showing fixation chamber, mounted image 
transducer, and connected pressurisation column. 
A phantom plaque was inserted into the middle of the artery, and the artery was 
mounted onto customised end fixture, positioned to avoid excessive artery sagging. 
The artery was then rinsed and filled with deionised water, with the end fixtures 
closed shut to keep a constant intraluminal hydrostatic pressure of approximately 0 
mmHg. 
The end fixtures were subsequently mounted inside an enclosing rectangular box, 
in which agar material (1% agar (Merck, KGaA, Darmstadt, Germany), 3% 
graphite powder (molecular weight: 12.01 g/mol, density: 5 g/cm3, particle size < 
50 µm, Merck KGaA, Darmstadt, Germany), 96% deionised water) was moulded 
to mimic surrounding connective tissue. Specifically, agar was chosen as a 
surrounding media instead of PVA, following its relatively quick set time 
(approximately 1-2 hours from manufacturing to set material). Once set, an 
ultrasound transducer was mounted on top of the moulded block, having the 
porcine artery and inserted phantom plaque centred in the middle of the field-of-
view, as shown in Figure 4.3. Following completion of a single imaging session, the 
surrounding agar tissue was removed, the artery cleaned, and the experiment 
repeated with another phantom plaque. 
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Figure 4.3: Experimental SWE setup used in Study II, showing (A) customised ex-vivo setup, (B) 
mounted image scenario, (C-D) longitudinal and transverse B-mode images. 
Advancing from the phantom specimens used in Study I and II, Study III made 
use of a purely ex-vivo tissue sample. Specifically, one human atherosclerotic plaque 
sample was acquired from performed endarterectomy, with the plaque belonging 
to the Biobank of Karolinska Endarterectomies (BiKE) project. 
Once extracted, the plaque sample was kept for 24 hours in formalin (to avoid 
biological degradation) and subsequently stored in ethanol prior to further testing. 
For the SWE imaging, the plaque was submerged in deionised water, resting 
statically on a stack of a large PVA plate and an absorbing rubber block, 
respectively. An ultrasound image transducer was then positioned above the 
plaque, tilted to image the plaque as straight as possible. 
c) In-vivo design 
For Study IV, 22 subjects with visually apparent carotid plaque lesions were 
enrolled and included (inclusion criteria: ≥18 years, suspected coronary artery 
disease, referred to the Mayo Clinic stress echocardiography laboratory, exclusion 
criteria: previous invasive cardiovascular surgery, contraindication to contrast 
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agents, pregnancy, or renal dysfunction). Subject characteristics are given in Table 
4.2. All subjects participated under informed, written consent (Mayo Clinic 
Institutional Review Board Protocol 14-000555). 
Table 4.2: Subject characteristics for the patient cohort of Study IV. 
Demographics and risk 
factor Mean ± SD or n Range (if applicable) 
Age, yrs 67.8 ± 8.4 45 – 84 
Male, n 16 (80%)  
BMI, kg/m2 30.6 ± 4.5  22.1 – 38.3 
Hypertension, n 12 (60%)  
SBP, mmHg 127.6 ± 20.2  74 – 153  
DBP, mmHg 75.3 ± 15.3 42 – 102 
History of cardiovascular 
disease, n 12 (60%)  
Coronary artery disease, n 8 (40%)  
Stroke, n 4 (20%)   
Transient ischemic attack, n 1 (5%)  
Smoking status   
Active, n 4 (20%)  
Quite, n 5 (25%)  
Never smoked, n 11 (55%)  
Hyperlipidaemia, n 17 (85%)  
Total cholesterol, mg/dL 170.1 ± 41.3 120 – 263  
    Triglycerides, mg/dL 175.3 ± 107.7 50 – 420  
   HDL cholesterol, mg/dL 46.9 ± 14.3 23 – 80  
   LDL cholesterol, mg/dL 89.1 ± 37.3 48 – 170  
Medication   
Aspirin, n 15 (75%)  
Statins, n 18 (90%)  
Nitrates, n 8 (40%)  
Beta blockers, n 12 (60%)  
Calcium channel blockers, 
n 5 (25%)  
ACEI, n 8 (40%)  
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From the 22 subjects, a total of 29 carotid plaques were identified. For each plaque 
and subject, SWE imaging was carried out, together with reference carotid MRI, all 
within the same episode of care (±4 weeks). 
4.1.3.  Image acquisition 
Due to available laboratory equipment at the time of each study, and following the 
suitability of equipment during in-vivo scanning, a few different ultrasound setups 
were used in the four different studies. 
In Study I and III, an Aixplorer (Supersonic Imaging, Aix-en-Provence, France) 
ultrasound machine with a custom, in-house shear wave research package (allowing 
for raw export of generated In-phase and Quadrature (IQ)-data) was used. An 
SL15-4 linear array transducer was utilised, generating an acoustic radiation force 
push sequence at 6 MHz at a push duration of 150 µs. Ultrafast plane wave 
imaging was automatically triggered following the push sequence, with imaging at 
7.5 MHz and a pulse repetition frequency of 8 kHz. With the Aixplorer system 
generating a supersonic push line consisting of three consecutive focussed pushes 
at increasing depth, in both Study I and III an ROI was positioned such that the 
second of the three pushes was centred inside the phantom or plaque, respectively. 
For the arterial phantoms in Study I, three consecutive acquisitions were acquired 
with pushing performed in longitudinal view, in the middle of both the posterior 
and the anterior phantom wall, respectively. For the geometry phantoms, pushes 
were positioned at the centre of each phantom. 
For the plaque specimen in Study III, again three consecutive acquisitions were 
made, however with acquisitions collected in both longitudinal and transverse 
view, respectively. For the plaque phantom specimen, the push was positioned at 
the edge of the plaque, to enable wave propagation through the entire specimen. 
For the combined plaque phantoms in Study II, a programmable Verasonics V1 
system (Verasonics, Kirkland, WA, USA) was used, also allowing for direct readout 
of generated IQ-data. An L7-4 linear array transducer (Philips Healthcare, 
Andover, MA) was utilised, with a push frequency of 4.09 MHz, and push duration 
of 196 µs. Ultrafast plane wave imaging was performed at 6.43 MHz, at a pulse 
repetition frequency of approximately 11.8 kHz. 
Carotid stenosis   
Severe (>70%), n 1 (5%)  
Moderate (50-69%), n 3 (18%)  
Not present (<50%), n 16 (80%)  
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Figure 4.4: SWE push locations used in Study II. 
To evaluate output accuracy as a function of push location, seven different 
acquisitions were performed in each phantom plaque. Specifically, pushing was 
performed: 
1) In longitudinal view, approximately 20 mm away from the phantom 
plaque boundary in the anterior aortic wall 
2) In the longitudinal view, just at the boundary of the phantom plaque at the 
anterior side 
3) In the longitudinal view in the middle of the anterior part of the phantom 
plaque 
4) In the longitudinal view, approximately 20 mm away from the phantom 
plaque boundary in the posterior aortic wall 
5) In the longitudinal view, just at the boundary of the phantom plaque at the 
posterior side 
6) In the transverse view, approximately 20 mm to the side of the porcine 
aorta 
7) In the transverse view, at the edge of the porcine aorta 
For clarity, the push locations are highlighted in Figure 4.4. 
For Study IV, a clinical General Electrics (GE) Logiq E9 (General Electric 
Healthcare, Milwaukee, WI, USA) system, allowing for SWE acquisition through 
double-sided edge pushing was used. A 9L linear array transducer was utilised, 
pushing at 4.1 or 5 MHz with push duration of approximately 400 µs. Ultrafast 
plane wave imaging was performed at 5 MHz, tracking the shear wave throughout 
the imaged field-of-view. For each patient and plaque, imaging was performed in 
both longitudinal and transverse view, with an ROI selected to cover the entire 
plaque. Pushing was manually triggered by the sonographer, with in-house 
conversion enabling for IQ-data retrieval from each acquisition. 
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Figure 4.5: Methodological overview of the SWE data post-processing used throughout Study I-IV. 
Superscript indicates in which study which analysis was performed. 
4.1.4.  Image analysis and data post-processing 
With IQ-data retrieved in all four studies, a set of post-processing image analysis 
steps were conducted in order to calculate either shear wave group or phase velocity, 
or to further estimate elastic shear modulus or signal quality of the evaluated sample. 
An overview of the performed analysis is given in Figure 4.5, with superscripts 
indicating which analysis was included in which Study. 
a) 2D autocorrelation and axial incremental displacement and velocity maps 
As a first step, tissue displacement and the temporal motion of the propagating 
wave was estimated by applying a 2D autocorrelator [200] on the IQ data, 
commonly used for ultrasound elastography. 
Specifically, incremental axial particle displacement ?̅?𝑢 was derived from the IQ data 
by 
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?̅?𝑢 = 𝑐𝑐4𝜋𝜋𝑓𝑓𝑐𝑐 tan−1 �
∑ �∑ �𝑄𝑄(𝑚𝑚,𝑛𝑛)𝐼𝐼(𝑚𝑚,𝑛𝑛 + 1) − 𝐼𝐼(𝑚𝑚,𝑛𝑛)𝑄𝑄(𝑚𝑚,𝑛𝑛 + 1)�𝑁𝑁−2𝑛𝑛=0 �𝑀𝑀−1𝑚𝑚=0∑ �∑ �𝐼𝐼(𝑚𝑚,𝑛𝑛)𝐼𝐼(𝑚𝑚,𝑛𝑛 + 1) + 𝑄𝑄(𝑚𝑚,𝑛𝑛)𝑄𝑄(𝑚𝑚,𝑛𝑛 + 1)�𝑁𝑁−2𝑛𝑛=0 �𝑀𝑀−1𝑚𝑚=0 �2𝜋𝜋 + tan−1 �∑ �∑ �𝑄𝑄(𝑚𝑚,𝑛𝑛)𝐼𝐼(𝑚𝑚 + 1,𝑛𝑛) − 𝐼𝐼(𝑚𝑚,𝑛𝑛)𝑄𝑄(𝑚𝑚 + 1,𝑛𝑛)�𝑁𝑁−2𝑛𝑛=0 �𝑀𝑀−1𝑚𝑚=0∑ �∑ �𝐼𝐼(𝑚𝑚,𝑛𝑛)𝐼𝐼(𝑚𝑚 + 1,𝑛𝑛) + 𝑄𝑄(𝑚𝑚,𝑛𝑛)𝑄𝑄(𝑚𝑚 + 1,𝑛𝑛)�𝑁𝑁−2𝑛𝑛=0 �𝑀𝑀−1𝑚𝑚=0 �, (4.1) 
where 𝐼𝐼  and 𝑄𝑄 denotes the in-phase and quadrature part of the IQ-data, 
respectively, acquired at 𝑆𝑆  frames and 𝑀𝑀  depth lines. 𝑓𝑓𝑐𝑐 is the centre frequency of 
the acquisition, and 𝑐𝑐 is the speed of sound in the imaged tissue, set to 1540 m/s. 
With the above, axial particle velocity can also be derived by dividing ?̅?𝑢 by the 
frame time 𝜕𝜕. 
With incremental axial particle displacement estimated in each pixel of the acquired 
image, the global wave front of the propagating wave can be represented by a so 
called incremental axial displacement map, or similarly by an axial velocity map. In short, 
such a displacement or velocity map is a 3D representation of the propagating 
wave over a selected number of depth lines in the acquired image. As seen in 
Figure 4.6, upon initiation from a focussed acoustic radiation force push, a shear 
wave will start to propagate from the push epicentre, changing its shape and 
position over time. By collecting incremental particle displacements or velocities at 
a given depth as a function of time, the propagation can hence be visualised in a 
2D manner, with a depth-time map showing the intensity of the wave as it 
propagates through the tissue, as in Figure 4.6. 
In Study I and III, incremental axial displacement maps were generated over five 
manually selected depth lines, positioned inside the phantom or plaque specimen, 
respectively. In Study II, a manually selected rectangular ROI was positioned inside 
the phantom plaques, within which axial velocity maps were estimated. For the in-
vivo plaques in Study IV, the outlines of the plaque in each image view were 
manually delineated, within which axial velocity maps were estimated. 
b) Group velocity estimation 
Using the axial incremental displacement or velocity maps, the global envelope of 
the propagating shear wave can be visualised. With the wave represented in a 
space-time domain, the velocity of this wave can thus be assessed by evaluating the 
positional slope within the given map. This velocity is denoted the wave group 
velocity, 𝑐𝑐𝑔𝑔, since it again represents the envelope speed of the propagating wave. 
In Study I and III, 𝑐𝑐𝑔𝑔 was retrieved from the axial incremental displacement maps 
by applying a Radon transform [353], summing the wave peak signal as a function 
of angle in the displacement map, and estimating 𝑐𝑐𝑔𝑔 based on the angle of 
maximum intensity. In Study I the entire map was utilised, whereas in Study III, 
visually identified sections of 𝑐𝑐𝑔𝑔 was cropped, each generating a specific output. 
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Figure 4.6: Schematic overview of the generation of an axial velocity map, showing (A) SWE setup, 
(B) correlated shear wave displacement as a function of time, and (C) coupled axial velocity map. 
In Study II and IV, a time-to-peak (TTP) method [354] with an additional random 
sample consensus (RANSAC) filter [355] was employed to identify the peak 
intensity in the axial velocity maps. Using such, a linear fit with a corresponding 𝑐𝑐𝑔𝑔-
slope could be automatically identified. In Study II, the TTP estimate was 
generated over the entire axial velocity maps, whereas in Study IV, the domain was 
cropped in half in both time and space, and if necessary, manually identification of 
the main wave was employed. 
c) Phase velocity estimation 
To retrieve the dispersion of the acquired signal, the axial incremental 
displacement or velocity maps were used as data input. The frequency content of 
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this wave envelope was retrieved by applying a 2D Fast Fourier Transform (FFT), 
transforming the data from space-time domain into a wave-number-frequency 
domain (hence sometimes denoted 𝑘𝑘-space). Specifically, the 2DFFT acts on the 
retrieved ?̅?𝑢 as 𝐹𝐹𝐹𝐹𝑇𝑇 [?̅?𝑢(𝑥𝑥, 𝜕𝜕)] = � � � 𝑒𝑒−𝑖𝑖2𝜋𝜋(𝑘𝑘𝑚𝑚𝑥𝑥+𝑓𝑓𝑛𝑛𝑡𝑡)∞𝑛𝑛=−∞ �∞𝑚𝑚=−∞ , 
 
(4.2) 
with 𝑘𝑘 and 𝑓𝑓  being the specific wave number and frequency, respectively. 
Within Fourier space, the data were cleaned by an amplitude mask (set in all 
studies at 12 dB) to remove low-amplitude background signal. Following the 
symmetric nature of the 2DFFT the upper right quadrant were cropped and used 
for further analysis. 
With Fourier space masked and cropped, a so called phase velocity map was 
generated, simply by converting the wave number dimension to phase velocity, 𝑐𝑐𝑝𝑝, 
using 𝑐𝑐𝑝𝑝 = 2𝜋𝜋𝑓𝑓𝑘𝑘 . 
 
(4.3) 
At a given frequency, 𝑐𝑐𝑝𝑝 was then identified as the wave velocity for which 
maximum intensity is given in the phase velocity map. By connecting discrete wave 
velocities over the entire given frequency spectrum, a so called dispersion curve could 
then be obtained. An overview of the above processing sequence is given in Figure 
4.7. 
Important to note is that the dispersion curve is not the result of one propagating 
wave mode, but is rather the sum of all wave modes occurring within a given 
confined media. Both symmetric and antisymmetric wave modes appear in 
confined media [201, 202], and higher order modes will be excited at higher 
frequencies. Especially, in thin hollow media higher order modes will interfere at 
lower frequencies, causing characteristic bumps or dispersion curve deviations to 
appear [202, 203, 280]. However, for the sake of the analysis in all SWE studies of 
this thesis, and in-line with the expression derived in Equation 3.35, focus will here 
be on the so called zero-order antisymmetric mode, present throughout the entire 
frequency spectrum. 
Another important aspect of the dispersion curve and the analysed Fourier domain 
data is that the frequency content will be dependent on defined acquisition and 
processing settings. Widman et al. [198] showed how shorter push duration 
generates increased frequency content, and similarly, harmonic wave tracking [356, 
357] has also shown to affect frequency-based elastography wave speed estimates. 
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Figure 4.7: Phase velocity generation, starting from a cropped axial velocity map, and creating a k-
space dispersion curve from which discrete phase velocities can be retrieved. 
In Study I and III, the obtained dispersion curve was cropped at the lower end 
when the relative change between neighbouring 𝑐𝑐𝑝𝑝-values was >50%, and at the 
higher end when the intensity in the phase velocity map had decreased to <30% of 
the maximum intensity. With such, the dispersion curve was used as input for 
estimation of shear modulus. 
For Study II and IV the retrieved phase velocity was analysed in discrete frequency 
band, where the mean phase velocity was estimated in each band. Specifically, 
mean phase velocities were in Study II estimated in bands of 450-550 Hz, 700-800 
Hz, and 950-1050 Hz, and for Study IV in bands of 200-300 Hz, 300-400 Hz, and 
400-500 Hz, respectively. 
d) Shear modulus estimation 
With group and phase velocity estimates retrieved, quantification of tissue shear 
elasticity is possible using appropriate constitutive description of the imaged 
medium, as well as a description of the acoustic wave propagation. 
The most common way of estimating shear elasticity or shear modulus, 𝜇𝜇, is by 
evoking Equation 3.24, where a simple and direct relation exist between wave 
speed, shear modulus, and density. This relation has been employed in numerous 
elastography studies [255, 278, 358, 359], and also forms the basis for direct 
elasticity reconstruction for clinical liver or breast elastography applications [360-
362]. However, as pointed out several times, this relation only holds under the 
strict assumption that the wave propagates without geometrical constriction (so 
called infinite media assumption), and will be violated if assessing cardiac or 
vascular structures. 
Regardless, to evaluate the accuracy of this direct estimate, in Study I group 
velocity-based estimates of shear modulus were derived using Equation 3.24. 
For phase velocity analysis, in both Study I and III the leaky Lamb-wave-based 
estimate from Equation 3.35 (derived initially by Bernal et al. [203]) was fitted to 
the acquired dispersion curve. Specifically, by varying tissue shear modulus and 
keeping all other variables fixed (material thickness, density, speed of sound) a 
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Lamb-wave-based estimate of tissue shear modulus could be retrieved for the 
imaged material. 
In Study I and Study III, Lamb wave fitting and dispersion-based shear modulus 
estimation was performed over the entire frequency spectrum. In Study I, an 
additional estimate was also obtained by only analysing data above a given 
frequency limit of 500 Hz (corresponding to approximately half of the acquired 
band width). This lower frequency cut-off was introduced following reasoning by 
Couade et al. [280], indicating that dispersion behaviour in a hollow cylinder 
converges to that of a plate-based Lamb model with increasing frequency. 
e) Signal quality estimation 
In Study II, signal quality was evaluated by two metrics: Signal-to-noise ratio (SNR) 
and maximum particle velocity. 
The SNR was retrieved by identifying axial particle velocity signal from identified 
TTP-estimates, and conversely noise was quantified from the lower left corner of 
the same map with pixels being the farthest away from the propagating shear wave. 
With such, SNR was calculated by 𝑆𝑆𝑆𝑆𝑅𝑅 = 𝑚𝑚𝜎𝜎 , (4.4) 
where 𝑚𝑚 was the mean of the signal, and 𝜎𝜎 the standard deviation of the noise. 
Maximum particle velocity was identified as the single maximum particle velocity at 
any given time point within the identified ROI. 
4.1.5.  Reference imaging and validation setup 
In all four SWE studies, reference imaging or complementary validation were 
performed in order to quantify and evaluate SWE output. 
a) Study I – Mechanical tensile testing 
In Study I, reference mechanical tensile testing was performed to assess phantom 
material shear modulus. 
Importantly, mechanical testing of constitutive shear properties typically involves 
imposing direct shear loads [363] or, in the case of tubular structures, assessing the 
relationship between applied torque and resulting angular twist [364]. For the 
relatively soft PVA phantoms in Study I however, such testing would be 
complicated by material buckling and non-conforming geometries. For this reason, 
and under the assumption that the generated phantoms were homogeneous and 
isotropic, material shear modulus 𝜇𝜇 was derived from the tensile Young’s or elastic 
modulus 𝐸𝐸 by 
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with the Poisson’s ratio 𝜈𝜈 = 0.5 for incompressible cryogel or soft tissue materials. 
For the geometrical phantoms, tensile compression tests (quasi-static loading up to 
10% strain) were performed on a large PVA cylinder, created from the same PVA 
batch as the tested phantoms. 𝐸𝐸 was then estimated as the optimal linear slope of 
the generated stress-strain data. 
For the pressurised arterial phantoms, customised end fixtures were mounted into 
the tensile testing machine, allowing for the phantoms to be tested in axial tension 
under the same stress conditions as during SWE measurements. Specifically, the 
arterial phantoms were pressurised at 60, 80, 100, and 120 mmHg, respectively 
(using the same water column system as in the SWE experiments), and an axial 
pre-stretch was applied identical to that in the SWE experiments. Quasi-static 
loading up to 10% strain was applied, and 𝐸𝐸 was again estimated as the optimal 
linear slope of the measured stress-strain data. 
All mechanical tests were performed using an MTS Insight 100 kN mechanical 
testing system (MTS Systems Corp., Eden Prairie, MN, USA) with an Instron 
M8500+ electric controller (Instron Worldwide, Norwood, MA, USA) and a 
VETEK 10 kg load-cell (capacity 100 N, accuracy limit <0.03%). 
b) Study II – Geometrically unconfined SWE 
In Study II, no quantification of shear elasticity was performed, but rather shear 
wave group and phase velocity were evaluated. For this reason, reference wave 
velocity values were obtained from large cylindrical PVA phantoms, created from 
the same batch as the phantom plaques, at 2-5 FT-cycles, respectively. 
Importantly, the dimensions of these large cylindrical phantoms were such that the 
generated SWE propagation was unconstrained during acquisition. Hence, 
phantom plaque velocity values (where clear geometrical confinement was present) 
could be compared to velocities of an identical, but geometrically unconstrained 
wave. 
c) Study III – Micro-CT  
In Study III, ex-vivo plaque SWE imaging was complemented by micro-CT imaging. 
The imaging was performed using a built in-house micro-CT system, using a 
microfocus X-ray source (Hamamatsu MX-L10951-04, focal spot size: 15-80 µm), 
with a complementary metal oxide semiconductor (CMOS) flat panel (Hamamatsu 
C7942CA-22, total area: 12 cm2, pixel size: 50 µm2), frame grabber (EPIX PIXCI 
D2X-C7942), and steering gantry. 
86 
4.1. VASCULAR SHEAR WAVE ELASTOGRAPHY 
Pre-calibration of acquisition settings was performed on embedded ex-vivo plaques 
from the Karolinska BiKE-project, choosing a tube voltage: 36 kV, tube current: 
800 mA, and frame time: 1500 ms, for optimal image contrast. 360 projections 
were collected in a tomographic acquisition, with projections calibrated for 
detector lag, dark current, faulty detector pixels, and geometrical misalignment. 3D 
image reconstruction was then performed using a simultaneous iterative 
reconstruction algorithm (SIRT), stopped at 400 iterations. 
Reconstructed micro-CT images were visually compared to acquired B-mode and 
SWE images, correlating potential SWE changes to morphological micro-CT 
changes. 
d) Study IV – MRI  
In Study IV, the in-vivo SWE imaging was complemented with reference carotid 
MRI acquisitions carried out in connection to the ultrasound session. The imaging 
was performed using a 3T scanner with custom-made carotid phase-array surface 
6-channel coils (Necocoil LLC) utilised together with a multi-contrast protocol 
[365]. Specifically, 3D time-of-flight MR angiography (TOF-MRA), magnetisation-
prepared rapid acquisition gradient echo (MPRAGE), 2D pre-contrast black-blood 
T1 weighting (T1W), 2D T2 weighting (T2W), and post-contrast 2D black-blood 
T1W (CE-T1W) were performed, each providing information on different plaque 
components. All sequences had an in-pane resolution of 0.625 mm2, with slice 
thickness of 1 or 2 mm in 3D or 2D sequences, respectively. 
Plaque components were classified in the multi-contrast MR images using 
dedicated analysis tools (MRI-PlaqueView, VP Diagnostics, Seattle, WA, USA) 
[301, 366]. Particularly, plaque lipid-rich necrotic core, fibrous cap, intraplaque 
haemorrhage, loose matrix, and calcification were identified, with absolute and 
relative volumes quantified. Also, fibrous cap dimensions were measured, including 
maximum, mean, and minimum thickness. In general, the identification was based 
on pre-defined criteria where: a) lipid-rich necrotic core without haemorrhage 
appears as hypointense on T2W and CE-T1W, and isointense on T1W and 
MPRAGE, b) intraplaque haemorrhage appears as hyperintense on TOF, T1W, 
and MPRAGE, c) calcifications appear as hypointense on all sequences, d) loose 
matrix appear as hyperintense on T2W and CE-T1W, and e) fibrous cap was 
identified as the dark band separating lumen and the necrotic core in TOF and 
CE-T1W. 
Lastly, each plaque was given a global type classification score following the 
modified American Heart Association (AHA) classification of atherosclerotic 
plaques [140]. 
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4.1.6.  Data evaluation 
With slightly different data analysis for each study, data evaluation also varied 
accordingly. 
a) Study I 
For the geometrical phantoms, reference shear modulus from mechanical testing 
was compared to shear modulus calculated by group velocity, shear modulus 
calculated by the full band width phase velocity, and shear modulus calculated by 
phase velocities above 500 Hz, respectively, using a one-sample t-test (significant 
deviations inferred at 𝑝𝑝 < 0.05). 
For the arterial phantoms comparison was made with the mechanical testing of the 
pressurised, pre-stretch phantoms, again using a one-sample t-test to infer potential 
statistical differences (𝑝𝑝 < 0.05). For the arterial phantoms, results were also 
grouped as a function of pressure, FT-cycles, and wall position. 
b) Study II 
The ability to differentiate phantom plaques of different stiffness was evaluated 
using a two-sided Wilcoxon rank sum test (significance inferred at 𝑝𝑝 < 0.05). This 
was performed in each image view, and for each derived velocity metric, 
respectively. 
Signal quality as a function of push location was evaluated using a one-way analysis 
of variance (ANOVA) test, with a Tukey’s range test serving as a post-hoc 
assessment to quantify significant differences. 
c) Study III 
The group velocity derived from the axial incremental displacement maps were 
visually correlated to 2D slices of the micro-CT reconstruction. Lamb wave-fitted 
phase velocity-based shear modulus estimate was generated as a proof-of-concept, 
and no quantification of accuracy was performed. 
d) Study IV 
The group and phase velocity data was evaluated as a function of AHA type, with 
differences statistically evaluated using a two-sided Wilcoxon rank sum test 
(significance inferred at 𝑝𝑝 < 0.05). 
Correlations between SWE metrics and MRI-identified plaque components were 
assessed by the Pearson and Spearman correlation coefficient (correlation defined 
at |𝑅𝑅| > 0.5 and 𝑝𝑝 < 0.05). If a plaque component could not be identified in a 
given plaque, it was excluded from that particular correlation analysis. 
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4.2. Non-invasive cardiovascular relative pressure estimation 
Three studies have been completed in the field of non-invasive cardiovascular 
relative pressure estimation. 
4.2.1.  Study overview 
The work on non-invasive relative pressure estimations build upon each other, 
extending and using a method developed in Study V. As an overview, Table 4.3 
summarises the basic methodological features of the three studies. 
Table 4.3: Methodological overview of the three studies on non-invasive relative pressure estimation  
4.2.2.  Theory and method derivation 
The developed method, termed the virtual Work-Energy Relative Pressure (νWERP) 
method, originates from an earlier direct work-energy method (WERP) derived by 
Donati et al. in 2015 [324], summarised briefly in Section 3.4.2. However, for 
completeness, a recapitulation of the method background is provided, although 
here outlined for the νWERP method variation. 
For a complete description of 3D blood flow we resort to the Navier-Stokes 
equations, which for an isothermal, incompressible, Newtonian, viscous fluid 𝒗𝒗 
states that 𝜌𝜌 𝜕𝜕𝒗𝒗𝜕𝜕𝜕𝜕 + 𝜌𝜌𝒗𝒗 ⋅ ∇𝒗𝒗 − 𝜇𝜇𝛻𝛻2𝒗𝒗 +  𝛻𝛻𝑝𝑝 = 0 
 
(4.6) ∇ ∙ 𝒗𝒗 = 0, 
 (4.7) 
identical to the expression given in Equations 3.7-3.8. For the relative pressure 
analysis, we choose to evaluate a fluid domain Ω with boundaries Γ. 
  Study 
  V VI VII 
Application 
area 
Cardiac (+) (+) + 
Vascular + + + 
Study design 
In-silico + + + 
In-vitro  +  
In-vivo +  + 
Concept  Method development 
Method 
extension 
Clinical 
study 
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To obtain a work-energy formulation, Equations 4.6-4.7 can be multiplied with 
an arbitrary velocity field – or virtual field – 𝒘𝒘, and integrated over the entire 
domain Ω, yielding � 𝜌𝜌 𝜕𝜕𝒗𝒗𝜕𝜕𝜕𝜕 ∙ 𝒘𝒘𝑑𝑑Ω +Ω � 𝜌𝜌(𝒗𝒗 ∙ ∇𝒗𝒗) ∙ 𝒘𝒘𝑑𝑑ΩΩ − � 𝜇𝜇∇2𝒗𝒗 ∙ 𝒘𝒘𝑑𝑑ΩΩ+ � ∇𝑝𝑝 ∙ 𝒘𝒘𝑑𝑑Ω = 0.Ω  (4.8) 
If choosing 𝒘𝒘 = 𝒗𝒗, this simplifies to the traditional WERP formulation [324], 
representing an expression of the actual work and energy within Ω. However, 
when 𝒘𝒘 ≠ 𝒗𝒗, Equation 4.8 instead describes the work-energy within 𝒗𝒗 in the 
direction of the virtual field 𝒘𝒘. Importantly though, the sought pressure field 
expressed within ∇𝑝𝑝 is still originating from 𝒗𝒗, independent of 𝒘𝒘; a key point in 
the usage of νWERP for clinical analysis. 
Using integration by parts* to convert volume to surface integrals on the viscous 
third term, and identifying separate virtual energy terms, Equation 4.8 can be 
reformulated into 𝜕𝜕𝜕𝜕𝑒𝑒𝜕𝜕𝜕𝜕 + 𝐴𝐴𝑒𝑒 − 𝑆𝑆𝑒𝑒+ 𝑉𝑉𝑒𝑒 + 𝐻𝐻(𝑝𝑝) = 0, (4.9) 
where 𝜕𝜕𝜕𝜕𝑒𝑒𝜕𝜕𝜕𝜕 = � 𝜌𝜌Ω 𝜕𝜕𝒗𝒗𝜕𝜕𝜕𝜕 ∙ 𝒘𝒘𝑑𝑑Ω (4.10) 𝐴𝐴𝑒𝑒 = � 𝜌𝜌(𝒗𝒗 ∙ ∇𝒗𝒗) ∙ 𝒘𝒘Ω  (4.11) 𝑆𝑆𝑒𝑒 = � (𝜇𝜇∇𝒗𝒗 ∙ 𝒏𝒏) ∙ 𝒘𝒘𝑑𝑑ΓΓ  (4.12) 
*Recall that integration by parts in higher dimensions states that ∫ ∇𝒗𝒗 ∙ 𝒘𝒘 𝑑𝑑ΩΩ =∫ 𝒗𝒗 ∙ 𝒘𝒘 ∙ 𝒏𝒏 𝑑𝑑ΓΓ − ∫ 𝒗𝒗 ∙ ∇𝒘𝒘 𝑑𝑑ΩΩ , for any higher dimensional vector-valued function 𝒗𝒗 
and 𝒘𝒘, over the domain Ω with boundary Γ and boundary normal vector 𝒏𝒏. 
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4.2. NON-INVASIVE RELATIVE PRESSURE ESTIMATION 𝑉𝑉𝑒𝑒 = � 𝜇𝜇∇𝒗𝒗 ∶ ∇𝒘𝒘Ω 𝑑𝑑Ω (4.13) 𝐻𝐻(𝑝𝑝) = � 𝑝𝑝 𝒘𝒘 ∙ 𝒏𝒏𝑑𝑑ΓΓ − � 𝑝𝑝∇ ∙ 𝒘𝒘 𝑑𝑑ΩΩ . (4.14) 
As in Equations 3.47-3.51 in Section 3.4.2., the above terms denote the kinetic 
energy (𝜕𝜕𝑒𝑒), advective energy transfer (𝐴𝐴𝑒𝑒), viscous energy dissipation (𝑉𝑉𝑒𝑒), 
hydraulic power input (𝐻𝐻) and shear energy rate (𝑆𝑆𝑒𝑒) of 𝒗𝒗, however this time in 
the direction of the virtual field 𝒘𝒘. 
With the goal of isolating the relative pressure between two boundaries, we can 
choose to assign certain attributes to 𝒘𝒘. Specifically, by setting 𝒘𝒘 to be a 
solenoidal field (∇ ∙ 𝒘𝒘 = 0), and splitting the domain boundary into an inlet, 
outlet, and wall domain, respectively (Γ = Γ𝑖𝑖 ∪ Γ𝑜𝑜 ∪ Γ𝑤𝑤), the hydraulic power 
formulation in Equation 4.14 can be expressed as 𝐻𝐻(𝑝𝑝) = 𝑝𝑝𝑖𝑖 �  𝒘𝒘 ∙ 𝒏𝒏𝑑𝑑ΓΓ𝑖𝑖 + 𝑝𝑝𝑜𝑜 �  𝒘𝒘 ∙ 𝒏𝒏𝑑𝑑ΓΓ𝑜𝑜 + 𝑝𝑝𝑤𝑤 �  𝒘𝒘 ∙ 𝒏𝒏𝑑𝑑ΓΓ𝑤𝑤 , 
 
(4.15) 
which, in the case that 𝒘𝒘 = 0 on Γ𝑤𝑤 (again something that can be user-assigned 
to 𝒘𝒘), reduces into 𝐻𝐻(𝑝𝑝) = 𝑝𝑝𝑖𝑖 �  𝒘𝒘 ∙ 𝒏𝒏𝑑𝑑ΓΓ𝑖𝑖 + 𝑝𝑝𝑜𝑜 �  𝒘𝒘 ∙ 𝒏𝒏𝑑𝑑ΓΓ𝑜𝑜 . 
 
(4.16) 
Importantly, Γ𝑤𝑤 does not necessarily need to represent a physical vessel wall, but 
can just as well represent the sum of the vessel wall and all other vascular outlets 
not considered in the specific relative pressure computation. As an example: if 
assessing a domain with 𝑆𝑆  inlets and 𝑀𝑀  outlets, Equation 4.16 still holds for any 
arbitrary inlet Γ𝑖𝑖 and outlet Γ𝑜𝑜 as long as 𝒘𝒘 = 0 on all remaining boundary 
domains (i.e. on Γ𝑤𝑤, ∑ Γ𝑛𝑛𝑁𝑁𝑛𝑛=0,𝑛𝑛≠𝑖𝑖 , and ∑ Γ𝑚𝑚𝑀𝑀𝑚𝑚=0,𝑚𝑚≠𝑜𝑜 , respectively). 
With the above, applying the divergence theorem we observe that the total 
inflow 𝑄𝑄 given by 𝒘𝒘 is identical to its outflow, i.e. 0 = � ∇ ∙ 𝒘𝒘𝑑𝑑Ω = � 𝒘𝒘 ∙ 𝒏𝒏𝑑𝑑ΓΓΩ = � 𝒘𝒘 ∙ 𝒏𝒏𝑑𝑑ΓΓ𝑖𝑖∪Γ𝑜𝑜 , (4.17) 
which, for Equation 4.16 means that 
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Lastly, by ensuring that 𝒘𝒘 acts in the surface normal direction, and knowing 
that the gradients of 𝒗𝒗 are negligibly small at the vicinity of the vessel 
boundaries, the shear energy rate of Equation 4.12 can be effectively set to zero. 
Thus, Equation 4.9 can be reformulated into Δ𝑝𝑝 = − 1𝑄𝑄�𝜕𝜕𝜕𝜕𝜕𝜕𝜕𝜕𝑒𝑒 + 𝐴𝐴𝑒𝑒 + 𝑉𝑉𝑒𝑒�, (4.19) 
being identical to the WERP formulation in Section 3.4.2., however with each 
term now referring to the virtual work of 𝒘𝒘. 
All that remains for computing Δ𝑝𝑝 is then to find a virtual field 𝒘𝒘 in line with 
the assumptions outlined above. In theory, any such virtual field can be selected, 
but for simplicity, we choose to solve 𝒘𝒘 as a Stokes problem, ensuring the 
existence of a unique solution and satisfying all the above outlined physical 
constraints. Specifically, 𝒘𝒘 is solved as 
 ∇2𝒘𝒘 + ∇𝜆𝜆 = 0 (4.20) ∇ ∙ 𝒘𝒘 = 0 (4.21) 𝒘𝒘 = �−𝑛𝑛,0, Γ𝑖𝑖 Γ𝑤𝑤 (4.22) 
where 𝜆𝜆 is the virtual pressure field corresponding to the virtual field 𝒘𝒘. Note 
that no constraint is set at the outflow plane Γ𝑜𝑜. 
4.2.3.  Expansion for turbulent flow 
In principle, the derivation in Section 4.2.2. holds for any velocity field governed 
by the Navier-Stokes equations. However, as discussed in Section 3.1.4., 
incoherent turbulent flows (i.e. stochastic flow fluctuations) may occur in certain 
pathological states where we can no longer describe the flow as quasi-periodic (i.e. 
that 𝒗𝒗(𝜕𝜕) ~ 𝒗𝒗(𝜕𝜕 + 𝑖𝑖𝑇𝑇 ) for a given period 𝑇𝑇  and 𝑖𝑖 ∈ ℕ). 
Instead we need to resort to a statistical description of the observed flow, all along 
the lines of the theory described in Section 3.1.4. In very brief summary, it was 
shown that if expressing the flow using a linear expected value operator 𝐸𝐸, the 
Navier-Stokes equations can be reformulated into 
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𝜌𝜌 𝜕𝜕𝑽𝑽𝜕𝜕𝜕𝜕 + 𝜌𝜌∇ ∙ (𝑽𝑽𝑽𝑽 ) + 𝜌𝜌∇ ∙ Cov[𝒗𝒗, 𝒗𝒗] − 𝜇𝜇𝛻𝛻2𝑽𝑽 +  𝛻𝛻𝑃𝑃 = 0 (4.23) ∇ ∙ 𝑽𝑽 = 0, 
 
(4.24) 
where an additional covariance term appears (Cov[𝒗𝒗, 𝒗𝒗]), numerically handling 
the stochastic fluctuations due to turbulent flow regimes. 
Thus, if assessing turbulent flows using the same virtual work-energy approach as 
before, all that is needed is to multiple Equations 4.23-4.24 with 𝒘𝒘, and integrate 
the expression over Ω. Doing so, we end up with separated energy terms, 
specifically expressed as 𝜕𝜕𝜕𝜕𝑒𝑒𝜕𝜕𝜕𝜕 + 𝐴𝐴𝑒𝑒 − 𝑆𝑆𝑒𝑒+ 𝑉𝑉𝑒𝑒 + 𝐻𝐻(𝑝𝑝) + 𝑇𝑇𝑒𝑒 = 0, (4.25) 
where 𝜕𝜕𝜕𝜕𝑒𝑒𝜕𝜕𝜕𝜕 = � 𝜌𝜌Ω 𝜕𝜕𝑽𝑽𝜕𝜕𝜕𝜕 ∙ 𝒘𝒘𝑑𝑑Ω (4.26) 𝐴𝐴𝑒𝑒 = � 𝜌𝜌(𝑽𝑽 ∙ ∇𝑽𝑽 ) ∙ 𝒘𝒘Ω  (4.27) 𝑆𝑆𝑒𝑒 = � (𝜇𝜇∇𝑽𝑽 ∙ 𝒏𝒏) ∙ 𝒘𝒘𝑑𝑑ΓΓ  (4.28) 𝑉𝑉𝑒𝑒 = � 𝜇𝜇∇𝑽𝑽 ∶ ∇𝒘𝒘Ω 𝑑𝑑Ω (4.29) 𝐻𝐻(𝑝𝑝) = � 𝑝𝑝 𝒘𝒘 ∙ 𝒏𝒏𝑑𝑑ΓΓ − � 𝑝𝑝∇ ∙ 𝒘𝒘 𝑑𝑑ΩΩ , (4.30) 
together with the additional turbulent dissipation term 𝑇𝑇𝑒𝑒 = � 𝜌𝜌 (∇ ∙ Cov[𝒗𝒗, 𝒗𝒗]) ∙ 𝒘𝒘 𝑑𝑑ΩΩ , (4.31) 
being the only additional change to the original νWERP formulation. With this 
addition for turbulent flows, the expansion is coined νWERP-t. 
As before, using integration by parts we can convert Equation 4.31 as 
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CHAPTER 4. METHODOLOGY 𝑇𝑇𝑒𝑒 = � 𝜌𝜌 (Cov[𝒗𝒗, 𝒗𝒗]𝒏𝒏) ∙ 𝒘𝒘 𝑑𝑑ΓΓ − � 𝜌𝜌 (Cov[𝒗𝒗, 𝒗𝒗]: 𝒘𝒘) 𝑑𝑑ΩΩ , (4.32) 
which under the assumption that 𝒗𝒗 is negligibly small at the vessel boundary, and 
that the turbulence is similarly negligible at inlet and outlet regions (Γ𝑖𝑖 and Γ𝑜𝑜), 
can be simplified into 
 𝑇𝑇𝑒𝑒 = −∫ 𝜌𝜌 (Cov[𝒗𝒗, 𝒗𝒗]:𝒘𝒘) 𝑑𝑑ΩΩ . (4.33) 
With this, and using the same assumptions on 𝒘𝒘 as in the original νWERP 
formulation, we can again isolate the relative pressure in Equation 4.25 as 
 Δ𝑝𝑝 = − 1𝑄𝑄 �𝜕𝜕𝜕𝜕𝑡𝑡 𝜕𝜕𝑒𝑒 + 𝐴𝐴𝑒𝑒 + 𝑉𝑉𝑒𝑒 + 𝑇𝑇𝑒𝑒�, (4.34) 
representing the extended νWERP-t method, applicable for flow regimes including 
turbulent energy dissipation. 
4.2.4. Numerical implementation 
Below follows a brief outline of the numerical realisation of νWERP and νWERP-
t, as well as the general implementation on acquired clinical flow data. The entire 
processing chain was implemented and evaluated using MATLAB R2016a 
(MathWorks, Natick, MA, USA). A simplified overview of the required processing 
steps is given in Figure 4.8 (νWERP) and Figure 4.9 (νWERP-t). 
a) Pre-processing and data segmentation 
In principle, νWERP is not bound to any specific imaging modality, but is rather a 
method based on any full-field acquisition of 3D flow. However, in all three 
νWERP-based studies of this thesis, 4D flow MRI has been utilised. 
Using 4D flow MRI, a vital pre-processing step lies in the calibration and 
correction of potentially erroneous data, following the presence of e.g. eddy 
currents, field inhomogeneities, or regions of signal aliasing. 
Once corrected, segmentation of the vascular domain of interest (Ω in the 
theoretical derivation) has to be performed, isolating the fluid domain from 
surrounding tissue structures by the creation of a binary image mask. In all three 
studies, fluid domain segmentation was performed by semi-automated data 
thresholding on generated velocity magnitude images. Within the same 
segmentation, user-defined inlet and outlet planes also have to be selected, defining 
the region over which relative pressures are to be computed. 
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Figure 4.8: Processing step of νWERP going from (a) acquired flow data, (b) segmented flow 
domain, (c) selection of inlet and outlet planes, (d) computation of virtual field, (e) assessment of 
virtual work-energy components, and (f) generated relative pressure trace. 
 
Figure 4.9: Processing step of νWERP-t, similar to νWERP in Figure 4.8 however with inclusion of 
acquired covariance data, which after diagonal masking is included in the energy balance to generate a 
relative pressure trace. 
b) Noise filtering 
With flow domain segmented, spatial noise filtering is incorporated into the 
νWERP method. Specifically, a k-order 3D polynomial fitting is used to 
approximate the signal within a defined voxel neighbourhood, with optimal filter 
settings (interpolation order and kernel size) defined by translating the estimated 
data noise level to a simplified 1D sinusoidal signal. 
For νWERP-t, additional covariance filtering is applied. Specifically, negative 
diagonal entries of the Covariance matrix were removed in order to avoid non-
physical entries (i.e. keeping strictly positive fluctuations of Cov[𝑣𝑣𝑖𝑖, 𝑣𝑣𝑖𝑖] for 𝑖𝑖 = 
1,2,3). 
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Figure 4.10: Computation of virtual field, 𝒘𝒘, from segmented flow data. (a) Segmented flow domain, 
(b) Labelling of domain voxels, (c) Identification of inlet and outlet planes of interest, (d) Domain 
subsampling, (e) Virtual field computation by a FDM approach, (f) Output virtual field. 
c) Virtual field computation 
A fundamental component of νWERP is the computation of 𝒘𝒘, outlined in Figure 
4.10. The process is initiated by a labelling of the fluid domain, where all voxels 
within the field-of-view is marked as being either interior (entirely within the fluid 
domain), exterior (voxels being entirely outside the fluid domain), inlet/outlet 
(voxels being within the inlet/outlet planes), or wall voxels (separating interior and 
exterior domain, but not belonging to inlet or outlet), respectively. Using this 
labelling, appropriate boundary conditions can be set in the computation of 𝒘𝒘. 
Prior to the computation of 𝒘𝒘 a domain subsampling is then performed. 
Specifically, the input data base-discretisation is subdivided by a chosen integer 
value, converting a single image voxel into several uniformly distributed nodal 
points. This operation is added to improve the accuracy of 𝒘𝒘, and is 
complemented by an additional subsampling of 𝒗𝒗. 
With domain, labelling, and sub-sampling introduced, boundary conditions from 
Equation 4.22 are transferred onto appropriate nodal points, and 𝒘𝒘 is solved 
numerically using a Finite Difference Method (FDM) with a staggered grid 
approach [367]. For efficient computation, an iterative solver based on the BFBT- 
preconditioning method [368] is additionally deployed (for specific details, please 
see [63]). 
d) νWERP discretisation and operator estimation 
For a numerical realisation, discretisation of the energy terms of Equation 4.19 has 
to be introduced. Since we are dealing with a voxelised version of Ω (denoted as Ω𝑅𝑅𝑅𝑅𝑅𝑅  with corresponding inlet plane, outlet plane, and normal vectors Γ𝑅𝑅,𝑅𝑅𝑅𝑅𝑅𝑅 , Γ𝑅𝑅,𝑅𝑅𝑅𝑅𝑅𝑅 , and 𝑵𝑵 , respectively), we compute separate energy terms by evaluating 𝒗𝒗 and 𝒘𝒘 at each voxel (𝑖𝑖, 𝑗𝑗, 𝑘𝑘) as 
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4.2. NON-INVASIVE RELATIVE PRESSURE ESTIMATION 𝜕𝜕𝑒𝑒(𝒗𝒗,𝒘𝒘) = 𝜌𝜌𝑑𝑑𝑉𝑉 � �𝒗𝒗(𝑖𝑖, 𝑗𝑗, 𝑘𝑘) ∙ 𝒘𝒘(𝑖𝑖, 𝑗𝑗, 𝑘𝑘)�(𝑖𝑖,𝑗𝑗,𝑘𝑘) 𝜖𝜖 Ω𝑅𝑅𝑅𝑅𝑅𝑅  (4.35) 𝐴𝐴𝑒𝑒(𝒗𝒗,𝒘𝒘) = 𝜌𝜌𝑑𝑑𝑉𝑉 � ��𝒗𝒗(𝑖𝑖, 𝑗𝑗, 𝑘𝑘) ∙ 𝜈𝜈(𝒗𝒗)(𝑖𝑖, 𝑗𝑗, 𝑘𝑘)� ∙ 𝒘𝒘(𝑖𝑖, 𝑗𝑗, 𝑘𝑘)�(𝑖𝑖,𝑗𝑗,𝑘𝑘) 𝜖𝜖 Ω𝑅𝑅𝑅𝑅𝑅𝑅  (4.36) 𝑉𝑉𝑒𝑒(𝒗𝒗,𝒘𝒘) = 𝜇𝜇𝑑𝑑𝑉𝑉 � �𝜈𝜈(𝒗𝒗)(𝑖𝑖, 𝑗𝑗, 𝑘𝑘) ∶ 𝜈𝜈(𝒘𝒘)(𝑖𝑖, 𝑗𝑗, 𝑘𝑘)�(𝑖𝑖,𝑗𝑗,𝑘𝑘) 𝜖𝜖 Ω𝑅𝑅𝑅𝑅𝑅𝑅  (4.37) 𝑄𝑄(𝒘𝒘) = 𝑑𝑑𝑆𝑆 � �𝒘𝒘(𝑖𝑖, 𝑗𝑗) ∙ 𝑵𝑵(𝑖𝑖, 𝑗𝑗)�,(𝑖𝑖,𝑗𝑗) 𝜖𝜖 Γ𝑅𝑅,𝑅𝑅𝑅𝑅𝑅𝑅  (4.38) 
where 𝑑𝑑𝑆𝑆 = ∏ ∆𝑥𝑥𝑖𝑖2𝑖𝑖=1  and 𝑑𝑑𝑉𝑉 = ∏ ∆𝑥𝑥𝑖𝑖3𝑖𝑖=1  are the pixel surface and voxel 
volume, respectively, based on the voxel length ∆𝑥𝑥 in each spatial dimension. 𝜈𝜈(∙) is the spatial gradient, operating on either 𝒘𝒘 or the smoothed version of 𝒗𝒗, 
respectively. 
For νWERP-t, the incorporated turbulent energy dissipation term can be 
similarly discretised as 𝑇𝑇𝑒𝑒(𝒗𝒗,𝒘𝒘) = −𝜌𝜌𝑑𝑑𝑉𝑉 � �Cov[𝒗𝒗, 𝒗𝒗](𝑖𝑖, 𝑗𝑗, 𝑘𝑘) ∶ 𝜈𝜈(𝒘𝒘)(𝑖𝑖, 𝑗𝑗, 𝑘𝑘)�(𝑖𝑖,𝑗𝑗,𝑘𝑘) 𝜖𝜖 Ω𝑅𝑅𝑅𝑅𝑅𝑅  (4.39) 
using the same indexing as before. 
With the above, the relative pressure can be estimated as for νWERP as ∆𝑝𝑝𝑡𝑡+12 = − 1𝑄𝑄(𝒘𝒘)�𝜕𝜕𝜕𝜕𝜕𝜕𝜕𝜕𝑒𝑒�𝒗𝒗𝑡𝑡+12,𝒘𝒘� + 𝐴𝐴𝑒𝑒�𝒗𝒗𝑡𝑡+12,𝒘𝒘�+ 𝑉𝑉𝑒𝑒�𝒗𝒗𝑡𝑡+12,𝒘𝒘��, (4.40) 
or for νWERP-t as ∆𝑝𝑝𝑡𝑡+12 = − 1𝑄𝑄(𝒘𝒘)�𝜕𝜕𝜕𝜕𝜕𝜕𝜕𝜕𝑒𝑒�𝒗𝒗𝑡𝑡+12, 𝒘𝒘� + 𝐴𝐴𝑒𝑒�𝒗𝒗𝑡𝑡+12,𝒘𝒘� + 𝑉𝑉𝑒𝑒�𝒗𝒗𝑡𝑡+12, 𝒘𝒘�+ 𝑇𝑇𝑒𝑒�Cov𝑡𝑡+12,𝒘𝒘��, (4.41) 
where central difference estimates of both 𝒗𝒗, Cov[𝒗𝒗, 𝒗𝒗], and all spatial and 
temporal gradients are utilised to improve temporal accuracy. 
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4.2.5.  Method evaluation and validation 
In this thesis, νWERP was implemented and studied in a few different setups: 
i) First, νWERP was tested in-silico to evaluate method performance in a 
set of challenging patient-specific cases, as well as to map 
spatiotemporal convergence behaviour as a function of image noise. 
This was performed as a first part of Study V. 
ii) Second, νWERP was tested in-vivo to evaluate the methods clinical 
performance, as well as to validate it against invasive catheter 
measurements. This was performed as a second part of Study V. 
iii) Lastly, the extension of νWERP-t into turbulent flows was evaluated 
in-silico as well as in-vitro in a controlled flow phantom setup, again 
validating method output against simulated or invasive measurements. 
This was performed in Study VI. 
Below follows a brief overview of the different test-beds. 
a) In-silico evaluation of νWERP 
To evaluate νWERP performance, two different cardiovascular pathological 
conditions were studied in-silico: one model of a coarctation of the aorta (CoA) 
[369], and one model of an acute type B aortic dissection (AAD) [177]. In both 
cases, the models originated from image-based patient-specific computational fluid 
dynamics (CFD) analysis, where simulation output was used as input for the 
νWERP analysis. Importantly, with complete 4D pressure fields generated as an 
output from the CFD analysis, a defined ground-truth existed for the performed 
νWERP evaluation. 
To mimic realistic imaging sampling, both models were spatiotemporally projected 
to resolutions of common 4D flow MRI acquisitions (voxel size: 2 mm3, with 22 
and 32 temporal phases over one cardiac cycle for CoA and AAD, respectively). 
 
Figure 4.11: Generation of synthetic image data, based on simulated CFD output. (a) Simulation 
output. (b) Voxelised equivalent. (c) Cut-through images at three different noise levels.   
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Image noise was added at two different noise levels (SNR = 10 and 30, 
respectively), generating a set of 100 different flow fields at each noise level, with 
each model subsequently fed into the νWERP analysis pipeline. An overview of 
this process is given in Figure 4.11. 
In each model, relative pressure was computed from aortic inlet to six different, 
arbitrarily chosen outlets. Importantly, outlets were chosen at several different 
bifurcating positions, specifically to extend beyond the application field of 
previously proposed method for non-invasive relative pressure estimations. 
For the AAD model, effects of varying spatiotemporal sampling was also 
evaluated. This was done by generating models with varying spatial resolution (1-3 
mm3) and temporal resolution (8-64 phases), and evaluating relative pressure over a 
set of defined inlet and outlet planes. Again, each set was evaluated without noise, 
as well as at noise levels of SNR = 10 and 30, respectively. 
For all cases, mean error between νWERP and the ground-truth CFD pressure 
field was quantified as 
𝜀𝜀Δ𝑝𝑝 = ⎝⎜⎛�∑  (∆𝑝𝑝𝑊𝑊 |𝑛𝑛 − ∆𝑝𝑝|𝑛𝑛)2𝑁𝑁𝑛𝑛 = 1�∑  ∆𝑝𝑝|𝑛𝑛2𝑁𝑁𝑛𝑛 = 1 ⎠⎟⎞ ∙ 100, (4.42) 
where ∆𝑝𝑝𝑊𝑊 |𝑛𝑛 is the νWERP estimate at a discrete time step 𝜕𝜕𝑛𝑛 and ∆𝑝𝑝|𝑛𝑛 is the 
corresponding true data closest to the νWERP estimate within 𝜕𝜕𝑛𝑛−1 < 𝜕𝜕 < 𝜕𝜕𝑛𝑛+1. 
In both in-silico models, νWERP output was also compared against alternative 
relative pressure methods, being Bernoulli (Equation 3.3), unsteady Bernoulli 
(Equation 3.6), and WERP (Equation 3.55), respectively. For a review of these 
methods, please see Section 3.1.4. 
b) In-vivo validation of νWERP 
To validate its clinical applicability, νWERP was also compared against gold-
standard catheter-based invasive pressure measurements in a defined clinical 
cohort. Specifically, 4D flow MRI (Philips Achieva 1.5T, voxel size: 2 mm3, 22 
temporal phases) was acquired on a cohort of five anaesthetised adolescent 
patients with complex congenital heart disease. Absolute invasive pressures were 
recorded at ascending, mid-descending, and diaphragm level of the aorta, in each 
patient, respectively. From the pressure traces, relative pressures were computed 
by ECG-correlation, and subsequently compared to νWERP output. As previously, 
mean errors were computed by Equation 4.42, with root mean square error, 𝜀𝜀𝑟𝑟𝑚𝑚𝑠𝑠, 
and error at peak pressure, 𝜀𝜀Δ𝑝𝑝𝑚𝑚𝑚𝑚𝑚𝑚 , additionally calculated as 
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c) In-vitro evaluation of νWERP-t 
To evaluate the accuracy of the νWERP-t, a series of steady-state turbulent flow 
cases were assessed. Specifically, a previously published dataset consisting of seven 
3D-printed aortic valve phantoms was utilised, where turbulent flow fields had 
been imaged using 4D flow MRI with six-directional icosahedral flow encoding 
(ICOSA6) [317]. By so, both mean field flow quantities and incoherent, 
turbulence-driven flow fluctuations had been mapped. For each phantom, datasets 
were available at four different flow rates, with invasive pressure measurements 
obtained from installed pressure ports within the custom-made flow circuit. A 
visualisation of flow field, covariance, and virtual field is provided in Figure 4.12. 
For each valve and flow rate, relative pressures were computed using νWERP-t 
and νWERP. For comparison, an extended WERP-t method was employed (using 𝒘𝒘 =  𝒗𝒗 in νWERP-t), as well as the original WERP formulation (Equation 3.55). 
Additionally, the turbulence production method formulated in Equation 3.57, TP, 
was also employed as this had been specifically tested on the same phantom 
dataset in [317]. Important however, is that in [317], the TP method had been 
employed together with an additional covariance filtering where 
−Cov[𝒗𝒗, 𝒗𝒗] ∶ ∇𝑽𝑽 = ��max �−Cov�𝒗𝒗𝛼𝛼, 𝒗𝒗𝛽𝛽� 𝜕𝜕𝑽𝑽𝛼𝛼𝜕𝜕𝑋𝑋𝛽𝛽 , 0�3𝛽𝛽=13𝛼𝛼=1 , (4.45) 
at each voxel (𝑖𝑖, 𝑗𝑗, 𝑘𝑘), effectively removing all negative integral arguments in 
Equation 3.57 from the relative pressure computations. Consequently, this 
masking was incorporated into the TP method when used in Study VI. 
For all methods, accuracy was assessed for all methods using linear regression 
analysis between predicted and true relative pressure. Additionally, Bland-Altman 
plots were derived to evaluate potential bias in the relative pressure predictions. 
 
𝜀𝜀𝑟𝑟𝑚𝑚𝑠𝑠 = �∑  (∆𝑝𝑝𝑣𝑣𝑊𝑊𝑆𝑆𝑅𝑅𝑣𝑣 (𝜕𝜕𝑛𝑛) − ∆𝑝𝑝(𝜕𝜕𝑛𝑛))2𝑁𝑁𝑛𝑛 = 1 𝑆𝑆 ∙ 100 (4.43) 
𝜀𝜀Δ𝑝𝑝𝑚𝑚𝑚𝑚𝑚𝑚 = �∆𝑝𝑝𝑊𝑊,𝑚𝑚𝑚𝑚𝑥𝑥 − ∆𝑝𝑝𝑚𝑚𝑚𝑚𝑥𝑥∆𝑝𝑝𝑚𝑚𝑚𝑚𝑥𝑥 � ∙ 100. (4.44) 
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d) In-silico evaluation of νWERP-t 
To expand on the steady-state in-vitro phantoms, νWERP-t was also applied on a 
transient flow case. Specifically, the patient-specific in-silico AAD from the in-silico 
validation of νWERP was utilised, however with output generated over 10 
consecutive cycles to initiate potential turbulent flow fluctuations. 
From the simulated data, mean field and covariance data were generated in two 
sets: one derived from the first 3 cycles, representing an initiation phase with 
enhanced flow covariance, and one derived from the last 7 cycles, representing a 
more quasi-periodic flow with less pronounced flow covariance. For both sets, 
relative pressures were derived from the aortic outlet to an approximate 180° bend 
of the descending false lumen of the thoracic aorta. A visualisation of the flow 
field, covariance, and corresponding virtual field is provided in Figure 4.13. 
As with the in-vitro cohort, relative pressure estimations were performed using 
νWERP-t, νWERP, WERP-t, WERP, and TP, respectively. 
Accuracy was assessed using linear regression analysis between predicted and true 
relative pressure together with corresponding Bland-Altman plots. Mean errors 
over the entire simulated cardiac cycle were also derived using Equation 4.42. 
 
Figure 4.12: Different valve configurations (left) and example of mean field (upper), covariance 
(middle), and virtual field (lower) for the stenotic flow phantoms in Study VI. 
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Figure 4.13: Mean field (left), covariance (middle), and virtual field (right) for the initialisation (upper 
row) and quasi-periodic phase (lower row) of the AAD in-silico data used in Study VI. 
4.2.6.  Clinical in-vivo analysis 
Building on the findings from the method evaluation, νWERP was applied in a 
final clinical study. In Study VII, aortic hemodynamics was evaluated in a DCM 
cohort, evaluating potential aortic changes in cardiac disease. 
a) Study population 
14 patients treated for moderate DCM-related heart failure, and 16 healthy subjects 
were enrolled for the study, all participating under informed consent as approved 
by the Regional Ethics Committee, South East London, United Kingdom (REC, 
12/LO/1456). The inclusion criteria were ≥18 years, suspected or known non-
ischemic DCM-related heart failure (NYHA class III, using beta blockers), and the 
exclusion criteria were airway disease (asthma, chronic obstructive pulmonary 
disease, bronchitis), pregnancy, renal or hepatic impairment, previous history of 
angina or cardiac arrhythmias for which beta blockers were necessary, and known 
contraindications to MRI. Subject demographics are provided in Table 4.4. 
Note that prior to imaging and data collection, the DCM subjects had their beta 
blocker treatment discontinued for 48 hours (this to study the response to esmolol 
administration as part of an independent side study). 
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Table 4.4: Subject characteristics for the patient cohort of Study VII. P-values were derived using a 
Mann-Whitney test or, in the case of nominal data, a 𝜒𝜒2 test. 
b) Imaging, data collection, and data processing 
For each subject, a range of image-based and non-invasive data was collected: 
i) Cardiac functional imaging.  
To assess cardiac efficiency and anatomy, cine steady-state free precession (SSFP) 
MRI (retrospective ECG triggering, spatial resolution ~2x2x8 mm3, temporal 
resolution ~20 ms) and 3D tagged MRI (prospective ECG triggering, spatial 
resolution ~3.4x7.7x7.7 mm3, temporal resolution ~30 ms) was acquired on all 
subjects (ACHIEVA 1.5 Tesla, Philips Healthcare Best, The Netherlands). Left 
and right ventricular volumes and functional output metrics (EF, SV, CO, cardiac 
index (CI)) were calculated by manually delineating the ventricles at end systole and 
diastole in short-axis stacks (CVI software, Circle Cardiovascular Imaging Inc, 
Alberta, Canada). 
ii) Vascular flow imaging and aortic relative pressure 
In direct sequence to the cardiac imaging, 4D flow MRI was acquired (prospective 
ECG triggering, spatial resolution ~2.5 mm3, temporal resolution ~30 ms, velocity 
encoding ~120 - 190 cm/s). With the thoracic aorta segmented using available in-
house software, aortic relative pressures were derived using νWERP from the left 
ventricular outflow tract (LVOT) down to the diaphragm-level of the descending 
aorta. To quantify the output traces, three relative pressure metrics were derived: 
maximum relative pressure over the entire cardiac cycle, minimum relative pressure 
over the entire cardiac cycle, and time-to-peak relative pressure (TTP), respectively 
(an illustration of the three metrics is given in Figure 4.14). 
Aortic PWV was derived by assessing the transit time between through-plane flow 
traces at LVOT and the diaphragm descending aorta [370], and, using these values, 
aortic stiffness estimates were calculated by the Moens-Korteweg equation [289]. 
Demographics  
Volunteers  
(n = 16), 
mean ± SD or  
n (%) 
DCM patients  
(n = 14), 
mean ± SD or  
n (%) 
p-value 
Age, yrs 42.4 ± 12.4 47.8 ± 10.7 0.23 
Weight, kg 72.3 ± 14.9 82.3 ± 19.7 0.07 
Height, cm 173.0 ± 8.7 167.9 ± 8.1 0.14 
Body surface area, m2 1.85 ± 0.23 1.96 ± 0.28 0.15 
Male/Female, n/n 9 / 7 7 / 6 0.73 
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Figure 4.14: νWERP overview for Study VII. From each subject, maximum relative pressure, 
minimum relative pressure, and time-to-peak relative pressure (TTP) was quantified, as illustrated on 
the right. 
iii) Central blood pressure estimation 
Non-invasive central blood pressure was derived from brachial 
sphygmomanometer cuffing using dedicated clinical equipment (Centron cBP30, 
SunTech Medical Inc., Morrisville, NC, USA), where cuff-based measured are 
converted into central blood pressure estimates by means of optimised transfer 
functions [371]. 
c) Reference virtual cohort analysis 
As a reference complement to the in-vivo analysis, and in order to isolate the 
independent influence of certain cardiovascular properties on aortic relative 
pressure, 1D simulations of aortic relative pressure were performed on a 
customised virtual cohort. The cohort was created by solving a system of 1D 
blood flow equations through a validated systemic circulatory model [372, 373], 
with cardiac and aortic anatomy and function adapted to patient-specific values 
derived from the imaging study. 
Using the virtual cohort, aortic relative pressures were derived as a function of 
varying cardiac or aortic properties, respectively. Specifically, the independent 
influence of SV, heart rate, arterial peripheral resistance, aortic stiffness, and aortic 
area was evaluated by varying these entities independently around the virtual 
cohort mean. By so, the isolated influence from these five entities could be defined 
for each clinical subgroup, respectively. 
d) Data analysis 
Statistical differences in subject characteristics were evaluated using a Mann-
Whitney U-test (continuous data) or 𝜒𝜒2 test (nominal data), both with significance 
inferred at 𝑝𝑝 < 0.05. Differences in cardiac and arterial output metrics were also 
evaluated using a Mann-Whitney U-test, with significance inferred at 𝑝𝑝 < 0.05. For 
all cases, potential outliers were assessed by the Tukey’s fences method [374]. 
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To this, correlation analysis between subject characteristics and derived aortic 
relative pressure metrics were performed by assessing the Pearson correlation 
coefficient (correlation defined at |𝑅𝑅| > 0.5 and 𝑝𝑝 < 0.05). 
4.3. Tomographic reconstruction for pre-clinical imaging 
As a final part of the thesis, a research paper has been written within pre-clinical 
imaging and X-ray tomographic reconstruction. 
4.3.1.  Study overview 
In contrast to the other parts of the thesis, the work on tomographic 
reconstruction is represented by a single paper. The work is not aimed at any 
particular application area, however specific examples for cardiovascular 
evaluations are provided. 
In general, a majority of the evaluations are performed on numerical in-silico 
phantoms, with some experimental in-vitro and ex-vivo tests added to complement 
the aforementioned evaluations. 
4.3.2.  Theory and method derivation 
In this work a method for tomographic multigrid reconstruction is developed, 
where data from a single acquisition is reconstructed in multiple domains, using 
either different levels of spatial discretisation, numerical regularisation, or a 
combination of the two. 
As outlined in Section 3.3.3., in X-ray tomographic image reconstruction we are 
dealing with recovering a function 𝑓𝑓  based on observed data 𝑔𝑔 and a descriptive 
forward operator 𝐴𝐴 (generically connected by Equation 3.31). For medical 
purposes we typically seek to find 𝑓𝑓  on a reconstruction domain Ω ⊂ ℝ𝑑𝑑 where 𝑑𝑑 ∈ {2,3}. 
For the sake of multigrid reconstruction, consider an ROI Ω1 ⊂ Ω and a 
complement Ω0 = Ω\Ω1. With the two mapping the entire reconstruction 
domain, this means that 
�Ω0 ∩ Ω1 = ØΩ0 ∪ Ω1 = Ω. (4.46) 
An identical domain splitting can also be extended onto the sought after 𝑓𝑓  by 
introducing masked functions 
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𝑓𝑓𝑖𝑖(𝑥𝑥) = �𝑓𝑓(𝑥𝑥), if 𝑥𝑥 𝜖𝜖 Ω𝑖𝑖0, otherwise,      𝑖𝑖 = 0,1. (4.47) 
We can then re-express our inverse problem from Equation 3.31 (neglecting noise) 
in the form of masked functions such that 𝑔𝑔 = 𝐴𝐴𝑓𝑓 = 𝐴𝐴(𝑓𝑓0 + 𝑓𝑓1) = 𝐴𝐴𝑓𝑓0 + 𝐴𝐴𝑓𝑓1, (4.48) 
noting that this holds for any linear operator, or alternatively for any pointwise 
nonlinear operators 𝐴𝐴. Figure 4.15 shows a visualisation of this domain 
partitioning. 
Similar splitting can be performed on the adjoint 𝐴𝐴∗. However, as Ω is part of the 
range of 𝐴𝐴∗, the splitting is performed post-hoc such that 𝐴𝐴∗𝑔𝑔 = (𝐴𝐴∗𝑔𝑔)0 + (𝐴𝐴∗𝑔𝑔)1. (4.49) 
If applying this onto the normal equation (Equation 3.33), we see that 𝐴𝐴∗𝐴𝐴𝑓𝑓 = 𝐴𝐴∗𝑔𝑔 ⟺ 𝐴𝐴∗(𝐴𝐴𝑓𝑓0 + 𝐴𝐴𝑓𝑓1) = 𝐴𝐴∗𝑔𝑔 ⟺ (𝐴𝐴∗𝐴𝐴𝑓𝑓0)0 + (𝐴𝐴∗𝐴𝐴𝑓𝑓0)1 + (𝐴𝐴∗𝐴𝐴𝑓𝑓1)0 + (𝐴𝐴∗𝐴𝐴𝑓𝑓1)1 = (𝐴𝐴∗𝑔𝑔)0 + (𝐴𝐴∗𝑔𝑔)1. (4.50) 
If we in the above separate terms acting on different domains, we can rewrite the 
above as an equation system such that (𝐴𝐴∗𝐴𝐴𝑓𝑓0)0 + (𝐴𝐴∗𝐴𝐴𝑓𝑓1)0(𝐴𝐴∗𝐴𝐴𝑓𝑓0)1 + (𝐴𝐴∗𝐴𝐴𝑓𝑓1)1 = (𝐴𝐴∗𝑔𝑔)0(𝐴𝐴∗𝑔𝑔)1. (4.51) 
As seen and following the off-diagonal terms there will be a defined cross-talk 
between the different domains, where errors in 𝑓𝑓0 will influence 𝑓𝑓1 and vice versa. 
It can also be shown that the expression in Equation 4.51 can be extended into 
regularised approaches, such as the general variational method given in 
Equation 3.34. For such, the split equation system is given by (𝐴𝐴∗𝐴𝐴𝑓𝑓0)0 + (𝐴𝐴∗𝐴𝐴𝑓𝑓1)0 + 𝜆𝜆0𝑆𝑆(𝑓𝑓0)(𝐴𝐴∗𝐴𝐴𝑓𝑓0)1 + (𝐴𝐴∗𝐴𝐴𝑓𝑓1)1 + 𝜆𝜆1𝑆𝑆(𝑓𝑓1) = (𝐴𝐴∗𝑔𝑔)0(𝐴𝐴∗𝑔𝑔)1, (4.52) 
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Figure 4.15: Simplified illustration of multigrid domain partitioning, showing how the disjoint Ω0 
and Ω1 can be represented by masked functions 𝑓𝑓0 and 𝑓𝑓1. For linear, or pointwise non-linear 
operators, the partitioning can be similarly translated onto the forward problem. 
where 𝑆𝑆(𝑓𝑓𝑖𝑖) represents the split subgradient of the variational approach. By so, 
Equation 4.52 also opens up for multigrid regularisation, where separated 
regularisation is achieved when 𝜆𝜆0 ≠ 𝜆𝜆1. 
4.3.3.  Numerical implementation 
With theory provided in Section 4.3.2., the domain splitting approach for multigrid 
reconstruction is implemented as a Python sub-library to the Operator 
Discretisation Library (ODL, https://github.com/odlgroup/odl). Implementation 
specifics can be found under the github repository https://github.com/kohr-
h/odl-multigrid/. To exemplify the simplicity of use, below follows a pseudo-code 
comparison between conventional and multigrid discretisation reconstruction, 
both using typical implementation logic of ODL 
Conventional reconstruction Multigrid reconstruction 
# Define discretisation 
reco_space = ... 
# Define discretisations 
coarse_reco_space = ... 
fine_reco_space = ... 
insert_reco_space =  
     insert_discr(coarse_reco_space,                                                                      
                  fine_reco_space,                                                         
                  ...) 
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As seen, domain splitting is achieved either by operator masking (MaskingOp) or by 
limiting the acting operator domain (insert_ray_trafo is limited to the domain 
defined by the insert_discr). Further, by invoking a reduction operator (ReducOp, 
identical to Equation 4.51), the multigrid approach is brought back into the general 
framework of ODL, where any reconstruction operator or optimisation scheme 
can be invoked. 
4.3.4.  Method evaluation 
To evaluate the performance of the proposed multigrid reconstruction approach, a 
series of numerical and experimental tests were performed. 
# Define geometry 
angle_partition = ... 
detector_partition = ... 
geometry =  
    FanFlatGeom(angle_part,                        
                detector_part,  
                ...) 
# Define geometry 
angle_partition = ... 
detector_partition = ... 
geometry =  
FanFlatGeom(angle_part,                        
                 detector_part,  
                 ...) 
# Define forward operator 
ray_trafo =  
    RayTrafo(geometry,                           
             reco_space,  
             ...) 
# Define forward operators 
coarse_ray_trafo =  
RayTrafo(geometry,                                             
              coarse_reco_space,  
              ...) 
 
insert_ray_trafo =  
     RayTrafo(geometry,                                                   
              insert_reco_space,  
              ...) 
 
# Define masking operator 
masking_operator =  
     MaskingOp(coarse_reco_space,                                     
               insert_reco_space,                                                            
               ...) 
 
masked_coarse_ray_trafo =  
     coarse_ray_trafo * masking_operator  
 
# Create reduction operator 
sum_ray_trafo =  
     ReducOp(masked_coarse_ray_trafo, 
             insert_ray_trafo,  
             ...) 
 
# Define reconstruction      
# operator 
reco_op = RecoOp(ray_trafo,     
                 ...) 
# Define reconstruction  
# operator 
reco_op = RecoOp(sum_ray_trafo, ...) 
# Reconstruction 
reco = reco_op(data) 
# Reconstruction 
reco = reco_op(data) 
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a) In-silico evaluation 
For the in-silico evaluation, tomographic image data was simulated from a Shepp-
Logan phantom using line-integral forward projection with a pixel discretisation of 
4002 and Gaussian noise with a standard deviation of 10%. 
Three scenarios were evaluated 
i) Piecewise discretisation, reconstructing at different levels of spatial 
discretisation, evaluating discretisation ratios of 1:1, 1:2, 1:4, 1:8, and 
1:16 between the two different domains. 
ii) Piecewise regularisation, reconstruction at different levels image 
regularisation, evaluating regularisation ratios of 10:1, 1:1, 0.1:1, 0.01:1, 
and 0.001:1 between the two different domains (baseline 𝜆𝜆 =  
8 ⋅ 10-3). 
iii) Piecewise discretisation and regularisation, combining i) and ii), evaluating 
ranging discretisation (1:1 to 1:16) at a regularisation ratio of 0.1:1. 
In all cases, ROI was empirically set around the three dorsal inserts of the Shepp-
Logan phantom. 
For all cases, reconstruction quality was assessed by the Euclidean distance 𝑘𝑘 
between reoncstruction 𝑓𝑓  and ground truth 𝑓𝑓𝑡𝑡𝑟𝑟𝑡𝑡𝑒𝑒, defined as 𝑘𝑘 = �‖𝑓𝑓 − 𝑓𝑓𝑡𝑡𝑟𝑟𝑡𝑡𝑒𝑒‖22𝑑𝑑𝑥𝑥Ω , (4.53) 
as well as the structural similarity index (SSIM), given by 𝑆𝑆𝑆𝑆𝐼𝐼𝑀𝑀(𝑓𝑓, 𝑓𝑓𝑡𝑡𝑟𝑟𝑡𝑡𝑒𝑒) = �2𝜇𝜇𝑓𝑓𝜇𝜇𝑓𝑓𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 + 𝑐𝑐1��2𝜎𝜎𝑓𝑓𝑓𝑓𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 + 𝑐𝑐2��𝜇𝜇𝑓𝑓2 + 𝜇𝜇𝑓𝑓𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡2 + 𝑐𝑐1��𝜎𝜎𝑓𝑓2 + 𝜎𝜎𝑓𝑓𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡2 + 𝑐𝑐2� , (4.54) 
with 𝜇𝜇 and 𝜎𝜎 being the mean and variance of 𝑓𝑓  and 𝑓𝑓𝑡𝑡𝑟𝑟𝑡𝑡𝑒𝑒, and 𝑐𝑐1 and 𝑐𝑐2 are 
conventionally used stabilising coefficients [375]. Additionally, an assessment of 
computation time on a single NVIDIA TITAN X GPU was also performed in 
all three cases, with the number of pixels increased from 4002 to 128002. 
b) Experimental evaluation 
In addition to the numerical examples, multigrid reconstruction was also attempted 
on experimentally acquired micro-CT data. 
As in Study III of the SWE-analysis, an in-house micro-CT system with a 
microfocus X-ray source (Hamamatsu MX-L10951-04, focal spot size: 15-80 µm), 
109 
CHAPTER 4. METHODOLOGY 
a CMOS flat panel (Hamamatsu C7942CA-22, total area: 12 cm2, pixel size: 50 
µm2, frame grabber (EPIX PIXCI D2X-C7942), and a steering gantry was utilised. 
From each acquisition, data was converted into standardised openCT format [376], 
with calibrations introduced for detector misalignment, detector lag effect, and 
defective detector pixels. 
Three objects were imaged in the micro-CT setup: 
i) Low contrast calibration phantom, used to identify low-contrast inserts of 
varying image contrast (4% and 8% contrast, respectively). 
ii) Ex-vivo atherosclerotic plaque, used to exemplify the clinical usage of the 
proposed multigrid reconstruction approach. 
iii) 3D-printed CT angiography of the thoracic cavity, used as a second example 
of the usability of the approach, evaluating arbitrarily chosen ROIs 
within the field-of-view. 
In all cases, image quality was assessed either on a basis of retrieved contrast 
(low contrast calibration phantom), or by mere qualitative visual inspection. 
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Chapter 5 
 
Results 
 
5.1. Vascular shear wave elastography 
Study I: Vascular shear wave elastography – method accuracy and stiffness reconstruction 
a) Fundamental geometries 
For the geometrical phantoms of Study I, shear modulus estimation using three 
different estimation approaches is presented in Figure 5.1. Specifically, estimation 
using direct group velocity reconstruction, leaky Lamb-wave-based estimation 
using full bandwidth phase velocity, and leaky Lamb-wave-based estimation using 
high-pass filtered phase velocity (allowing f > 500 Hz) are all presented. 
Results show that utilising group velocity to directly estimate shear modulus leads 
to significant underestimation of shear modulus in the evaluated confined 
phantoms (mean average of 15.1 ± 0.2, 8.1 ± 0.1, and 6.7 ± 0.1 kPa for the three 
different geometries, respectively). 
For the plate phantom, the full bandwidth phase velocity-based leaky Lamb-wave 
estimation rendered optimal results, with no statistical deviation inferred from the 
reference mechanical testing (30.1 ± 2.6 kPa versus reference 30.5 ± 0.4 kPa). 
For the solid cylinder, none of the methods could accurately match the reference 
value, even if smallest deviation was observed against full bandwidth phase velocity 
estimates. However, for the hollow cylinder the high-pass filtered phase velocity 
approach rendered accurate results, with no significant difference in estimated 
shear modulus observed against the reference mechanical testing (30.6 ± 3.2 kPa 
versus reference 30.5 ± 0.4 kPa). 
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Figure 5.1: Elastic shear modulus estimation for the three different geometrical phantoms of Study I, 
calculated using three different estimation approaches (group velocity (light blue), full bandwidth 
(BW) phase velocity (medium blue), and phase velocities >500 Hz (dark blue)). Statistical difference 
from the mechanical testing reference (black dashed line) indicated as * (p < 0.05), ** (p < 0.01), or 
*** (p < 0.001). 
b) Arterial phantoms 
To validate the aforementioned findings, results from the pressurised arterial 
phantoms are provided in Figure 5.2. For the SWE-derived shear modulus, all 
values are calculated using the leaky Lamb-wave-based estimation with high-pass 
filtered phase velocity (allowing f > 500 Hz). 
As seen, phantom shear modulus increased with increasing number of FT-cycles 
and intraluminal pressure, respectively. In general, good agreement was observed 
between SWE-derived measures and reference mechanical testing at all evaluated 
FT- and pressure levels, with a mean absolute error of 5.6 ± 4.1 kPa, 
corresponding to a relative error of 8.8 ± 6.0%. 
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Figure 5.2: Elastic shear modulus estimation for the arterial phantoms (light blue), presented as a 
function of freeze-thaw (FT) cycles and intraluminal pressure (60, 80, 100, 120 mmHg), respectively. 
Reference mechanical testing values are also provided at each level (dark blue). 
Study II: Plaque characterisation by SWE – differentiability and accuracy 
a) Push location 
Figure 5.3 shows SWE velocities as a function of push location, comparing values 
against reference velocities from a large cylindrical phantom. In this case, accuracy 
did not seem to improve as the push location was moved closer to the imaged 
phantom plaque. Instead, the most dominant difference is observed between 
longitudinal (push location 1-5) and transverse (push location 6-7) imaging plane, 
where a slightly higher underestimation seemed indicated in transverse view. 
Group velocity was consistently underestimated regardless of push location. For 
the phase velocity, similar underestimation is apparent at lower frequencies (450-
550 Hz), however with a distinct improvement apparent with increasing frequency. 
In particular, at the highest frequency band (950-1050 Hz) estimations are centred 
at an underestimation of -2%, compared to -18% and -4% at 450-500 Hz and 700-
800 Hz, respectively. 
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Figure 5.3: Accuracy of estimated SWE velocity as a function of push location, calculated as the 
relative error against reference unconfined SWE group velocity. Results are presented for group 
velocity (upper left), phase velocity at 450-550 Hz (upper right), phase velocity at 700-800 Hz (lower 
left) and phase velocity at 950-1050 Hz (lower right), respectively). Based on an ANOVA test with a 
Tukey post-hoc test for significance, all push locations differed significantly from each other apart 
from group velocity (1-3/4/5, 2-3, 3-4, 4-5, 5-7, 6-7), phase velocity 450-550 Hz (1-4, 2-4, 3-5/6/7, 
5-6/7, 6-7), 700-800 Hz (1-2/4, 2-4, 3-5/6/7, 5-6/7, 6-7), and 950 – 1050 Hz (1-3/4/5/6/7, 2-3/4, 
3-4/5/6/7, 4/7, 5-6/7, 6-7), respectively. 
Albeit the underestimation, the group velocity estimates showed the lowest 
deviation out of the four evaluated metrics, with a standard deviation of 
approximately 11%, compared to 19, 21, and 20% for phase velocities at 450-550, 
700-800, and 950-1050 Hz, respectively. 
Regarding image quality, both SNR and maximum particle velocity increased as the 
push location was moved closer to the plaque. In particular, push location 3 (inside 
the anterior part of the plaque) rendered maximum SNR. 
b) Differentiation of phantom plaques of varying stiffness 
Figure 5.4 shows the summarised results for the assessed phantom plaques, with 
results separated as a function of plaque stiffness, as well as lumen size, lumen 
position, and plaque wall, respectively. For all plaque sizes, the results from the 
push location analysis are confirmed, where an underestimation of group velocity 
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seem apparent, with increasing accuracy seen with increase phase velocity 
frequency (comparing box plot output against the horizontal, red reference lines). 
Noteworthy, this underestimation seemed to increase with increasing phantom 
plaque stiffness, with an average group velocity underestimation of 0.4 m/s or 
12% at 2FT-cycles, compared to 1.0 m/s or 18% at 5FT-cycles. 
Despite the systematic underestimation, the ability to differentiate phantom 
plaques of different stiffness was strongest using group velocity analysis: out of the 
18 evaluated group differences at different lumen sizes, 16 could be statistically 
inferred using group velocity. As a comparison, 7, 11, and 13 out of 18 could be 
differentiated using phase velocity at 450-500, 700-800, and 950-1050 Hz, 
respectively. Similar behaviour was also observed with varying lumen position and 
plaque wall, respectively, where group velocity again showed the highest ability to 
differentiate phantom plaques of different stiffness. 
As a last result from Study II, Figure 5.5 shows SWE velocity estimates at different 
phantom plaque stiffness levels, given as a function of varying imaging plane. 
Again an underestimation is observed for group velocity and low-frequency phase 
velocity measures, with increasing accuracy seen at the highest frequency band 
(950-1050 Hz). Noteworthy, transverse imaging plane showed a more pronounced 
underestimation, with e.g. group velocity metrics showing a relative error of –9% 
versus -20% for longitudinal and transverse imaging, respectively. 
With respect to differentiability, longitudinal imaging seemed superior to 
transverse imaging, where only 3 and 4FT-cycle phantom plaques could not be 
separated. Conversely, in transverse imaging, only group velocity estimation 
rendered comparable differentiation, with none of the stiffer plaques being 
distinguishable using phase velocity analysis. 
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Figure 5.4: SWE results for different phantom plaque lumen size, position, and wall, respectively. 
Wave speeds given for group velocity, phase velocity at 450-550 Hz, phase velocity at 700-800 Hz 
and phase velocity at 950-1050 Hz, respectively. In each subfigure, results are given as a function of 
plaque stiffness (2-5 FT-cycles), with reference values in red. Statistical differences are inferred by the 
green horizontal bars, alternatively by the red dashed line if no difference could be inferred. 
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Figure 5.5: SWE results for different phantom plaques as a function of imaging plane. Results are 
presented in similar fashion to Figure 5.4. 
Study III: Experimental ex-vivo setup for SWE plaque assessment 
Figure 5.6 shows a reconstructed micro-CT image of the analysed endarterectomy 
specimen of Study III. As visually apparent, the specimen had a fairly irregular 
shape, covering almost the entire circumference of the intraluminal opening. At the 
anterior end, an approximately 2 mm calcified nodule could be identified. Soft 
tissue attenuation variations could also be seen in the vicinity of the nodule, 
however apart from that the micro-CT images seemed to indicate a fairly 
homogeneous plaque tissue specimen. Figure 5.6 also shows a B-mode image of 
the same plaque (delineated in orange), with acoustic push line (blue) and selected 
tracking depth (red) indicated. The reconstructed incremental displacement map is 
provided, with manually selected TTP-regions overlaid showing variations in the 
spatiotemporal wave front. 
Starting from the push location, the wave seem to be travelling with a group 
velocity of 3.7 m/s, before increasing to 5.7 m/s after around 6 mm – a distance 
qualitatively corresponding to the calcified nodule visible in both B-mode and 
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Figure 5.6: (a) longitudinal micro-CT reconstruction, (b) B-mode imaging with indicate push (blue) 
and tracking lines (red), (c) axial incremental displacement map, and (d) corresponding k-space and 
dispersion curve.  
micro-CT image, respectively. Once having passed through the nodule, the group 
velocity retreats to its initial value of around 3.8 m/s. 
With regards to phase velocity, the retrieved dispersion curve seemed to follow the 
dominant zero-order antisymmetric mode (A0). As an example, the dispersion 
curve could be fairly well estimated by a full bandwidth leaky Lamb wave (white 
dashed line in Figure 5.6), with optimal fit given at a shear modulus of 36 kPa. 
No valid data could be obtained in the transverse imaging plane. 
Study IV: In-vivo plaque characterisation by SWE – validation with MRI 
a) AHA type classification 
In-vivo SWE and MRI were successfully performed in all but 2 subjects, rendering a 
total of 27 plaques for the final analysis. Out of these, AHA type III (n = 7), type 
V (n = 8), type VI (n = 8) and type VII (n = 4) plaques were identified. For these, 
group and phase velocities are provided in Figure 5.7. 
AHA type VI plaques showed significantly higher group velocity in both 
longitudinal and transverse view, with a mean average of 5.8 m/s (longitudinal) and 
7.3 m/s (transverse) compared to 4.0-4.2 m/s and 3.1-3.6 m/s for all other AHA 
types. This separation deteriorated when switching to phase velocity, even though 
a statistically significant differentiation could be observed at the highest frequency 
band (400-500 Hz) in longitudinal view (7.0 m/s versus 4.1-4.8 m/s). 
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Figure 5.7: SWE group and phase velocity for the studied in-vivo cohort, classified according to 
plaque AHA type. Data is separated for longitudinal (light blue) and transverse (dark blue) imaging, 
respectively. Significance against all other groups is given as * (p<0.05) or ** (p<0.01). 
b) Correlation analysis 
Correlations for a few MRI-identified plaque parameters are provided in Figure 
5.8. Specifically, the correlations are based on their apparent strength (|𝑅𝑅| > 0.5, 𝑝𝑝 
< 0.05) as well as their relation to plaque stability. 
For group velocity, positive correlation was observed against the amount of lipid-
rich necrotic core in both imaging planes (Pearson 𝑅𝑅 = 0.57/0.58, 𝑝𝑝 = 0.02/0.02 
for longitudinal/transverse imaging). Positive correlations were also observed with 
necrotic core volume (Pearson 𝑅𝑅 = = 0.60/0.62, 𝑝𝑝 = 0.01/0.01 for 
longitudinal/transverse imaging) as well as plaque cap volume; however in this case 
only seen in the longitudinal view (Pearson 𝑅𝑅 = 0.6, 𝑝𝑝 = 0.02). 
For the phase velocity analysis, the number of correlated parameters increased with 
increasing frequency band, with a maximum of 4 correlations identified at 400-500 
Hz. Specifically at 400-500 Hz, transverse imaging indicated negative nonlinear 
rank correlation to the ratio between fibrous cap and necrotic core volume 
(Spearman 𝑅𝑅 = -0.61, 𝑝𝑝 = 0.02), positive linear correlation against plaque 
calcification volume (Pearson 𝑅𝑅 = 0.64, 𝑝𝑝 = 0.04) and negative linear correlation 
against plaque loose matrix (Pearson 𝑅𝑅 = -0.64, 𝑝𝑝 = 0.03). Furthermore, at 300-
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400 Hz longitudinal imaging indicated strong negative nonlinear rank correlation 
against plaque haemorrhage volume (Spearman 𝑅𝑅 = -0.94, 𝑝𝑝 = 0.02). 
 
Figure 5.8: Correlations with group (uppermost rows) and phase velocity (lowermost rows) for a few 
selected plaque parameters, presented for longitudinal (left column) and transverse (right column) 
imaging, respectively. 
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5.2. Non-invasive cardiovascular relative pressure estimation 
Study V: Non-invasive cardiovascular relative pressure estimation using virtual work-energy 
a) νWERP in-silico evaluation 
Results from the νWERP assessment of relative pressure in the patient-specific in-
silico AAD is presented in Figure 5.9. For similar data on the in-silico CoA, see [63]. 
In the AAD, accurate estimates are generated throughout the vasculature, with 
output seemingly unaffected by the complex flow through the false lumen opening 
in the aortic arch. For all evaluated planes, a mean error of below 14/16/21% was 
reported at SNR = ∞/30/10. 
A particularly challenging flow scenario is given for plane F, where a renal artery is 
connected first to the true lumen, and then into the false lumen through intraseptal 
tears. Despite this, accurate results could still be generated (mean error of 12%), 
given sufficient spatial sampling (1 mm3). 
The table within Figure 5.9 also shows spatiotemporal behaviour of νWERP when 
estimating relative pressure into true (A-E) and false (A-D) lumen, respectively. As 
expected, accuracy increases with increasing spatiotemporal sampling. However, at 
clinical sampling (2 mm3 and 32 time frames), accurate estimates are given into 
both outlets and for all noise levels, respectively (mean error if 16/20/32% into 
true lumen, and 10/10/12% into the false lumen, at SNR = ∞/30/10). 
At the noise-free state, slightly higher dependence against temporal sampling seems 
apparent. Specifically: with a twofold increase in temporal sampling a decrease in 
mean error of 32% is given, compared to a decrease in mean error of 19% in the 
case of a twofold increase in spatial sampling. The effect however diminishes with 
introduced image noise, where spatial and temporal refinements seem to generate 
similar accuracy improvements. 
In the in-silico data, alternative relative pressure methods perform poorly, 
specifically since the evaluated models expand beyond the intended use of these 
specific methods. Bernoulli-based metrics neglects a large portion of the flow field, 
and have difficulties defining appropriate centre-line metrics when going through 
turbulent regimes as the one presented in the AAD lumen tear. Similarly, 
conventional WERP will diverge in late diastolic low-flow regimes, and as a result, 
all three renders inaccurate outputs. To exemplify, estimates into the true lumen of 
the AAD (A – E in Figure 5.9) renders mean errors of 100%, 88%, and >200% if 
applying the simplified Bernoulli, unsteady Bernoulli, or direct WERP method. 
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Figure 5.9: νWERP relative pressure estimations through a patient-specific AAD. (a) Visualised 
velocity field with (b-c) inlet (A) and outlet planes (B-G) shown in highlighted zoom boxes. (d) 
Relative pressure traces as a function of time, with data ground truth simulations given in red, and 
νWERP output given for SNR = ∞/30/10 in dashed black, dark grey, and light grey, respectively. (e) 
Spatiotemporal behaviour of the relative pressure estimation from A to D and E, respectively, with 
data shown for SNR = ∞/30/10 in red/blue/green. The tables present the mean error (lower left) 
and the error at peak relative pressure with standard deviation (upper right). 
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Figure 5.10: Cumulative results from the in-vivo evaluations showing (left) νWERP estimates against 
invasive catheterisation in the in-vivo cohort, and (right) absolute error of νWERP at peak relative 
pressure in the in-vivo cohort. Relative errors of ±10% are given by the dashed black lines. 
b) νWERP in-vivo validation 
For the in-vivo evaluation a mean error of 16 ± 13% was observed over all subjects, 
corresponding to an absolute error of <1.0 mmHg. Even though the error varied 
slightly over time, the initial systolic peak in maximum relative pressure seems 
accurately captured in all subjects, with a mean error of <18% or 1.2 mmHg 
(complete relative pressure traces are provided in [63]). As a cumulative summary 
of the validation, Figure 5.10 shows how a strong linear correlation between 
νWERP and catheter measurements is seen (k = 0.87), indicating only a slight 
underestimation of -0.6 ± 1.5 mmHg or -8 ± 26% over all evaluated subjects. 
Study VI: Extension of νWERP into turbulent flow regimes 
a) In-vitro validation 
For the in-vitro stenotic flow phantoms, cumulative linear regression and Bland-
Altman plots are provided in Figure 5.11. Additionally, tabulated numerical data is 
presented in full in the appended manuscript in Part II. As seen, νWERP-t showed 
high accuracy throughout all valves, with a 1:1 correlation observed from 
regression analysis and a mean error of 1.0 ± 4.1 mmHg. In comparison, the non-
extended νWERP showed a systematic underestimation of -6.5 ± 6.7 mmHg and a 
linear regression slope of k = 0.78. For the real work-energy approaches, WERP-t 
and WERP showed distinctly larger errors (mean error of -10.9 ± 12.8 mmHg and 
-23.2 ± 29.2 mmHg, respectively), whereas TP rendered relatively accurate results 
(1.0 ± 4.1 mmHg, k = 0.89). 
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Figure 5.11: Cumulative results from the in-vitro stenotic flow phantoms, presented as linear 
regression plots (upper row, estimated relative pressure, ∆𝑃𝑃𝑒𝑒, versus reference relative pressure, ∆𝑃𝑃 ) 
and Bland-Altman plots (bottom row), respectively. Data shown for νWERP-t, νWERP, WERP-t, 
WERP, and TP, respectively. 
With respect to energy components, the virtual νWERP-t approach was dominated 
by advective 𝐴𝐴𝑒𝑒, representing in average 76% of the total relative pressure, with 
only 21% added by 𝑇𝑇𝑒𝑒. In comparison, the real work-energy approaches were 
governed by turbulent 𝑇𝑇𝑒𝑒, contributing to in average 93% of the total relative 
pressure, with a comparably negligible advective 𝐴𝐴𝑒𝑒 (approximately 2%). 
b) In-silico verification 
Relative pressure estimations through the transient in-silico data is provided in 
Figure 5.12-5.13. Relative pressure traces are shown for each evaluated estimation 
approach, together with separate plots showing how different energy components 
fluctuate over the cardiac cycle. 
νWERP-t shows good agreement with reference in-silico relative pressures, having a 
mean error of 6.8% and 6.2% during the initiation and quasi-periodic phase, 
respectively. For the non-extended νWERP, estimations deteriorate around the 
systolic peak during the initiation phase following the lack of included 𝑇𝑇𝑒𝑒, and a 
mean error of 47.8% is reported. However, during the quasi-periodic phase, 
significantly lower 𝑇𝑇𝑒𝑒 is seen, with the mean error decreasing to 6.9% is seen. 
For the real work-energy approaches, significant output deterioration is observed, 
with mean errors exceeding 100% in all but one case (WERP-t having a mean error 
of 89.0% during the initiation phase). Cumulative visualisations of Figure 5.12-5.13 
are provided in the appended manuscript in Part II. 
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Figure 5.12: Relative pressure traces (upper row) through the in-silico AAD model during initialisation 
phase as predicted by νWERP-t, νWERP, WERP-t, WERP, and TP, respectively. Additionally, 
separated energy components (lower row) are presented for each estimation approach, shown as 𝜕𝜕𝜕𝜕𝑡𝑡𝐾𝐾𝑡𝑡 
in green, 𝐴𝐴𝑒𝑒 in blue, 𝑉𝑉𝑒𝑒 in yellow, and 𝑇𝑇𝑒𝑒 in red. 
 
Figure 5.13: Relative pressure traces (upper row) through the in-silico AAD model during the quasi-
periodic phase as predicted by νWERP-t, νWERP, WERP-t, WERP, and TP, respectively. 
Additionally, separated energy components (lower row) are presented for each estimation approach, 
shown as 𝜕𝜕𝜕𝜕𝑡𝑡𝐾𝐾𝑡𝑡 in green, 𝐴𝐴𝑒𝑒 in blue, 𝑉𝑉𝑒𝑒 in yellow, and 𝑇𝑇𝑒𝑒 in red.  
Study VII: Aortic relative pressure in DCM 
Measurements and imaging was performed on all recruited subjects. Upon 
evaluation, the DCM cohort was split into two subgroups: one with reduced LV 
function (DCMred, EF < 50%, n = 9) and one with moderate LV function 
(DCMmod, EF ≥ 50%, n = 5). Furthermore, one subject was excluded following a 
severely stenotic aortic valve (mean aortic outflow velocity = 1.8 m/s versus a 
group mean of 0.8 ± 0.3 m/s) and altered aortic geometry (aortic radius = 0.5 cm 
versus a group mean of 0.8 ± 0.1 cm, LVOT area = 1.5 cm2 versus a group mean 
of 5.9  ± 2.9 cm2). Complete characteristics are provided in the appended 
manuscript in Part II. 
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Figure 5.14: Maximum relative pressure, normalised time-to-peak, pulse wave velocity, and derived 
aortic stiffness shown for DCMs with reduced and moderate LV function, and the volunteer control 
group, respectively. P-values are reported for all intragroup comparisons, with significances indicated 
by *(p <0.05) or ** (p<0.01). 
a) Aortic hemodynamics in DCM 
Aortic relative pressure, TTP, aortic pulse wave velocity, and aortic stiffness are 
shown for all subjects in Figure 5.14. 
The DCMred group had a significantly lower maximum aortic relative pressure 
compared to both the control and DCMmod group, respectively. Similarly, a 
prolonged TTP was seen for all DCM patients, regardless of LV status. The 
DCMred group also showed a significantly higher aortic PWV compared to the 
other two groups, with similar data derived for aortic stiffness. 
b) Correlation to aortic relative pressure 
Pearson correlation coefficients are presented in complete in the appended 
manuscript in Part II. In summary, no correlation was observed with maximum 
relative pressure in any of the DCM groups. For minimum relative pressure, 
correlation was only observed with weight in the DCMred group. 
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For TTP, RVEF showed positive correlation in the DCMred group, however, this 
trend was not reflected in the DCMmod group. Generally weak correlation strengths 
were also reported with regards to PWV, and aortic stiffness, respectively. 
Noteworthy is that the retrieved central blood pressure measurements did not 
correlate strongly to any of the assessed relative pressure parameters. 
c) Influence of cardiovascular properties on aortic relative pressure 
Aortic relative pressures for virtual along with clinical cohort groups are given in 
Figure 5.15 showing variations as a function of isolated cardiovascular parameters. 
In the virtual cohort, aortic maximum relative pressure varied within a range of 
23.9 - 56.5, 28.3 - 62.5, and 30.4 - 72.1, and Pa/m, compared to 61.2 ± 10.0, 79.6 
± 14.2, and 78.9 ± 18.0 Pa/m in the clinical cohort, with data presented for the 
DCMred, DCMmod, and control group, respectively. 
In the virtual cohort, aortic stiffness and aortic area were the two dominating 
factors influencing relative pressure. For the DCMred group, variations in aortic 
stiffness accounted for 47% of the possible variations in maximum relative 
pressure, 63% of the possible variations in the DCMmod group, and 100% of the 
possible variations in the control group. On the other hand, variations in aortic 
area accounted for 87% of the possible variations in maximum relative pressure in 
the DCMred group, 91% of the possible variations in the DCMmod group, and 73% 
of the possible variations in the control group. Cardiac parameters had a 
comparably smaller influence, with only SV showing any noticeable visual impact. 
Here, variations in SV accounted for 66%, 46%, and 46% of the possible 
variations in maximum relative pressure in the DCMred, DCMmod, and control 
group, respectively.  
For minimum relative pressure, aortic stiffness and aortic area were again deemed 
the primary determinants. Specifically, aortic stiffness equalled variations of 70, 63, 
and 94% of all possible variations in minimum relative pressure, compared to 
aortic area with 95, 100, and 72% (percentages given for the DCMred, DCMmod, and 
control group, respectively). 
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Figure 5.15: Aortic relative pressure from clinical (top row) and virtual (remaining rows) cohort. 
Data is presented for DCMs with reduced and normal EF, as well as for the volunteer control group. 
For the virtual cohort data, isolated variations are presented for arterial resistance, SV, cardiac period, 
aortic area, and PWV, respectively. 
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5.3. Tomographic reconstruction for pre-clinical imaging 
Study VIII: Multigrid tomographic reconstruction for pre-clinical micro-CT imaging 
a) Numerical verification 
Figure 5.16 shows a Shepp-Logan phantom, reconstructed using multiple 
discretisation domains. Numerical error quantification is provided in Table 5.1. As 
visually apparent, the three dorsal inserts can be recovered at all discretisation 
ratios. However, image quality deterioration becomes increasingly apparent 
towards the edges of the high-discretisation ROI. 
Despite this, Euclidean distance and SSIM are fairly high even at the coarsest 
background discretisation (Euclidean distance = 2.56, SSIM = 0.87), indicating a 
fairly robust reconstruction of the ROI with varying background discretisation. 
Similar results for variation in regularisation are provided in Figure 5.16, with 
numerical quantifications again given in Table 5.1. Compared to the multigrid 
discretisation without regularisation, the multigrid regularised reconstruction show 
more accurate SSIM and Euclidean distance, potentially following the noise-
smoothing behaviour. 
Results for the combination of multigrid discretisation and regularisation are 
provided in Figure 5.16. As previously, variations in discretisation ratio do not 
seem to impact the ability to recover the dorsal inserts, albeit image quality 
deteriorations towards the ROI edges seem apparent. With respect to SSIM and 
Euclidean distance, the combined approach seem to generate slightly more 
accurate values compared to the non-regularised case (e.g. at discretisation ratio 
1:4, SSIM = 0.99 versus 0.88 when using added regularisation). 
Regarding computational cost, a significant decrease in computation time is seen 
with decreasing background discretisation (at problem size N = 128002, a 1:16 
reconstruction can be performed in less than 10% of the time required to complete 
a 1:1 reconstruction). These results are underlined in the combined discretisation 
and regularisation approach, where a speed-up of a factor of >35 is seen at the 
largest evaluated problem size (for N = 128002, 1:16/0.01:1 
discretisation/regularisation requires 207 s, compared to 7385 s for conventional 
reconstruction). Noteworthy is also that for purely multigrid regularisation (i.e. 
identical discretisation in the two separated domains) no difference in computation 
was observed. 
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Figure 5.16: Multigrid reconstruction using piecewise discretisation (left), piecewise regularisation 
(middle), and combined piecewise discretisation and regularisation (right). 
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Table 5.1: SSIM and Euclidean distance for variations of multigrid discretisation and regularisation 
for the Shepp-Logan phantom in Study VIII. 
b) Experimental evaluation 
For the experimental evaluation of the multigrid regularisation approach, three 
acquisitions sessions were performed, all shown in Figure 5.17. Apart from the 
visual, qualitative results, the low-contrast phantom insert (reference contrast 8%) 
were evaluated at different discretisation ratio. At all ratios, an approximate insert 
contrast of 9% was recovered, indicating reasonably accurate reconstruction even 
in the real-life experimental setting. Moreover, numerical data in Table 5.2 
indicates robust behaviour even when using a fairly coarse background 
discretisation. 
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1:16 - 0.98 0.86 1.80 2.56 
1:8 - 0.99 0.87 0.95 2.14 
1:4 - 1.00 0.88 0.39 1.87 
1:2 - 1.00 0.89 0.12 1.73 
1:1 - 1.00 1.00 0.00 0.00 
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- 10:1 0.99 0.99 0.40 0.67 
- 1:1 1.00 1.00 0.00 0.00 
- 0.1:1 0.99 0.99 0.05 0.54 
- 0.01:1 0.99 0.99 0.06 0.52 
- 0.001:1 0.99 0.99 0.06 0.57 
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n 1:16 0.1:1 0.97 0.96 2.75 2.78 
1:8 0.1:1 0.99 0.99 0.82 1.01 
1:4 0.1:1 1.00 0.99 0.24 0.57 
1:2 0.1:1 1.00 0.99 0.07 0.46 
1:1 0.1:1 1.00 1.00 0.00 0.00 
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Figure 5.17: Experimental micro-CT acquisitions and multigrid discretisation reconstructions. Upper 
row: low-contrast phantom (insert reconstructed at 1:8 discretisation), middle row: endarterectomy 
plaque specimen, positioned entirely inside the high-resolution ROI, lower row: 3D-printed CTA, 
with two regions (epicardium and pulmonary veins) reconstructed at detector resolution. 
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Table 5.2: SSIM, Euclidean distance, and insert contrast for variations of multigrid discretisation and 
regularisation for the low contrast phantom in Study VIII. 
Discretisation SSIM Euclidean distance Insert contrast 
1:64 0.86 974.49 0.09 
1:32 0.93 222.35 0.09 
1:16 0.98 217.49 0.09 
1:8 1.00 47.20 0.09 
1:4 1.00 16.02 0.09 
1:2 1.00 4.42 0.09 
1:1 1.00 0.00 0.09 
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Chapter 6 
 
Discussion 
 
Over the last century, truly remarkable advancements have been made in the field 
of medical science where interdisciplinary, translational research has led to a much 
more comprehensive understanding of human physiology and disease 
development. Today, scientific research is the foundation on which all clinical 
decisions are made, and it is through such efforts that we progress towards 
improved health care – developing and validating effective assessment tools, 
isolating and identifying accurate diagnostic biomarkers, and introducing novel 
evaluation techniques with improved clinical abilities. 
Within this endeavour, medical imaging has played a particularly important role, 
and in cardiovascular health care imaging has practically revolutionised the way we 
diagnose disease. As showcased throughout this thesis, advancements are however 
not restricted to the development of new imaging modalities, but refined 
diagnostic abilities and novel biomarkers are more than often a result of refined 
acquisition and post-processing schemes. This aim of clinical imaging research – to 
develop effective and refined diagnostic tools, and to identify accurate and specific 
clinical biomarkers – has also been the specific aim of this thesis. 
In Study I – IV vascular SWE has been clinically applied for atherosclerotic plaque 
characterisation, in Study V – VII a novel method for non-invasive relative 
pressure assessment has been developed, and in Study VIII a reconstruction 
method for multigrid tomographic imaging has been implemented in a pre-clinical 
setting. Together, these separate parts complement each other in the attempt of 
improved cardiovascular image diagnostics: SWE providing constitutive tissue 
mapping, νWERP enabling for refined hemodynamic probing, and the multigrid 
reconstruction approach allowing for efficient pre-clinical imaging, being an 
important contributor to progress in imaging and clinical research. In the following 
paragraphs the main outcomes and implications of all studies will be discussed, 
putting the results into a clinical context as well as commenting on specific study 
limitations. 
6.1.  Vascular shear wave elastography 
In the first part of this thesis, focus was on evaluating the ability of using SWE for 
vascular image diagnostics, quantifying tissue stiffness as a biomarker for plaque 
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risk stratification, or in order to track changes in arterial constitutive behaviour.  
However, as explored extensively throughout Study I–IV, confined cardiovascular 
tissue aggravates elastographic assessments by inducing complex acoustic response. 
a) Group and phase velocity and confined wave propagation 
In Study I, the impact of geometrical confinement on SWE accuracy was 
highlighted, where conventional group velocity analysis showed a systematic 
underestimation of shear modulus in confined media. On the contrary, fitting 
dispersion-induced high-frequency phase velocities to a Lamb-wave based 
propagation model (taking the confined geometries into account) rendered 
accurate estimates of shear modulus, with relative errors of below 10% over a 
range of physiological stress levels.  
Even though intuitive from an engineering perspective, the fact that unconfined 
group velocity estimates are unsuccessful in quantifying the stiffness of 
geometrically confined specimens is important for the clinical usage of SWE. To 
date, all commercially available clinical elastography devices are using group 
velocity-based stiffness reconstructions, and consequently there are no physical 
restrictions in simply transferring the same equipment into cardiovascular 
diagnostics. In fact, studies exist employing group velocity-based stiffness 
reconstruction for arterial [377] or atherosclerotic purposes [255, 278], but as 
highlighted by the results of Study I the quantification might underestimate true 
stiffness. If not utilising confined wave propagation models, reporting group 
velocity alone (i.e. not quantifying shear modulus) could be a preferable option, as 
e.g. in Study IV. With confined media presenting a non-linear relationship between 
group velocity and tissue stiffness (as in e.g. Equation 3.35), the clinical value of 
arterial group velocity however remains to be assessed, even though Studies II-IV 
indicate a defined potential in atherosclerotic plaque differentiation. 
Others have employed phase velocity analysis to estimate arterial stiffness [203, 
280, 378], and only in the last few years a growing number of studies have been 
published utilising refined wave propagation models to accurately recover arterial 
stiffness [279, 379-382]. With reference to existing literature, it is important to note 
that the utilised propagation description (Equation 3.35) is based on a plate-based 
Lamb wave model [203], itself simplifying the assessed arterial phantom 
geometries. As observed, derived estimates will depend on the utilised frequency 
spectrum, and it is only if restricting data to higher frequencies (above 500 Hz) that 
accurate stiffness values can be retrieved. That estimates of the arterial phantoms 
deviate when incorporating lower frequencies is a direct result of the fundamental 
difference in wave propagation between a plate (constricting the waves in one 
dimension - thickness) and a hollow cylinder (constricting the waves in two 
dimensions – thickness and curvature). At low frequencies, the wavelength of the 
propagating acoustic shear wave will be in the same length scale as the curvature of 
the arterial phantom, and apparent differences will be observed between the 
experimental data and the theoretical plate-based model. However, at high 
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frequencies, the wavelength will be significantly smaller than the curvature of the 
arterial phantom, and experimental data will converge towards the plate-based 
model. This fact has been observed previously where Couade et al. [280] 
recommended fitting data above 1 kHz to obtain accurate estimates in arterial 
phantoms. Along the same lines, Maksuti et al. [383] showed from numerical 
studies how the fundamental flexural F(1,1) mode of a hollow cylinder converges 
with the plate-based antisymmetric A(0) mode at around 400 Hz in geometries 
identical to the ones experimentally assessed in Study I. In a recent study, Li et al. 
even proposed an inverse procedure to determine a critical frequency above which 
dispersion data can be used to determine arterial stiffness [379], again supporting 
the findings in Study I. In comparison to these aforementioned studies, the cut-off 
threshold of 500 Hz in Study I was empirically chosen based on preliminary data 
observations, attempting to remove significant low-frequency deviations whilst still 
maintaining sufficiently large bandwidth. 
Regarding the observed dispersion behaviour, it should also be noted that the 
utilised propagation model only takes into account geometrical dispersion, i.e. 
dispersion caused by the interference between the propagating wave and the 
confining geometrical boundaries. To this, dispersion may also arise due to 
intrinsic material properties, where material thermal conductance, chemical 
composition, or viscoelastic behaviour causes wave energy absorption. In 
particular, viscous dispersion behaviour has been utilised to derive viscoelastic 
properties of imaged tissue [384, 385], however for bounded cardiovascular media 
it has been shown that viscous dispersion plays a comparably inferior role to 
geometrical dispersion [386, 387]. In fact with PVA exhibiting viscoelastic 
behaviour [388], the accurate estimates in Study I support the notion that 
geometrical dispersion may suffice in describing observed phase velocities in 
confined media. 
Advancing from Study I, the subsequent Studies II-IV were all performed with the 
clinical goal of improved plaque risk stratification using SWE. In comparison to 
the arterial tissue or the arterial phantoms of Study I, atherosclerotic plaques 
exhibit even greater geometrical confinement, with in-vivo plaques being both 
irregular in shape and composition. For that reason, Study II was conducted again 
on simplified phantom specimens, specifically designed to isolate the influence of 
plaque-like confined media on SWE differentiability and performance. In-line with 
the results of Study I, Study II shows how group velocity consistently 
underestimates reference values, whereas accuracy improves with phase velocities 
at increasing frequencies. However, opposing results are seen with regards to 
phantom plaque differentiability where group velocity showed superior ability in 
separating phantom plaques of different stiffness from each other. Only when 
using phase velocities at around 1 kHz was comparable phantom plaque 
differentiation observed, but even then group velocity showed superior 
differentiability. This poses interesting implications when translated into a clinical 
setting: if striving for improved plaque risk stratification – i.e. attempting to 
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separate plaques of different constitutive composition – a method with inferior 
absolute accuracy might be preferred. As supported by the findings from Study IV, 
group velocity seem to have certain diagnostic abilities, and similar examples exist 
in literature supporting this notion [255, 278, 389]. The reason for the improved 
differentiability by group velocity analysis is difficult to isolate, but may spur from 
the improved robustness in group velocity compared to phase velocity estimates. 
As reported in Study II, group velocity estimates exhibited an average variation of 
11% compared to 20% in corresponding phase velocity, with phase velocity 
variations potentially spurring from low frequency interactions with geometrical 
boundaries, as well as high frequency signal deterioration. High-frequency 
estimates might improve in precision if utilising shorter push duration [198] or 
modified beam width [390], however the effect on plaque differentiability remains 
to be investigated. 
With this in mind, it is still important to remember that even though superior in 
differentiating phantom plaques of different stiffness, group velocity does not 
directly quantify tissue stiffness in such confined media. For a true quantification 
of plaque stiffness, one would again have to describe the observed wave 
propagation with an appropriate acoustic model (just like a Lamb-wave based 
model was utilised for the arterial phantoms in Study I). A defined obstacle 
however is the heterogeneity of atherosclerotic plaques as a group, with significant 
variations in size, shape, and composition observed between different plaque 
specimens. With that, no unique wave propagation model exist to describe their 
acoustic behaviour, and consequently, a major part of the results of Study II – IV 
consisted of direct estimates of wave velocity rather than indirect derivations of 
tissue stiffness. Detailed studies of elasticity imaging coupled to plaque stiffness 
have been performed using patient-specific numerical simulations [391-394], and 
such studies might shed further light on the correlation between observed wave 
velocity and plaque composition. However, a generalisation of such findings into a 
generic plaque population remains dubious, and the clinical implications of wave 
velocity versus tissue stiffness remain to be clarified for cardiovascular purposes. 
Apart from the main findings on plaque differentiability, results from Study II also 
highlighted the relation between phantom plaque differentiability and SWE push 
location and imaging plane, respectively. With SWE output seemingly invariant to 
push location within a given imaging plane, the difference between imaging planes 
is noteworthy. In particular, transverse imaging rendered higher particle velocity, 
lower SNR, and consistently lower shear wave velocities compared to longitudinal 
imaging. With phantom plaque stiffness independent of observer view plane, the 
behaviour is rather a consequence of the fundamental wave propagation of the 
induced shear waves. In longitudinal imaging, the induced shear wave will 
propagate in the axial vessel direction, following the arterial wall and phantom 
plaque as an effective wave guide [202, 395, 396]. On the contrary, in transverse 
imaging, the induced shear wave will propagate seemingly unobstructed through 
the surrounding tissue before traversing the arterial wall and phantom plaque as an 
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embedded inclusion rather than as a wave guide. Based on the results of Study II, it 
seem clear that the transverse inclusion based wave transfers a larger portion of the 
wave energy into the phantom plaque itself, whereas the longitudinal wave guide 
causes characteristic dispersion behaviour obstructing optimal energy transfer. 
That this would render lower observed wave velocities in the transverse view is not 
obvious, however the behaviour has been validated in numerical studies [397] 
where an identical phantom plaque setup was evaluated. In literature, plaque 
elastography has been attempted in both longitudinal [242, 243, 254, 255, 277, 278] 
and transverse imaging planes [253, 273] but, as indicated by Study IV, the two 
imaging planes might even perform differently with respect to plaque risk 
stratification. With that in mind, the observed differences in Study II are important 
to consider when progressing cardiovascular SWE into a clinical setting. 
b) Ex-vivo and in-vivo carotid plaque characterisation 
The utilised phantom setups of Study I and II both serve a defined purpose, where 
such controlled in-vitro experiments can successfully isolate effects of e.g. 
geometrical confinement or push location on SWE performance. However, 
extrapolating results from such simplified studies into a clinical setting is 
challenging, in particular when considering the complexity in shape and 
composition of human atherosclerotic plaques. In an attempt to translate the 
developed data analysis of Study I and II into more realistic plaque tissue, the 
experimental setup of Study III was therefore developed. Presented merely as a 
proof-of-concept setup, results show how SWE data can be retrieved from an ex-
vivo plaque sample but also how changes in observed wave velocity seemed 
correlated to intraplaque compositional changes seen by micro-CT imaging. 
Results also indicate defined dispersion-like behaviour in ex-vivo plaque tissue, even 
though the fitted Lamb-based model may not be a suitable approach outside the 
presented proof-of-concept setup. To this, the results also highlight the difficulty 
of plaque SWE, where the irregular shape of the investigated plaque obstructed 
transverse SWE imaging. Isolated ex-vivo investigation of plaque tissue has been 
used in several studies as a validating complement to performed in-vivo imaging 
[246, 253, 273, 398], and has even been utilised to study detailed constitutive 
response [399]. With such, the developed setup of Study III has a defined potential 
to serve as a tool for further detailed plaque investigations, however was not 
explored to any further extent in this thesis. 
Instead, a direct advancement into clinical practice was carried out in Study IV, 
where an implementation of the developed SWE data analysis was performed on a 
clinical carotid plaque cohort. The main finding of the study was that AHA type 
VI plaques showcased significantly higher group velocity compared to any other 
plaque type, and that similar differentiation was observed for longitudinal phase 
velocity imaging at the highest frequency band (400-500 Hz). The findings bear 
particular clinical impact, where AHA type VI plaques are not only identified as the 
most rupture prone phenotype [140, 151, 152], but also since AHA type VI 
plaques do not necessarily correlate with stenosis degree [400]. By so, the 
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differentiation provided by SWE expands on current clinical guidelines for plaque 
risk stratification, where both group and phase velocity could act as novel 
biomarkers for plaque differentiation. 
It is noteworthy and slightly counterintuitive that the culprit set of AHA type VI 
plaques showcases increasing wave velocities, especially considering the traditional 
view of a lipid-rich, soft plaque being the most rupture prone one. The causal 
reason for this observed wave velocity increase is also difficult to isolate, especially 
considering the inhomogeneous plaque phenotypes incorporated in the AHA type 
VI classification (including visible surface defects, active plaque core, intraplaque 
haemorrhage, thrombus formation, etc.). However, it is worth noting that in the 
studied cohort of Study IV, the increasing LRNC content seemed balanced by an 
increasing fibrous cap volume. That is, the studied lipid-rich culprit lesions were 
also associated with a generally larger fibrous cap, potentially leading to an 
observed stiffer behaviour. This reasoning is also supported by other findings, 
where collagenous deposits have been correlated to reduced plaque displacement 
levels [276]. To disentangle the exact effect of lipid-rich core content and fibrous 
cap distribution on observed wave propagation, further isolated experimental or 
numerical studies might be necessary. Regardless, the observed differentiation 
indicates a promising potential of SWE for cardiovascular plaque characterisation. 
In addition to the plaque type differentiation, a set of intraplaque parameters 
correlated to retrieved group and phase velocity, respectively. In particular, group 
velocity showed positive correlation with LRNC content, and high-frequency 
phase velocity correlated with fibrous cap/necrotic core volume – both parameters 
associated with the identification of vulnerable TFCA. The correlations are in-line 
with the increasing velocities for AHA type VI plaques, and might again be 
influenced by the apparent increase in fibrous cap volume. However, with 
correlations also observed with other important structural plaque characteristics 
(most importantly decreasing phase velocities with increasing intraplaque 
haemorrhage volume, supporting previous findings where increasing strain levels 
were observed in (fibro)atheromatous plaques [253]), the combined group and 
phase velocity approach of Study I-IV provides a novel set of plaque biomarkers 
with which larger studies on plaque risk stratification and improved patient 
outcome could be studied. Again, detailed numerical studies could also be 
attempted to disentangle specific wave propagation behaviour as a function of 
varying intraplaque composition. 
Discussing Study IV, it is worth contrasting the retrieved results to the ones 
observed in Study I-III. The plaque cohort did not come with any reference wave 
velocity or stiffness, however slightly higher phase velocities seemed indicated at 
400-500 Hz compared to the corresponding group velocity metric, supporting the 
observed group velocity underestimation in Study I and II. However, this 
behaviour did not seem to be present for the important AHA type VI plaques in 
transverse view, where group velocities exceeded the corresponding phase 
velocities. The robustness of group velocity compared to phase velocity indicated 
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in Study II however seemed reflected in Study IV, where consistently larger 
deviations were observed for the retrieved phase velocities compared to the 
corresponding group velocity metric. With this, it should be noted that the 
retrieved phase velocities in Study IV were given at consistently lower frequencies 
than what was studied in-detail in Study II. The reason for this was restrictions in 
the clinically used SWE system, where a pre-defined 400 µs push duration was set. 
With push duration inversely proportional to dispersion bandwidth [198], a 
shortened push might have rendered higher phase velocities, with potentially 
improved accuracy (as indicated by Study I-II). However, the exact implication of a 
shortened push in a clinical setting remains to be evaluated. 
c) Reference methods 
In Study I, mechanical tensile-testing was performed to validate the retrieved 
phantom shear modulus. However, using the customised fixation and 
pressurisation setup, the testing was performed under effective biaxial tension 
(with the intraluminal pressurisation inducing orthogonal circumferential stress), 
mimicking the stress state of the SWE imaging. With such, the quasi-static testing 
rendered reference values of Young’s modulus, which using assumptions of tissue 
isotropy, could be converted to shear modulus. Alternatively, direct shear modulus 
estimations could have been achieved by imposing angular twisting and torque 
loading (as recommended for tubular structures by the American Society for 
Testing and Materials [364]). However, when assessing hyperelastic soft tissue 
(such as PVA [351]), low energy torsional buckling may aggravate twist testing and 
complicate the derivation of elastic properties [401], and consequently the tensile-
test substitute was chosen as a validating testing method. 
In Study II, SWE group velocity from large homogeneous blocks of PVA was 
chosen ahead of mechanical testing. This was primarily chosen since validation was 
here performed against wave velocity rather than tissue stiffness. Importantly, 
group velocity was consistently used as a reference metric ahead of phase velocity, 
following the minor viscous dispersion observed in PVA, as well as the 
comparably large dimensions of the reference phantoms, minimising geometrical 
dispersion. Following this, the wave propagation through the reference phantoms 
could be likened to the wave propagation through an infinite, elastic medium, 
without any apparent dispersion (as shown in the extended results in [402]). 
In Study III, pre-clinical micro-CT imaging was utilised as a reference method to 
the ex-vivo SWE imaging. For plaque tissue, CT has excellent calcium specificity, 
and a small intraplaque calcification was successfully identified in the imaged 
endarterectomy specimen. Additionally, micro-CT showcases excellent spatial 
resolution, with the imaged plaque in Study III reconstructed at a resolution of less 
than 50 µm3. However, CT somewhat lacks plaque soft-tissue contrast, and pre-
clinical MRI would have enabled differentiation of e.g. fibrous cap from plaque 
loose matrix. However calcifications are poorly observed in traditional MRI, and a 
multi-contrast protocol similar to the one utilised in Study IV might have been 
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required for optimal results. With all this in mind, the main determinant of the 
utilised micro-CT over pre-clinical MRI came from equipment availability, where 
developments of an in-house micro-CT system (in part through Study VIII) 
spurred the incorporation of the equipment in Study III. 
Lastly, in Study IV, MRI with dedicated carotid surface coils was utilised as a 
reference modality to the in-vivo SWE. As a non-invasive tool MRI represents the 
validating gold-standard with regards to plaque characterisation, and it has been 
used as a reference method in previous image-based studies [242, 403, 404]. By so 
the method served as an excellent benchmark for the retrieved SWE imaging, even 
though reader bias and lack of intermodality spatial registration could have 
influenced the retrieved data. 
d) Comparative performance and clinical perspective 
In all of the above, SWE has been evaluated as a method for refined vascular 
assessment. However, as reviewed in Section 3.4.1., SWE is only one of several 
available ultrasound elastography techniques. Clinical interrogation of plaque 
composition has been attempted by both intravascular [194] and non-invasive 
strain imaging [242], and ARFI for constitutive carotid plaque characterisation has 
been explored in conjunction to validating MRI [404] or with reference histology 
[243, 276, 398]. In comparison, SWE has not been as extensively employed for 
carotid plaque characterisation, with only a few examples of feasibility and 
reproducibility existing in literature, in these cases using direct group velocity 
reconstruction [255, 278]. With this in mind, the summarised results of Study I-IV 
represent a definite technique advancement, progressing refined SWE into clinical 
studies of plaque behaviour and phenotype. 
To date, no extensive comparison of the different ultrasound elastography 
techniques exist with regards to carotid plaque characterisation. In particular, with 
the different techniques employed using different acquisition settings, imaging 
setups, cohort specifications, and at different clinical stages, a quantified 
comparison is also difficult. As with all imaging techniques, the different 
ultrasound elastography variations all come with specific pros and cons. IVUS 
strain imaging has demonstrated high sensitivity for vulnerable plaques [194, 246, 
273] however suffers from its inherent invasiveness. Relatively mature clinical 
results have been obtained using non-invasive strain imaging [242, 253], but the 
technique is slightly limited by the connection to physiologically induced 
displacements. ARFI imaging has also shown exciting results in several recent 
plaque studies [243, 276, 405], however only provides a relative measure of strain 
against surrounding tissue. In comparison SWE enables absolute quantification of 
tissue stiffness, but is at the same time obstructed by complex wave propagation 
behaviour and the need for tracking shear waves over a series of frames to 
reconstruct an imaged object. However, rather than competing against each other, 
the summarised efforts spent on atherosclerotic ultrasound elastography today 
clearly shows how refined plaque characterisation can be achieved by image-based 
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constitutive mapping. Isolation of vulnerable culprit lesions has a direct connection 
to improved patient outcome, and further advancements in the general field of 
cardiovascular ultrasound elastography bears high promise for improved health 
care. 
To sum up, Study I-IV were all conducted with the aim of progressing 
cardiovascular SWE closer to clinical practice, refining data output and evaluating 
performance specifically for atherosclerotic plaque characterisation. The performed 
studies have all highlighted the importance of taking acoustic wave propagation 
into account when evaluating SWE output, with method accuracy and 
performance directly related to the behaviour of the assessed shear wave. In 
particular, combined group and phase velocity analysis provide a set of novel 
biomarkers for plaque risk stratification, showcasing exciting potential in detecting 
vulnerable culprit lesions in-vivo. In general, the ability to complement conventional 
structural imaging with non-invasive constitutive imaging by SWE has exciting 
clinical implementation, and could serve as an important tool for refined screening 
or assessment of atherosclerotic plaques as well as in the evaluation of early-stage 
cardiovascular remodelling. 
6.2.  Non-invasive cardiovascular relative pressure estimation 
In the second part of this thesis, focus was shifted from constitutive assessment of 
the cardiovascular system, to hemodynamic evaluation of cardiovascular flow. 
a) νWERP – Original method performance 
In Study V, a novel method for non-invasive relative pressure assessment was 
introduced: νWERP. In νWERP, a complete fluid mechanical description of 
cardiovascular flow is utilised, using the concept of a virtual field to enable arbitrary 
probing of relative pressure throughout any imaged vascular structure. As shown 
in Study V, the method shows excellent accuracy in isolated patient-specific 
models, with precise relative pressures derived through complex, tortuous 
vasculatures, and with outputs being robust against high levels of added, spurious 
image noise. Furthermore, the method was also validated in a clinical in-vivo setting, 
where aortic relative pressures were successfully assessed in five adolescent 
patients with congenital cardiovascular disease. In fact, the utilised in-vivo cohort 
represented a particularly challenging study case, where the assessed hemodynamic 
environment was complicated by narrow aortic geometries and abnormal flow 
profiles [406]. With this in mind, the maintained νWERP accuracy underlines the 
method’s versatility, enabling probing of relative pressure into previously 
inaccessible flow domains. 
In Study V, analysis of νWERP spatiotemporal behaviour was performed using the 
simulated flow through a patient-specific AAD. As presented in Section 5.2., 
temporal sampling had slightly higher influence on output accuracy at the noise-
free state, whereas a virtually equal influence was observed with introduced image 
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noise. As such, trade-off between spatial versus temporal resolution could be 
determined by the assessed flow rather than by the utilised method. If evaluating 
low flow domains with high anatomical constriction such as more peripheral 
vasculatures, high spatial resolution would be required to capture the assessed 
morphology. Conversely, higher temporal resolution might be required if 
evaluating quick transient events. Regardless, the versatility of νWERP makes it 
applicable in both scenarios, allowing for robust refined hemodynamic analysis of 
cardiovascular events. 
For all vasculatures evaluated in Study V, relative pressures were also derived using 
a few alternative method approaches. However, applying these flow based 
estimates onto the unconventional and complex cases of Study V become 
problematic, specifically following these previous methods’ inherent assumptions. 
The clinical standard of simplified Bernoulli [58, 313] relies on a single measure of 
peak velocity, and the extended unsteady Bernoulli also neglects a large portion of 
the assessed flow [62]. Consequently, significant errors are reported in Study V, in 
particular for the highly non-laminar AAD. The direct work-energy formulation 
WERP also deteriorates with vascular branching, and divergence is observed in 
low-flow diastolic regimes again making the method unfit for the assessed flows of 
Study V. With more refined full-field approaches such as PPE showing inferior 
behaviour even in simplified setups [322], this all underlines the novelty of 
νWERP, improving estimate accuracy and enabling the extension of relative 
pressure into unexplored flow domains. 
b) νWERP-t – extension into turbulent flow domains 
As presented in Study V, νWERP uses an explicit description of fluid mechanical 
behaviour to derive relative pressures over arbitrary flow segments. However, as 
reviewed in Section 3.1.4., the appearance of stochastic flow variations may induce 
turbulent energy dissipation, potentially influencing the assessed relative pressure. 
For severe degrees of stenosis, incoherent post-stenotic turbulence is a typically 
observed feature [81, 135], and similarly complex congenital disease may induce 
stochastic flow [407, 408]. With the in-silico cases of Study V retrieved as a synthetic 
measure over a single cardiac cycle only, and with the corresponding in-vivo cohort 
not necessarily inducing high-turbulent flows, such stochastic behaviour did thus 
not play a significant role for the retrieved results. However, to broaden method 
applicability, as well as to allow for the incorporation of turbulent cardiovascular 
flow scenarios, an appropriate method extension was implemented in Study VI. 
In Study VI νWERP-t was presented, derived by statistically describing acquired 
flow as a mean field and a related covariance quantity, and including such 
behaviour in the evaluation of virtual work-energy. Applied on both stenotic in-vitro 
phantoms as well as appended cycles from the complex AAD of Study V (by so 
allowing for incoherent intra-cycle variation to occur), the method showed 
excellent accuracy with relative errors similar to that in Study V. Again comparing 
favourably against alternative approaches, the method also underlines the 
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versatility initially showcased in Study V, with the approach now handling not only 
multibranched, tortuous vasculatures, but also turbulence-inducing high-flow 
regimes. 
In the comparison to other methods, the evaluation again becomes hampered by 
these alternative methods’ inherent assumptions. Specifically real work-energy 
approaches such as WERP-t or TP will be obstructed by branching vasculatures 
where 𝑄𝑄|Γ𝑖𝑖 ≠ 𝑄𝑄|Γ𝑜𝑜 , or in phases of low flow, where 𝑄𝑄 → 0: both points 
highlighted in the in-silico results where severe method deterioration occurs during 
the later diastolic phase. However, the difference between νWERP-t and WERP-t 
in the steady-state stenotic phantoms is less intuitive. Without any low diastolic 
flows, and with a single-vessel geometry, νWERP-t and WERP-t should 
theoretically converge. However, WERP-t showcased a systematic underestimation 
of 𝛥𝛥𝑃𝑃  compared to νWERP. 
One hypothesis explaining this difference could be that the acquired flow field is 
affected by high-turbulent noise, where the acquired mean quantity is shifted from 
its expected theoretical value. However, as shown by the extended results on 
noise-corrupted νWERP-t estimates in the appended paper in Part II, this 
hypothesis is not sufficient in explaining the observed discrepancy, and would 
rather cause a random shift around the accurate νWERP-t value. 
Instead, a second explanation could be that the acquired flow field appears as non-
divergence free (i.e. 𝛻𝛻 ∙ 𝑽𝑽 ≠ 0), again following stochastic flow fluctuations in the 
assessed flow. If such would be the case, fundamental physical flow behaviour 
would be violated, and the derivation of WERP-t would no longer hold. However, 
νWERP-t would still be valid, as the introduced virtual field is guaranteed to be 
divergence free (∇ ∙ 𝒘𝒘 = 0). 
To test this hypothesis, an alternative divergence-free Stokes equivalent 𝑽𝑽 † can be 
introduced, solved as 𝑽𝑽 † + ∇2𝑽𝑽 † + ∇𝜆𝜆 = 𝑽𝑽 + ∇2𝑽𝑽  (6.1) ∇ ∙ 𝑽𝑽 † = 0 (6.2) 𝑽𝑽 † = �𝑽𝑽 ,0, Γ𝑖𝑖 Γ𝑤𝑤. (6.3) 
With such, 𝑽𝑽 † preserves the spatial properties of 𝑽𝑽  whilst at the same time having 
a guaranteed divergence free behaviour. 
In fact, if applying WERP-t on the Stokes equivalent 𝑽𝑽 † of the in-vitro dataset, 
estimation output improves drastically, with only minor deviations observed 
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against the aforementioned νWERP-t results (comparative performance provided 
in the appended paper in Part II). Even in the in-silico dataset, this renders 
improved output accuracy where the initial systolic peak is recovered at higher 
precision using the divergence free WERP-t. 
This does not only explain the observed discrepancy between νWERP-t and 
WERP-t, but does also provide further evidence of the advantages of νWERP-t: 
using the virtual approach divergence free flow behaviour is guaranteed, and 
regardless of flow variations robust output measures can be achieved. Along the 
same lines, the difference in energy weighting between virtual and real approach 
means that the different methods will rely differently on mean field and covariance 
data, respectively. With νWERP-t enhancing advective contributions over 
turbulent energy dissipation, the accuracy of the mean field estimation will be of 
higher importance compared to the accuracy of the covariance estimation, and vice 
versa in the real work-energy case. With covariance capture potentially sensitive to 
velocity encoding or apparent SNR [409-411] this might have clinical implications, 
however the general applicability of these results remains to be explored. 
Continuing on the comparative performance in Study VI, the TP formulation is 
also worth commenting. The theoretical formulation of WERP-t and TP coincides 
for relative pressure exclusively governed by turbulent energy dissipation. 
However, distinct method differences are observed following the covariance 
filtering introduced in TP by Equation 4.45. As evident, the masking of non-
positive covariance entries improves accuracy in the evaluated in-vitro set. 
Importantly however, is that there exists no theoretical reason to why such filtering 
would be applicable in an arbitrary flow case, and in reality negative off-diagonal 
covariance entries can very well appear (i.e. for Cov[𝒗𝒗𝑖𝑖, 𝒗𝒗𝑗𝑗] in which 𝑖𝑖 ≠ 𝑗𝑗). As 
evident in the complex AAD, the masking of TP incorrectly exaggerates turbulent 
energy dissipation, skewing data output even further away from the true estimates, 
than WERP-t does. It remains to be clarified why TP performs satisfactory in the 
in-vitro cohort, but the general applicability of the masking seems doubtful. 
In its presented form, νWERP and νWERP-t relies on full-field measurements of 
blood flow to derive accurate estimates of relative pressure. Simplifications into 
planar 2D flow acquisitions have been evaluated using the direct-work WERP 
method [64] and similar adjustments could be envisaged for the virtual approach. 
However, this would again involve reducing the complexity of the assessed fluid 
mechanical environment, and it remains to be determined how this would affect 
output accuracy, especially in the evaluated multibranched, tortuous vasculatures of 
Study V. Based on the rapid development of medical imaging, more complex data 
analysis is being brought into clinical practice, and 3D-based flow metrics could 
very well be incorporated into clinical diagnostics following promising clinical 
results [19, 218, 412, 413]. The progress in 3D ultrasound flow-imaging [185, 186] 
also indicates how such analysis would not be modality-specific, again showing 
defined promise for such refined clinical hemodynamic analysis. 
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c) Clinical applicability and potential of relative pressure analysis 
With both νWERP and νWERP-t presented, and with the methods aimed at 
refined hemodynamic assessment, a final clinical investigation was performed in 
Study VII. The study not only showcased a clinical implementation of νWERP, but 
was also conducted using νWERP as a tool for assessing cardiovascular disease 
behaviour. Specifically, aortic hemodynamics was evaluated in a DCM cohort, 
investigating aortic relative pressure in cardiac disease. Importantly, as patients had 
time to respond to treatment between inclusion and imaging, the cohort was split 
in two: one group containing responding patients with recovered LV function, 
DCMmod, and one containing non-responding patients with maintained reduced LV 
function, DCMred. With that, the hemodynamic changes could also be inferred in 
conjunction to patient treatment response.  
In short, the DCMred group showed a significantly reduced maximum aortic relative 
pressure, whilst maintaining their minimum aortic relative pressure. The same 
group also indicated significantly increased PWV, aortic stiffness, and systolic 
blood pressure, whereas TTP was significantly increased in all DCM patients, 
regardless of LV status or treatment response. 
The results are worth coupling to their relation to fundamental cardiovascular 
physiology. Firstly, maximum aortic relative pressure represents the forward-
directed peak acceleration of ejected blood coming from the heart. That the 
DCMred group showed an impaired peak acceleration is thus not surprising, and is 
also in-line with previous findings in DCM indicating deteriorating aortic outflow 
acceleration [414] and reduced LVOT outflow gradient [415] as a function of 
progressing disease. Together, the findings also illustrate how impaired ventricular 
function impacts downstream vascular hemodynamics, highlighting how vascular 
response could be used as a secondary measure of cardiac function. 
Secondly, minimum aortic relative pressure is related to the deceleration of blood 
during late systole, and was seemingly not affected by the progressing disease. In 
fact, minimum aortic relative pressure has been less coupled to cardiac function, 
and is rather associated with aortic reservoir function [416]. A maintained 
minimum aortic relative pressure might thus indicate maintained reservoir 
behaviour, however, this is opposed by the significant differences inferred in aortic 
stiffness. Instead, the findings suggest a complex relationship between cardiac 
function, aortic behaviour, and derived relative pressure. In other conditions, aortic 
relative pressure has been associated to both cardiac and aortic function [220], 
further supporting this coupled notion. 
Thirdly, TTP is a metric directly associated to the temporal pumping efficiency of 
the LV, where a shortened TTP indicates a faster ventricular contraction, and vice 
versa. With this in mind, it is noteworthy that all DCM subjects showed a 
significantly increased TTP, regardless of LV status. That is: even though patients 
respond differently to the administered treatment (with some indicating 
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significantly improved cardiac functionality), an underlying conductive deficiency 
seems to prevail. Ventricular conduction delay is commonly reported in DCM 
[417], and has also been shown to be one of the strongest predictors of long-term 
mortality [418]. Our results seem to indicate a remaining, latent conductive 
abnormality masked by the pharmaceutically improved cardiac output, and with 
idiopathic DCM connected to the development of heart failure [419], such 
underlying pathological remains could have detrimental long-term effects even 
when short-term cardiac recovery is observed. 
Further, aortic stiffness directly relates to reservoir aortic function and the 
constitutive properties of the systemic vasculature. From the reported results, 
aortic stiffness was significantly increased in the DCMred group, being in-line with 
previous findings on similar patients [420]. In general, aortic stiffening is a 
commonly described vascular response to cardiac deficiencies, where increasing 
stiffness may help to maintain an effective forward-flow of blood into the 
peripheral circulation. With such, the results again highlight how vascular adaption 
follows on cardiac disease, with aortic assessment potentially complementing 
existing clinical protocols. 
Complementing the functional evaluation above, the correlation analysis indicated 
fairly weak relationships between aortic relative pressure and cardiac structural and 
functional metrics in DCM. This is worth contrasting to the clear differentiation 
observed with the derived aortic metrics. That is: the assessment of relative 
pressure successfully separates DCM patients with different cardiac function, 
however, is not strongly correlated to any conventional metric used to clinically 
assess such patients. Others have also indicated an independent association 
between aortic relative pressure and LV remodelling [421], highlighting relative 
pressure as a complementary and independent biomarker for refined cardiac 
diagnosis. 
To isolate causal factors influencing aortic relative pressure an additional virtual in-
silico cohort was also analysed. Results showed how reservoir aortic stiffness and 
radius were the two dominating factors influencing aortic relative pressure, with 
cardiac properties having a comparably inferior impact. The two however 
counteract in their influence on relative pressure: increasing aortic stiffness 
increases relative pressure, whereas increasing aortic area decreases relative 
pressure. With both stiffness and area increasing in the DCMred group, the net 
decrease in maximum aortic relative pressure might thus not be completely 
clarified by these aortic components. Instead, the reduction could be attributed to 
cardiac changes such as modified contractility [422] or delayed contraction (as 
indicated by the increased TTP), however could just as well indicate a nonlinear 
coupling between individual reservoir factors. Regardless, the combined clinical 
and virtual results suggest that both reservoir and cardiac function is altered in 
DCM. 
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With several aortic hemodynamic factors altered in DCM, and with non-
responding DCMred patients showing different behaviour from responding DCMmod 
patients, Study VII has one interesting clinical indication. Namely, that cardiac 
treatment efficacy might be coupled to vascular adaption abilities. In general, the 
antihypertensive treatment administered to the evaluated cohort has been shown 
to reduce both blood pressure and arterial stiffness [423], being part of a general 
strategy to reduce ventricular load. However, in the non-responding group, poor 
vascular adaption might render an ineffective response, keeping the ventricle in a 
state where excessive work is required to maintain systemic perfusion. Further, 
with sustained hypertension linked to aortic dilation [424], and with area shown to 
decrease relative pressure (from the virtual cohort results), the non-responders will 
experience decreasing acceleration of the ejected blood, despite working harder to 
maintain cardiac output. If further medication is introduced to force a decrease in 
aortic stiffness, a continuous depression in relative pressure will occur, pushing the 
patient down a detrimental pathological remodelling spiral. Thus, through poor 
adaption of the vasculature, the clinical treatment protocol fails to unload the 
heart. Coupling drug efficacy to arterial function is not a new concept [425], 
however our study indicates how a unified look at cardiac, aortic, and system 
function is required to successfully unload and treat pathological cardiac 
conditions. 
To summarise, in Study V-VII a novel method for accurate probing of relative 
pressure was formulated, evaluated, validated, and clinically implemented. Results 
indicate improved estimation accuracy, and the preliminary clinical data in Study 
VII highlights how such refined assessment can aid in our understanding of 
cardiovascular disease. The introduction of refined imaging with enhanced 
diagnostic abilities and associated novel biomarkers is quickly helping clinicians to 
progress from a population-based to a patient-specific diagnostic approach. 
νWERP and νWERP-t are examples of such refined methods, opening up for the 
non-invasive evaluation of relative pressure through previously unexplored and 
inaccessible vasculatures. Its clinical impact remains to be determined, however 
incorporating hemodynamic behaviour into the overall assessment of 
cardiovascular disease is not to be overlooked. 
6.3.  Tomographic reconstruction for pre-clinical imaging 
In Study VIII a multigrid reconstruction approach was presented, with specific 
application examples given for cardiovascular research (reconstructing both an 
endarterectomy ex-vivo plaque as well as a 3D printed CTA model of the thoracic 
vasculature). Conceptually, the approach uses domain splitting and connected 
operator masking to separate regions of different discretisation or regularisation, 
with cross-talk between regions handled through reduction and broadcast 
operators. While the method does not enhance the quality of available single-grid 
reconstructions, it does enable maintained accuracy within a pre-determined ROI 
even when the surrounding background is reconstructed at considerably lower 
quality. As shown, neither multigrid discretisation, regularisation, nor a 
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combination of discretisation and regularisation had any significant effect on ROI 
recovery in the evaluated numerical phantoms. 
In addition to the maintained ROI image quality, a particular advantage of the 
developed multigrid reconstruction method lies in the resulting computational 
speed-up. If utilising a multigrid resolution approach with a coarsely discretised 
background, high-resolution ROI reconstructions can be achieved in less than 10% 
of the time required for a total complete reconstruction. With coarser background 
reconstruction resulting in decreased memory usage and less demanding forward 
and backward projections, the observed speed-up is not surprising, but the 
obtained results do indicate efficient implementation of the proposed multigrid 
approach. Furthermore, the method not only enables computational speed-up, but 
also allows for full-resolution ROI reconstruction in cases where complete full-
resolution reconstructions would be obstructed by sheer data size. As exemplified 
by the utilised micro-CT system, 400 projections acquired at 2400x2400 pixels 
would result in sinogram data of approximately 8.3 GB. Even though physically 
permissible, forward and backward projection of such data would put high 
demands on available computational resources. Instead, the multigrid 
reconstruction approach allows for ROI-reconstruction at full resolution using 
conventional desktop computers. 
It is important to note that the developed multigrid method only handles cases of 
ROI reconstruction in a completely acquired dataset, and that the method does not 
naturally translate into problems of so called local tomography where parts of the 
imaged objected is truncated during acquisition. For such, single-grid 
reconstruction methods have been proposed [426-429], and confusingly the term 
ROI reconstruction has also sometimes been used in this field [426-428]. In theory 
a combination of local tomography and multigrid reconstruction could very well be 
attempted, however was deemed beyond the scope of Study VIII. 
Along the same lines it should also be noted that the presented approach assumes 
a-priori knowledge of the chosen multigrid ROI. That is: ROI positioning is 
provided as an input for the multigrid reconstruction method. Even though 
limiting potential out-of-view incidental findings, there are experimental settings 
where a-priori ROI positioning would be known. Ex-vivo imaging such as the 
endarterectomy sample is one example, and a cardiac ROI could very well be pre-
determined in a thoracic scan. The presented multigrid method could even be 
utilised to generate a hierarchically discretised reconstruction following user-guided 
refinements of ROI positioning, and it should be noted that the presented 
multigrid approach is not limited to a single ROI, but can be expanded into 
multiple, or nested ROIs. Larger scan volume could thus be included in the 
multigrid setting, coarsely reconstructing larger volumes before potential nested 
refinements are introduced in a secondary step. 
In Study VIII, the multigrid approach was presented in isolation and was only 
benchmarked against corresponding single-grid reconstruction results. Other 
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multiresolution reconstruction approaches have been proposed using either 
wavelets [430-432], or by imposing explicit continuity constraints on the boundary 
between ROI and background [433, 434]. In contrast to the presented multigrid 
approach, the boundary handling in [433, 434] might be advantageous in handling 
domain cross-talk, however the effect of imposed boundary conditions on the ROI 
reconstruction remains to be determined.  
To summarise, in Study VIII a multigrid reconstruction approach was developed 
and verified in both a numerical and experimental setting. The method was 
specifically developed for the reconstruction of pre-clinical micro-CT data, where 
multigrid discretisation enables full-resolution ROI reconstructions and where a-
priori ROI positioning is feasible when imaging ex-vivo structures or pre-
determined objects. Work remains to be done in benchmarking against alternative 
approaches, however its usage for pre-clinical cardiovascular research was 
highlighted in Study III, as well as in experimental test results in Study VIII.
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Chapter 7 
 
Future outlook 
 
Even though seemingly endless at the beginning, there is only so much you can do 
in five years of PhD studies. Importantly, the studies of this thesis are not 
providing finalised or completed forms of the presented methods, but are rather 
forming a foundation on which further developments, refinements, and clinical 
investigations can be performed. With such, there are several areas were future 
work can be envisaged and where continued research could lead to a matured 
clinical usage of the presented techniques. 
SWE seems to have potential for improved atherosclerotic plaque characterisation, 
however, as indicated by the results of Study I-IV cardiovascular structures impose 
complex wave propagation response. Detailed technical investigations could thus 
be highly beneficial in understanding observed clinical response. Patient-specific 
modelling has been utilised to study acoustic response in atherosclerotic plaques 
[391-394], and experimental inverse modelling has also been attempted to describe 
mechanical plaque behaviour [399, 435]. Incorporating anisotropic or viscous 
tissue behaviour into such models could shed further light on the complex 
response of atherosclerotic SWE, and coupling pre-clinical data as such from Study 
III with histological validations could also be highly beneficial in deciphering 
defined tissue response. In particular SWE-based attenuation-mapping [436] could 
have specific potential for diagnostic plaque imaging, considering the importance 
of soft-tissue components on predicted plaque vulnerability. 
If staying with the derived outputs of Study IV, the diagnostic abilities of SWE 
group and phase velocity should be studied in larger cohorts in order to clarify 
their clinical implications. Additionally, alternative image acquisition protocols 
should be explored to improve the frequency range over which phase velocities 
can be retrieved, as well as to map the robustness of the evaluated outputs. To this, 
shear wave tracking along tilted vessels or automated ECG triggered pushing could 
also be introduced to overcome potential practical issues related to clinical 
ultrasound elastography. 
Looking ahead with regards to cardiovascular SWE, the transition from 2D to 3D 
imaging poses interesting technical challenges, and even though 3D strain imaging 
has been attempted by others [186, 196, 437] 3D ultrasound elastography plaque 
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imaging remains to be explored. Additionally, translation of SWE into myocardial 
assessment has clear clinical implications, especially considering the constitutive 
myocardial changes observed in heart failure patients [191], or following 
myocardial infarction [438]. Myocardial elastography is under exploration [439-
441], however developments to handle temporal cardiac movements and 
aggravated image quality are still required. 
For cardiovascular flow assessment, νWERP has exciting potential in advancing 
clinical assessments into previously unexplored vasculatures. Study VII showcases 
only one example of where novel hemodynamic assessment improves our 
understanding of cardiovascular disease, but many other application areas could be 
explored. Renal failure has been coupled to hemodynamic alterations [442], 
intraventricular flow and pressure changes seem determining in the long-term 
development of hypertrophic cardiomyopathy [89, 90], and flow disruptions are 
intrinsically coupled to the initiation and development of atherosclerosis [141, 443, 
444]. Using νWERP on cerebrovascular flows, and mapping plaque phenotype to 
hemodynamic environment would be a very exciting method translation, coupling 
the developments in Study V-VII to the clinical question explored in Study I-IV. 
With regards to the practical implementation of νWERP, development work is still 
required to create an automated and clinician-friendly user interface. The necessity 
of full-field data might also be slightly limiting in a clinical setting, wherefore 
translation into 2D flow assessments (as attempted with WERP in [64, 90]) could 
be explored. However, with the added clinical value of 4D flow MRI showcased in 
a number of studies [19, 22, 81, 218, 220, 413] and with 2D/3D Doppler 
ultrasound showing promising potential in preliminary studies [184-186] the 
clinical incorporation of full-field flow measurements could very well be realised in 
the near future. 
The turbulence-driven behaviour in Study VI should also be explored in a clinical 
setting. Firstly, in-vivo validation of the method would be advisable, and secondly, 
specific method behaviour as a function of covariance or mean field quality could 
also be mapped in detail. Furthermore, with incoherent flow associated to a range 
of cardiovascular pathologies, the method could be applied in novel clinical 
settings exploring turbulence-induced pulmonary hypertension, mapping post-
stenotic relative pressure in relation to bicuspid aortic valve disease and thoracic 
aortic aneurysms, or again assessing turbulent energy dissipation around plaque-
prone vasculatures. 
Lastly some methodological features of νWERP could also be further evaluated, 
implementing a temporally changing virtual field (suitable for e.g. intraventricular 
flows where the geometrical domain varies over time), or evaluating the effect of 
different virtual fields or boundary conditions on method accuracy and robustness. 
For the multigrid reconstruction approach, a majority of the evaluation was 
performed on simplified numerical phantoms and further detailed validation in a 
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 clinical setting could be beneficial. The introduced concept of domain splitting 
however opens up for interesting technical advancements, one being multithreaded 
parallelisation where full-field high-resolution reconstructions could be achieved by 
distributed multigrid solvers. Incorporating energy-dependent operators would be 
another possibility, especially if attempting an implementation towards spectral CT.   
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Chapter 8 
 
Conclusion 
 
The eight studies of this thesis have all been conducted with the same endeavour: 
to refine current state cardiovascular image diagnostics, and to improve our ability 
to non-invasively assess cardiovascular disease. The results have shown how non-
invasive ultrasound Shear Wave Elastography (SWE) can be used to accurately 
quantify vascular stiffness as well as to differentiate atherosclerotic plaques of 
varying stiffness or rupture vulnerability. Furthermore, νWERP - a novel method 
for non-invasive relative pressure estimation – has been introduced and validated, 
with abilities spanning beyond state-of-the-art including assessments of turbulent, 
multi-branched, highly complex vasculatures, with a clinical implementation 
performed to highlight arterial changes in cardiac disease. Lastly, a study on pre-
clinical image reconstruction has shown how high-resolution imaging can be 
achieved by effective domain splitting, proving valuable as a complementary tool in 
clinical research. 
Specific conclusions from each of the eight included studies are summarised 
below. 
Study I Geometrical confinement has a significant impact on SWE output 
accuracy. However, using appropriate frequency-based phase 
velocity analysis, accurate quantification of tissue stiffness can be 
achieved as demonstrated on tissue-mimicking arterial phantoms. 
On the contrary, spatiotemporal group velocity analysis with 
assumptions of infinite medium wave propagation systematically 
underestimates tissue stiffness when applied on geometrically 
confined media. 
Study II SWE can be used to differentiate phantom plaques of different 
mechanical stiffness. However this ability seems directly dependent 
on the used wave speed metrics and image specifications, with 
longitudinal imaging using either group or high-frequency (≥1 kHz) 
phase velocity showing superior differentiability. Results also 
indicate that SWE accuracy and plaque differentiability is 
independent of push location. 
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Study III Using combined SWE and micro-CT imaging, changes in ex-vivo 
assessed shear wave group velocity seemed correlated with 
intraplaque composition. Isolated ex-vivo analysis using SWE was 
however aggravated by the irregular geometry and constricted size 
of the isolated plaque. 
Study IV Non-invasive detection of vulnerable carotid plaque lesions can be 
achieved by combined group and phase velocity SWE analysis, as 
indicated by results from a clinical in-vivo cohort. Furthermore, the 
combined approach provides a set of biomarkers correlated to 
vulnerable plaque features, offering a more comprehensive 
mapping of plaque morphology in-clinics. 
Study V Using the concept of virtual work-energy – isolating vascular 
regions by the introduction of a virtual field – the νWERP method 
can be used to accurately estimate cardiovascular relative pressures 
through arbitrary vasculatures. νWERP shows excellent 
performance in complex, patient-specific simulations, and also 
performs satisfactory in a validating in-vivo cohort. 
Study VI By incorporating incoherent turbulent flow fluctuations in the 
theoretical derivation, an extended νWERP-t formulation can be 
utilised to estimate turbulence-driven relative pressures. νWERP-t 
compares favourably against alternative state-of-the-art methods, 
showing excellent accuracy in both in-vitro and in-silico tests. 
Study VII Utilising non-invasive phase-contrast imaging, significant changes 
in aortic hemodynamics were observed in DCM patients. 
Specifically, decreased maximum positive relative pressure, 
increased time-to-peak relative pressure, as well as increased PWV 
and aortic stiffness were all inferred. With a virtual cohort analysis 
isolating arterial stiffness and area to be the determining factors 
influence relative pressure this signals a defined role of the arterial 
side even in cardiac disease, acting as a complement to 
conventional cardiac biomarkers and potentially linking vascular 
adaption to cardiac treatment efficacy. 
Study VIII Using domain splitting and corresponding operator masking, 
tomographic multigrid image reconstruction can be achieved with 
both numerical and experimental tests indicating a significant 
computational speed-up compared to conventional full-resolution 
methods. Importantly, the proposed multigrid approach even 
allows for full-system high-resolution ROI reconstructions in cases 
where complete high-resolution reconstructions are complicated by 
sheer data size – as shown in a pre-clinical micro-CT system. 
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